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 The Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008, presents evidence-
based recommendations on the preferred methods for cleaning, disinfection and sterilization of patient-
care medical devices and for cleaning and disinfecting the healthcare environment. This document 
supercedes the relevant sections contained in the 1985 Centers for Disease Control (CDC) Guideline for 
Handwashing and Environmental Control. 1 Because maximum effectiveness from disinfection and 
sterilization results from first cleaning and removing organic and inorganic materials, this document also 
reviews cleaning methods. The chemical disinfectants discussed for patient-care equipment include 
alcohols, glutaraldehyde, formaldehyde, hydrogen peroxide, iodophors, ortho-phthalaldehyde, peracetic 
acid, phenolics, quaternary ammonium compounds, and chlorine. The choice of disinfectant, 
concentration, and exposure time is based on the risk for infection associated with use of the equipment 
and other factors discussed in this guideline. The sterilization methods discussed include steam 
sterilization, ethylene oxide (ETO), hydrogen peroxide gas plasma, and liquid peracetic acid. When 
properly used, these cleaning, disinfection, and sterilization processes can reduce the risk for infection 
associated with use of invasive and noninvasive medical and surgical devices. However, for these 
processes to be effective, health-care workers should adhere strictly to the cleaning, disinfection, and 
sterilization recommendations in this document and to instructions on product labels. 
 
 In addition to updated recommendations, new topics addressed in this guideline include  
1. inactivation of antibiotic-resistant bacteria, bioterrorist agents, emerging pathogens, and 
bloodborne pathogens;  
2. toxicologic, environmental, and occupational concerns associated with disinfection and 
sterilization practices;  
3. disinfection of patient-care equipment used in ambulatory settings and home care;  
4. new sterilization processes, such as hydrogen peroxide gas plasma and liquid peracetic acid; and  
5. disinfection of complex medical instruments (e.g., endoscopes). 
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 In the United States, approximately 46.5 million surgical procedures and even more invasive medical 
procedures—including approximately 5 million gastrointestinal endoscopies—are performed each year. 2 
Each procedure involves contact by a medical device or surgical instrument with a patient’s sterile tissue 
or mucous membranes. A major risk of all such procedures is the introduction of pathogens that can lead 
to infection. Failure to properly disinfect or sterilize equipment carries not only risk associated with breach 
of host barriers but also risk for person-to-person transmission (e.g., hepatitis B virus) and transmission of 
environmental pathogens (e.g., Pseudomonas aeruginosa). 
 
 Disinfection and sterilization are essential for ensuring that medical and surgical instruments do not 
transmit infectious pathogens to patients. Because sterilization of all patient-care items is not necessary, 
health-care policies must identify, primarily on the basis of the items' intended use, whether cleaning, 
disinfection, or sterilization is indicated. 
 
 Multiple studies in many countries have documented lack of compliance with established guidelines 
for disinfection and sterilization. 3-6 Failure to comply with scientifically-based guidelines has led to 
numerous outbreaks. 6-12 This guideline presents a pragmatic approach to the judicious selection and 
proper use of disinfection and sterilization processes; the approach is based on well-designed studies 
assessing the efficacy (through laboratory investigations) and effectiveness (through clinical studies) of 




 This guideline resulted from a review of all MEDLINE articles in English listed under the MeSH 
headings of disinfection or sterilization (focusing on health-care equipment and supplies) from January 
1980 through August 2006. References listed in these articles also were reviewed. Selected articles 
published before 1980 were reviewed and, if still relevant, included in the guideline. The three major peer-
reviewed journals in infection control—American Journal of Infection Control, Infection Control and 
Hospital Epidemiology, and Journal of Hospital Infection—were searched for relevant articles published 
from January 1990 through August 2006. Abstracts presented at the annual meetings of the Society for 
Healthcare Epidemiology of America and Association for professionals in Infection Control and 
Epidemiology, Inc. during 1997–2006 also were reviewed; however, abstracts were not used to support 
the recommendations. 
 
Definition of Terms 
 
 Sterilization describes a process that destroys or eliminates all forms of microbial life and is carried 
out in health-care facilities by physical or chemical methods. Steam under pressure, dry heat, EtO gas, 
hydrogen peroxide gas plasma, and liquid chemicals are the principal sterilizing agents used in health-
care facilities. Sterilization is intended to convey an absolute meaning; unfortunately, however, some 
health professionals and the technical and commercial literature refer to “disinfection” as “sterilization” 
and items as “partially sterile.” When chemicals are used to destroy all forms of microbiologic life, they 
can be called chemical sterilants. These same germicides used for shorter exposure periods also can be 
part of the disinfection process (i.e., high-level disinfection). 
 
 Disinfection describes a process that eliminates many or all pathogenic microorganisms, except 
bacterial spores, on inanimate objects (Tables 1 and 2). In health-care settings, objects usually are 
disinfected by liquid chemicals or wet pasteurization. Each of the various factors that affect the efficacy of 
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disinfection can nullify or limit the efficacy of the process. 
 
 Factors that affect the efficacy of both disinfection and sterilization include prior cleaning of the object; 
organic and inorganic load present; type and level of microbial contamination; concentration of and 
exposure time to the germicide; physical nature of the object (e.g., crevices, hinges, and lumens); 
presence of biofilms; temperature and pH of the disinfection process; and in some cases, relative 
humidity of the sterilization process (e.g., ethylene oxide). 
 
 Unlike sterilization, disinfection is not sporicidal. A few disinfectants will kill spores with prolonged 
exposure times (3–12 hours); these are called chemical sterilants. At similar concentrations but with 
shorter exposure periods (e.g., 20 minutes for 2% glutaraldehyde), these same disinfectants will kill all 
microorganisms except large numbers of bacterial spores; they are called high-level disinfectants. Low-
level disinfectants can kill most vegetative bacteria, some fungi, and some viruses in a practical period of 
time (≤10 minutes). Intermediate-level disinfectants might be cidal for mycobacteria, vegetative bacteria, 
most viruses, and most fungi but do not necessarily kill bacterial spores. Germicides differ markedly, 
primarily in their antimicrobial spectrum and rapidity of action. 
 
 Cleaning is the removal of visible soil (e.g., organic and inorganic material) from objects and surfaces 
and normally is accomplished manually or mechanically using water with detergents or enzymatic 
products. Thorough cleaning is essential before high-level disinfection and sterilization because inorganic 
and organic materials that remain on the surfaces of instruments interfere with the effectiveness of these 
processes. Decontamination removes pathogenic microorganisms from objects so they are safe to 
handle, use, or discard. 
 
 Terms with the suffix cide or cidal for killing action also are commonly used. For example, a germicide is 
an agent that can kill microorganisms, particularly pathogenic organisms (“germs”). The term germicide 
includes both antiseptics and disinfectants. Antiseptics are germicides applied to living tissue and skin; 
disinfectants are antimicrobials applied only to inanimate objects. In general, antiseptics are used only on 
the skin and not for surface disinfection, and disinfectants are not used for skin antisepsis because they can 
injure skin and other tissues. Virucide, fungicide, bactericide, sporicide, and tuberculocide can kill the type of 
microorganism identified by the prefix. For example, a bactericide is an agent that kills bacteria. 13-18 
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A Rational Approach to Disinfection and Sterilization 
 
 More than 30 years ago, Earle H. Spaulding devised a rational approach to disinfection and 
sterilization of patient-care items and equipment.14 This classification scheme is so clear and logical that it 
has been retained, refined, and successfully used by infection control professionals and others when 
planning methods for disinfection or sterilization. 1, 13, 15, 17, 19, 20 Spaulding believed the nature of 
disinfection could be understood readily if instruments and items for patient care were categorized as 
critical, semicritical, and noncritical according to the degree of risk for infection involved in use of the 
items. The CDC Guideline for Handwashing and Hospital Environmental Control 21, Guidelines for the 
Prevention of Transmission of Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) to 
Health-Care and Public-Safety Workers22, and Guideline for Environmental Infection Control in Health-




 Critical items confer a high risk for infection if they are contaminated with any microorganism. Thus, 
objects that enter sterile tissue or the vascular system must be sterile because any microbial 
contamination could transmit disease. This category includes surgical instruments, cardiac and urinary 
catheters, implants, and ultrasound probes used in sterile body cavities. Most of the items in this category 
should be purchased as sterile or be sterilized with steam if possible. Heat-sensitive objects can be 
treated with EtO, hydrogen peroxide gas plasma; or if other methods are unsuitable, by liquid chemical 
sterilants. Germicides categorized as chemical sterilants include ≥2.4% glutaraldehyde-based 
formulations, 0.95% glutaraldehyde with 1.64% phenol/phenate, 7.5% stabilized hydrogen peroxide, 
7.35% hydrogen peroxide with 0.23% peracetic acid, 0.2% peracetic acid, and 0.08% peracetic acid with 
1.0% hydrogen peroxide. Liquid chemical sterilants reliably produce sterility only if cleaning precedes 





 Semicritical items contact mucous membranes or nonintact skin. This category includes respiratory 
therapy and anesthesia equipment, some endoscopes, laryngoscope blades 24, esophageal manometry 
probes, cystoscopes 25, anorectal manometry catheters, and diaphragm fitting rings. These medical 
devices should be free from all microorganisms; however, small numbers of bacterial spores are 
permissible. Intact mucous membranes, such as those of the lungs and the gastrointestinal tract, 
generally are resistant to infection by common bacterial spores but susceptible to other organisms, such 
as bacteria, mycobacteria, and viruses. Semicritical items minimally require high-level disinfection using 
chemical disinfectants. Glutaraldehyde, hydrogen peroxide, ortho-phthalaldehyde, and peracetic acid with 
hydrogen peroxide are cleared by the Food and Drug Administration (FDA) and are dependable high-
level disinfectants provided the factors influencing germicidal procedures are met (Table 1). When a 
disinfectant is selected for use with certain patient-care items, the chemical compatibility after extended 
use with the items to be disinfected also must be considered. 
 
 High-level disinfection traditionally is defined as complete elimination of all microorganisms in or on 
an instrument, except for small numbers of bacterial spores. The FDA definition of high-level disinfection 
is a sterilant used for a shorter contact time to achieve a 6-log10 kill of an appropriate Mycobacterium 
species. Cleaning followed by high-level disinfection should eliminate enough pathogens to prevent 
transmission of infection. 26, 27 
 
 Laparoscopes and arthroscopes entering sterile tissue ideally should be sterilized between patients. 
However, in the United States, this equipment sometimes undergoes only high-level disinfection between 
patients. 28-30 As with flexible endoscopes, these devices can be difficult to clean and high-level disinfect 
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or sterilize because of intricate device design (e.g., long narrow lumens, hinges). Meticulous cleaning 
must precede any high-level disinfection or sterilization process. Although sterilization is preferred, no 
reports have been published of outbreaks resulting from high-level disinfection of these scopes when they 
are properly cleaned and high-level disinfected. Newer models of these instruments can withstand steam 
sterilization that for critical items would be preferable to high-level disinfection. 
 
 Rinsing endoscopes and flushing channels with sterile water, filtered water, or tap water will prevent 
adverse effects associated with disinfectant retained in the endoscope (e.g., disinfectant-induced colitis). 
Items can be rinsed and flushed using sterile water after high-level disinfection to prevent contamination 
with organisms in tap water, such as nontuberculous mycobacteria, 10, 31, 32 Legionella, 33-35 or gram-
negative bacilli such as Pseudomonas. 1, 17, 36-38 Alternatively, a tapwater or filtered water (0.2µ filter) 
rinse should be followed by an alcohol rinse and forced air drying. 28, 38-40 Forced-air drying markedly 
reduces bacterial contamination of stored endoscopes, most likely by removing the wet environment 
favorable for bacterial growth. 39 After rinsing, items should be dried and stored (e.g., packaged) in a 
manner that protects them from recontamination.  
 
 Some items that may come in contact with nonintact skin for a brief period of time (i.e., hydrotherapy 
tanks, bed side rails) are usually considered noncritical surfaces and are disinfected with intermediate-
level disinfectants (i.e., phenolic, iodophor, alcohol, chlorine) 23. Since hydrotherapy tanks have been 
associated with spread of infection, some facilities have chosen to disinfect them with recommended 
levels of chlorine 23, 41. 
 
 In the past, high-level disinfection was recommended for mouthpieces and spirometry tubing (e.g., 
glutaraldehyde) but cleaning the interior surfaces of the spirometers was considered unnecessary. 42 
This was based on a study that showed that mouthpieces and spirometry tubing become contaminated 
with microorganisms but there was no bacterial contamination of the surfaces inside the spirometers. 
Filters have been used to prevent contamination of this equipment distal to the filter; such filters and the 




Noncritical items are those that come in contact with intact skin but not mucous membranes. Intact 
skin acts as an effective barrier to most microorganisms; therefore, the sterility of items coming in 
contact with intact skin is "not critical." In this guideline, noncritical items are divided into noncritical 
patient care items and noncritical environmental surfaces 43, 44. Examples of noncritical patient-care 
items are bedpans, blood pressure cuffs, crutches and computers 45. In contrast to critical and some 
semicritical items, most noncritical reusable items may be decontaminated where they are used and do 
not need to be transported to a central processing area. Virtually no risk has been documented for 
transmission of infectious agents to patients through noncritical items 37 when they are used as 
noncritical items and do not contact non-intact skin and/or mucous membranes. Table 1 lists several 
low-level disinfectants that may be used for noncritical items. Most Environmental Protection Agency 
(EPA)-registered disinfectants have a 10-minute label claim. However, multiple investigators have 
demonstrated the effectiveness of these disinfectants against vegetative bacteria (e.g., Listeria, 
Escherichia coli, Salmonella, vancomycin-resistant Enterococci, methicillin-resistant Staphylococcus 
aureus), yeasts (e.g., Candida), mycobacteria (e.g., Mycobacterium tuberculosis), and viruses (e.g. 
poliovirus) at exposure times of 30–60 seconds46-64 Federal law requires all applicable label instructions 
on EPA-registered products to be followed (e.g., use-dilution, shelf life, storage, material compatibility, 
safe use, and disposal). If the user selects exposure conditions (e.g., exposure time) that differ from 
those on the EPA-registered products label, the user assumes liability for any injuries resulting from off-
label use and is potentially subject to enforcement action under Federal Insecticide, Fungicide, and 
Rodenticide Act (FIFRA) 65. 
 
 Noncritcal environmental surfaces include bed rails, some food utensils, bedside tables, patient 
furniture and floors. Noncritical environmental surfaces frequently touched by hand (e.g., bedside tables, 
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bed rails) potentially could contribute to secondary transmission by contaminating hands of health-care 
workers or by contacting medical equipment that subsequently contacts patients 13, 46-48, 51, 66, 67. Mops and 
reusable cleaning cloths are regularly used to achieve low-level disinfection on environmental surfaces. 
However, they often are not adequately cleaned and disinfected, and if the water-disinfectant mixture is 
not changed regularly (e.g., after every three to four rooms, at no longer than 60-minute intervals), the 
mopping procedure actually can spread heavy microbial contamination throughout the health-care facility 
68. In one study, standard laundering provided acceptable decontamination of heavily contaminated 
mopheads but chemical disinfection with a phenolic was less effective. 68 Frequent laundering of mops 
(e.g., daily), therefore, is recommended. Single-use disposable towels impregnated with a disinfectant 
also can be used for low-level disinfection when spot-cleaning of noncritical surfaces is needed45. 
 
 
Changes in Disinfection and Sterilization Since 1981  
 The Table in the CDC Guideline for Environmental Control prepared in 1981 as a guide to the 
appropriate selection and use of disinfectants has undergone several important changes (Table 1).15 
First, formaldehyde-alcohol has been deleted as a recommended chemical sterilant or high-level 
disinfectant because it is irritating and toxic and not commonly used. Second, several new chemical 
sterilants have been added, including hydrogen peroxide, peracetic acid 58, 69, 70, and peracetic acid and 
hydrogen peroxide in combination. Third, 3% phenolics and iodophors have been deleted as high-level 
disinfectants because of their unproven efficacy against bacterial spores, M. tuberculosis, and/or some 
fungi. 55, 71 Fourth, isopropyl alcohol and ethyl alcohol have been excluded as high-level disinfectants 15 
because of their inability to inactivate bacterial spores and because of the inability of isopropyl alcohol to 
inactivate hydrophilic viruses (i.e., poliovirus, coxsackie virus).72 Fifth, a 1:16 dilution of 2.0% 
glutaraldehyde-7.05% phenol-1.20% sodium phenate (which contained 0.125% glutaraldehyde, 0.440% 
phenol, and 0.075% sodium phenate when diluted) has been deleted as a high-level disinfectant because 
this product was removed from the marketplace in December 1991 because of a lack of bactericidal 
activity in the presence of organic matter; a lack of fungicidal, tuberculocidal and sporicidal activity; and 
reduced virucidal activity.49, 55, 56, 71, 73-79 Sixth, the exposure time required to achieve high-level 
disinfection has been changed from 10-30 minutes to 12 minutes or more depending on the FDA-cleared 
label claim and the scientific literature. 27, 55, 69, 76, 80-84 A glutaraldehyde and an ortho-phthalaldehyde have 
an FDA-cleared label claim of 5 minutes when used at 35°C and 25°C, respectively, in an automated 
endoscope reprocessor with FDA-cleared capability to maintain the solution at the appropriate 
temperature. 85 
 
 In addition, many new subjects have been added to the guideline. These include inactivation of 
emerging pathogens, bioterrorist agents, and bloodborne pathogens; toxicologic, environmental, and 
occupational concerns associated with disinfection and sterilization practices; disinfection of patient-care 
equipment used in ambulatory and home care; inactivation of antibiotic-resistant bacteria; new 
sterilization processes, such as hydrogen peroxide gas plasma and liquid peracetic acid; and disinfection 
of complex medical instruments (e.g., endoscopes). 
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Disinfection of Healthcare Equipment 
 
Concerns about Implementing the Spaulding Scheme 
 One problem with implementing the aforementioned scheme is oversimplification. For example, the 
scheme does not consider problems with reprocessing of complicated medical equipment that often is 
heat-sensitive or problems of inactivating certain types of infectious agents (e.g., prions, such as 
Creutzfeldt-Jakob disease [CJD] agent). Thus, in some situations, choosing a method of disinfection 
remains difficult, even after consideration of the categories of risk to patients. This is true particularly for a 
few medical devices (e.g., arthroscopes, laparoscopes) in the critical category because of controversy 
about whether they should be sterilized or high-level disinfected. 28, 86 Heat-stable scopes (e.g., many rigid 
scopes) should be steam sterilized. Some of these items cannot be steam sterilized because they are 
heat-sensitive; additionally, sterilization using ethylene oxide (EtO) can be too time-consuming for routine 
use between patients (new technologies, such as hydrogen peroxide gas plasma and peracetic acid 
reprocessor, provide faster cycle times). However, evidence that sterilization of these items improves 
patient care by reducing the infection risk is lacking29, 87-91. Many newer models of these instruments can 
withstand steam sterilization, which for critical items is the preferred method. 
 
 Another problem with implementing the Spaulding scheme is processing of an instrument in the 
semicritical category (e.g., endoscope) that would be used in conjunction with a critical instrument that 
contacts sterile body tissues. For example, is an endoscope used for upper gastrointestinal tract 
investigation still a semicritical item when used with sterile biopsy forceps or in a patient who is bleeding 
heavily from esophageal varices? Provided that high-level disinfection is achieved, and all microorganisms 
except bacterial spores have been removed from the endoscope, the device should not represent an 
infection risk and should remain in the semicritical category 92-94 . Infection with spore-forming bacteria has 
not been reported from appropriately high-level disinfected endoscopes. 
 
 An additional problem with implementation of the Spaulding system is that the optimal contact time for 
high-level disinfection has not been defined or varies among professional organizations, resulting in 
different strategies for disinfecting different types of semicritical items (e.g., endoscopes, applanation 
tonometers, endocavitary transducers, cryosurgical instruments, and diaphragm fitting rings). Until simpler 
and effective alternatives are identified for device disinfection in clinical settings, following this guideline, 
other CDC guidelines 1, 22, 95, 96 and FDA-cleared instructions for the liquid chemical sterilants/high-level 
disinfectants would be prudent. 
 
 
Reprocessing of Endoscopes 
 Physicians use endoscopes to diagnose and treat numerous medical disorders. Even though 
endoscopes represent a valuable diagnostic and therapeutic tool in modern medicine and the incidence of 
infection associated with their use reportedly is very low (about 1 in 1.8 million procedures) 97, more 
healthcare–associated outbreaks have been linked to contaminated endoscopes than to any other medical 
device 6-8, 12, 98. To prevent the spread of health-care–associated infections, all heat-sensitive endoscopes 
(e.g., gastrointestinal endoscopes, bronchoscopes, nasopharygoscopes) must be properly cleaned and, at 
a minimum, subjected to high-level disinfection after each use. High-level disinfection can be expected to 
destroy all microorganisms, although when high numbers of bacterial spores are present, a few spores 
might survive. 
 
 Because of the types of body cavities they enter, flexible endoscopes acquire high levels of microbial 
contamination (bioburden) during each use 99. For example, the bioburden found on flexible 
gastrointestinal endoscopes after use has ranged from 105 colony forming units (CFU)/mL to 1010 CFU/mL, 
with the highest levels found in the suction channels 99-102. The average load on bronchoscopes before 
cleaning was 6.4x104 CFU/mL. Cleaning reduces the level of microbial contamination by 4–6 log10 83, 103. 
Using human immunovirus (HIV)-contaminated endoscopes, several investigators have shown that 
cleaning completely eliminates the microbial contamination on the scopes 104, 105. Similarly, other 
investigators found that EtO sterilization or soaking in 2% glutaraldehyde for 20 minutes was effective only 
when the device first was properly cleaned 106. 
Guideline for Disinfection and Sterilization in Healthcare Facilities (2008) 
 
Last update: Feburary 15, 2017 14 of 161 
  
 
FDA maintains a list of cleared liquid chemical sterilants and high-level disinfectants that can be used to 
reprocess heat-sensitive medical devices, such as flexible endoscopes [This link is no longer active: 
http://www.fda.gov/cdrh/ode/germlab.html. The current version of this document may differ from original 
version:FDA-Cleared Sterilants and High Level Disinfectants with General Claims for Processing Reusable 
Medical and Dental Devices - March 2015] 
(http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ReprocessingofReusableMedicalDevi
ces/ucm437347.htm). At this time, the FDA-cleared and marketed formulations include: ≥2.4% 
glutaraldehyde, 0.55% ortho-phthalaldehyde (OPA), 0.95% glutaraldehyde with 1.64% phenol/phenate, 
7.35% hydrogen peroxide with 0.23% peracetic acid, 1.0% hydrogen peroxide with 0.08% peracetic acid, 
and 7.5% hydrogen peroxide 85. These products have excellent antimicrobial activity; however, some 
oxidizing chemicals (e.g., 7.5% hydrogen peroxide, and 1.0% hydrogen peroxide with 0.08% peracetic acid 
[latter product is no longer marketed]) reportedly have caused cosmetic and functional damage to 
endoscopes 69. Users should check with device manufacturers for information about germicide 
compatibility with their device. If the germicide is FDA-cleared, then it is safe when used according to label 
directions; however, professionals should review the scientific literature for newly available data regarding 
human safety or materials compatibility. EtO sterilization of flexible endoscopes is infrequent because it 
requires a lengthy processing and aeration time (e.g., 12 hours) and is a potential hazard to staff and 
patients. The two products most commonly used for reprocessing endoscopes in the United States are 
glutaraldehyde and an automated, liquid chemical sterilization process that uses peracetic acid 107. The 
American Society for Gastrointestinal Endoscopy (ASGE) recommends glutaraldehyde solutions that do 
not contain surfactants because the soapy residues of surfactants are difficult to remove during rinsing 108. 
ortho-phthalaldehyde has begun to replace glutaraldehyde in many health-care facilities because it has 
several potential advantages over glutaraldehyde: is not known to irritate the eyes and nasal passages, 
does not require activation or exposure monitoring, and has a 12-minute high-level disinfection claim in the 
United States 69. Disinfectants that are not FDA-cleared and should not be used for reprocessing 
endoscopes include iodophors, chlorine solutions, alcohols, quaternary ammonium compounds, and 
phenolics. These solutions might still be in use outside the United States, but their use should be strongly 
discouraged because of lack of proven efficacy against all microorganisms or materials incompatibility. 
 
 FDA clearance of the contact conditions listed on germicide labeling is based on the manufacturer’s 
test results [This link is no longer active: http://www.fda.gov/cdrh/ode/germlab.html. The current version of 
this document may differ from original version:FDA-Cleared Sterilants and High Level Disinfectants with 
General Claims for Processing Reusable Medical and Dental Devices - March 2015 
(http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ReprocessingofReusableMedicalDevi
ces/ucm437347.htm)]. Manufacturers test the product under worst-case conditions for germicide 
formulation (i.e., minimum recommended concentration of the active ingredient), and include organic soil. 
Typically manufacturers use 5% serum as the organic soil and hard water as examples of organic and 
inorganic challenges. The soil represents the organic loading to which the device is exposed during actual 
use and that would remain on the device in the absence of cleaning. This method ensures that the contact 
conditions completely eliminate the test mycobacteria (e.g., 105 to 106 Mycobacteria tuberculosis in organic 
soil and dried on a scope) if inoculated in the most difficult areas for the disinfectant to penetrate and 
contact in the absence of cleaning and thus provides a margin of safety 109. For 2.4% glutaraldehyde that 
requires a 45-minute immersion at 25ºC to achieve high-level disinfection (i.e., 100% kill of M. 
tuberculosis). FDA itself does not conduct testing but relies solely on the disinfectant manufacturer’s data. 
Data suggest that M. tuberculosis levels can be reduced by at least 8 log10 with cleaning (4 log10) 83, 101, 102, 
110, followed by chemical disinfection for 20 minutes at 20°C (4 to 6 log10) 83, 93, 111, 112. On the basis of these 
data, APIC 113, the Society of Gastroenterology Nurses and Associates (SGNA) 38, 114, 115, the ASGE 108, 
American College of Chest Physicians 12, and a multi-society guideline 116 recommend alternative contact 
conditions with 2% glutaraldehyde to achieve high-level disinfection (e.g., that equipment be immersed in 
2% glutaraldehyde at 20°C for at least 20 minutes for high-level disinfection). Federal regulations are to 
follow the FDA-cleared label claim for high-level disinfectants. The FDA-cleared labels for high-level 
disinfection with >2% glutaraldehyde at 25°C range from 20-90 minutes, depending upon the product 
based on three tier testing which includes AOAC sporicidal tests, simulated use testing with mycobacterial 
and in-use testing. The studies supporting the efficacy of >2% glutaraldehyde for 20 minutes at 20ºC 
assume adequate cleaning prior to disinfection, whereas the FDA-cleared label claim incorporates an 
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added margin of safety to accommodate possible lapses in cleaning practices. Facilities that have chosen 
to apply the 20 minute duration at 20ºC have done so based on the IA recommendation in the July 2003 
SHEA position paper, “Multi-society Guideline for Reprocessing Flexible Gastrointestinal Endoscopes”19, 57, 
83, 94, 108, 111, 116-121.  
 Flexible GI Endoscope Reprocessing Update [June 2011]: Multisociety guideline on reprocessing 




 Flexible endoscopes are particularly difficult to disinfect 122 and easy to damage because of their 
intricate design and delicate materials. 123 Meticulous cleaning must precede any sterilization or high-level 
disinfection of these instruments. Failure to perform good cleaning can result in sterilization or disinfection 
failure, and outbreaks of infection can occur. Several studies have demonstrated the importance of 
cleaning in experimental studies with the duck hepatitis B virus (HBV) 106, 124, HIV 125and Helicobacter 
pylori. 126  
 
 An examination of health-care–associated infections related only to endoscopes through July 1992 
found 281 infections transmitted by gastrointestinal endoscopy and 96 transmitted by bronchoscopy. The 
clinical spectrum ranged from asymptomatic colonization to death. Salmonella species and Pseudomonas 
aeruginosa repeatedly were identified as causative agents of infections transmitted by gastrointestinal 
endoscopy, and M. tuberculosis, atypical mycobacteria, and P. aeruginosa were the most common causes 
of infections transmitted by bronchoscopy 12. Major reasons for transmission were inadequate cleaning, 
improper selection of a disinfecting agent, and failure to follow recommended cleaning and disinfection 
procedures 6, 8, 37, 98, and flaws in endoscope design 127, 128 or automated endoscope reprocessors. 7, 98 
Failure to follow established guidelines has continued to result in infections associated with gastrointestinal 
endoscopes 8 and bronchoscopes 7, 12. Potential device-associated problems should be reported to the 
FDA Center for Devices and Radiologic Health. One multistate investigation found that 23.9% of the 
bacterial cultures from the internal channels of 71 gastrointestinal endoscopes grew ≥100,000 colonies of 
bacteria after completion of all disinfection and sterilization procedures (nine of 25 facilities were using a 
product that has been removed from the marketplace [six facilities using 1:16 glutaraldehyde phenate], is 
not FDA-cleared as a high-level disinfectant [an iodophor] or no disinfecting agent) and before use on the 
next patient129. The incidence of postendoscopic procedure infections from an improperly processed 
endoscope has not been rigorously assessed. 
 
 Automated endoscope reprocessors (AER) offer several advantages over manual reprocessing: they 
automate and standardize several important reprocessing steps130-132, reduce the likelihood that an 
essential reprocessing step will be skipped, and reduce personnel exposure to high-level disinfectants or 
chemical sterilants. Failure of AERs has been linked to outbreaks of infections 133 or colonization 7, 134, and 
the AER water filtration system might not be able to reliably provide “sterile” or bacteria-free rinse water135, 
136. Establishment of correct connectors between the AER and the device is critical to ensure complete 
flow of disinfectants and rinse water 7, 137. In addition, some endoscopes such as the duodenoscopes (e.g., 
endoscopic retrograde cholangiopancreatography [ERCP]) contain features (e.g., elevator-wire channel) 
that require a flushing pressure that is not achieved by most AERs and must be reprocessed manually 
using a 2- to 5-mL syringe, until new duodenoscopes equipped with a wider elevator-channel that AERs 
can reliably reprocess become available 132. Outbreaks involving removable endoscope parts 138, 139 such 
as suction valves and endoscopic accessories designed to be inserted through flexible endoscopes such 
as biopsy forceps emphasize the importance of cleaning to remove all foreign matter before high-level 
disinfection or sterilization. 140 Some types of valves are now available as single-use, disposable products 
(e.g., bronchoscope valves) or steam sterilizable products (e.g., gastrointestinal endoscope valves). 
 
 AERs need further development and redesign 7, 141, as do endoscopes 123, 142, so that they do not 
represent a potential source of infectious agents. Endoscopes employing disposable components (e.g., 
protective barrier devices or sheaths) might provide an alternative to conventional liquid chemical high-
level disinfection/sterilization143, 144. Another new technology is a swallowable camera-in-a-capsule that 
travels through the digestive tract and transmits color pictures of the small intestine to a receiver worn 
outside the body. This capsule currently does not replace colonoscopies. 
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 Published recommendations for cleaning and disinfecting endoscopic equipment should be strictly 
followed 12, 38, 108, 113-116, 145-148. Unfortunately, audits have shown that personnel do not consistently adhere 
to guidelines on reprocessing 149-151 and outbreaks of infection continue to occur. 152-154 To ensure 
reprocessing personnel are properly trained, each person who reprocesses endoscopic instruments should 
receive initial and annual competency testing 38, 155. 
 
 In general, endoscope disinfection or sterilization with a liquid chemical sterilant involves five steps 
after leak testing: 
 
1. Clean: mechanically clean internal and external surfaces, including brushing internal channels and 
flushing each internal channel with water and a detergent or enzymatic cleaners (leak testing is 
recommended for endoscopes before immersion). 
2. Disinfect: immerse endoscope in high-level disinfectant (or chemical sterilant) and perfuse 
(eliminates air pockets and ensures contact of the germicide with the internal channels) 
disinfectant into all accessible channels, such as the suction/biopsy channel and air/water channel 
and expose for a time recommended for specific products. 
3. Rinse: rinse the endoscope and all channels with sterile water, filtered water (commonly used with 
AERs) or tap water (i.e., high-quality potable water that meets federal clean water standards at the 
point of use). 
4. Dry: rinse the insertion tube and inner channels with alcohol, and dry with forced air after 
disinfection and before storage. 
5. Store: store the endoscope in a way that prevents recontamination and promotes drying (e.g., 
hung vertically).  
Drying the endoscope (steps 3 and 4) is essential to greatly reduce the chance of recontamination of the 
endoscope by microorganisms that can be present in the rinse water 116, 156. One study demonstrated that 
reprocessed endoscopes (i.e., air/water channel, suction/biopsy channel) generally were negative (100% 
after 24 hours; 90% after 7 days [1 CFU of coagulase-negative Staphylococcus in one channel]) for 
bacterial growth when stored by hanging vertically in a ventilated cabinet157. Other investigators found all 
endoscopes were bacteria-free immediately after high-level disinfection, and only four of 135 scopes were 
positive during the subsequent 5-day assessment (skin bacteria cultured from endoscope surfaces). All 
flush-through samples remained sterile 158. Because tapwater can contain low levels of microorganisms159, 
some researchers have suggested that only sterile water (which can be prohibitively expensive) 160 or AER 
filtered water be used. The suggestion to use only sterile water or filtered water is not consistent with 
published guidelines that allow tapwater with an alcohol rinse and forced air-drying 38, 108, 113 or the 
scientific literature. 39, 93 In addition, no evidence of disease transmission has been found when a tap water 
rinse is followed by an alcohol rinse and forced-air drying. AERs produce filtered water by passage through 
a bacterial filter (e.g., 0.2 µ). Filtered rinse water was identified as a source of bacterial contamination in a 
study that cultured the accessory and suction channels of endoscopes and the internal chambers of AERs 
during 1996–2001 and reported 8.7% of samples collected during 1996–1998 had bacterial growth, with 
54% being Pseudomonas species. After a system of hot water flushing of the piping (60ºC for 60 minutes 
daily) was introduced, the frequency of positive cultures fell to approximately 2% with only rare isolation of 
>10 CFU/mL 161. In addition to the endoscope reprocessing steps, a protocol should be developed that 
ensures the user knows whether an endoscope has been appropriately cleaned and disinfected (e.g., 
using a room or cabinet for processed endoscopes only) or has not been reprocessed. When users leave 
endoscopes on movable carts, confusion can result about whether the endoscope has been processed. 
Although one guideline recommended endoscopes (e.g., duodenoscopes) be reprocessed immediately 
before use 147, other guidelines do not require this activity 38, 108, 115 and except for the Association of 
periOperative Registered Nurses (AORN), professional organizations do not recommended that 
reprocessing be repeated as long as the original processing is done correctly. As part of a quality 
assurance program, healthcare facility personnel can consider random bacterial surveillance cultures of 
processed endoscopes to ensure high-level disinfection or sterilization7, 162-164 . Reprocessed endoscopes 
should be free of microbial pathogens except for small numbers of relatively avirulent microbes that 
represent exogenous environmental contamination (e.g., coagulase-negative Staphylococcus, Bacillus 
species, diphtheroids). Although recommendations exist for the final rinse water used during endoscope 
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reprocessing to be microbiologically cultured at least monthly 165, a microbiologic standard has not been 
set, and the value of routine endoscope cultures has not been shown 166. In addition, neither the routine 
culture of reprocessed endoscopes nor the final rinse water has been validated by correlating viable 
counts on an endoscope to infection after an endoscopic procedure. If reprocessed endoscopes were 
cultured, sampling the endoscope would assess water quality and other important steps (e.g., disinfectant 
effectiveness, exposure time, cleaning) in the reprocessing procedure. A number of methods for sampling 
endoscopes and water have been described 23, 157, 161, 163, 167, 168. Novel approaches (e.g., detection of 
adenosine triphosphate [ATP]) to evaluate the effectiveness of endoscope cleaning 169, 170 or endoscope 
reprocessing 171 also have been evaluated, but no method has been established as a standard for 
assessing the outcome of endoscope reprocessing. 
 
 The carrying case used to transport clean and reprocessed endoscopes outside the health-care 
environment should not be used to store an endoscope or to transport the instrument within the health-
care facility. A contaminated endoscope should never be placed in the carrying case because the case 
can also become contaminated. When the endoscope is removed from the case, properly reprocessed, 
and put back in the case, the case could recontaminate the endoscope. A contaminated carrying case 
should be discarded (Olympus America, June 2002, written communication). 
 
 Infection-control professionals should ensure that institutional policies are consistent with national 
guidelines and conduct infection-control rounds periodically (e.g., at least annually) in areas where 
endoscopes are reprocessed to ensure policy compliance. Breaches in policy should be documented and 
corrective action instituted. In incidents in which endoscopes were not exposed to a high-level disinfection 
process, patients exposed to potentially contaminated endoscopes have been assessed for possible 
acquisition of HIV, HBV, and hepatitis C virus (HCV). A 14-step method for managing a failure incident 
associated with high-level disinfection or sterilization has been described [Rutala WA, 2006 #12512]. The 
possible transmission of bloodborne and other infectious agents highlights the importance of rigorous 
infection control172, 173.  
 
 
Laparoscopes and Arthroscopes 
 Although high-level disinfection appears to be the minimum standard for processing laparoscopes and 
arthroscopes between patients 28, 86, 174, 175, this practice continues to be debated 89, 90, 176. However, neither 
side in the high-level disinfection versus sterilization debate has sufficient data on which to base its 
conclusions. Proponents of high-level disinfection refer to membership surveys 29 or institutional 
experiences 87 involving more than 117,000 and 10,000 laparoscopic procedures, respectively, that cite a 
low risk for infection (<0.3%) when high-level disinfection is used for gynecologic laparoscopic equipment. 
Only one infection in the membership survey was linked to spores. In addition, growth of common skin 
microorganisms (e.g., Staphylococcus epidermidis, diphtheroids) has been documented from the umbilical 
area even after skin preparation with povidone-iodine and ethyl alcohol. Similar organisms were recovered 
in some instances from the pelvic serosal surfaces or from the laparoscopic telescopes, suggesting that 
the microorganisms probably were carried from the skin into the peritoneal cavity 177, 178. Proponents of 
sterilization focus on the possibility of transmitting infection by spore-forming organisms. Researchers have 
proposed several reasons why sterility was not necessary for all laparoscopic equipment: only a limited 
number of organisms (usually ≤10) are introduced into the peritoneal cavity during laparoscopy; minimal 
damage is done to inner abdominal structures with little devitalized tissue; the peritoneal cavity tolerates 
small numbers of spore-forming bacteria; equipment is simple to clean and disinfect; surgical sterility is 
relative; the natural bioburden on rigid lumened devices is low179; and no evidence exists that high-level 
disinfection instead of sterilization increases the risk for infection 87, 89, 90. With the advent of laparoscopic 
cholecystectomy, concern about high-level disinfection is justifiable because the degree of tissue damage 
and bacterial contamination is greater than with laparoscopic procedures in gynecology. Failure to 
completely dissemble, clean, and high-level disinfect laparoscope parts has led to infections in patients180. 
Data from one study suggested that disassembly, cleaning, and proper reassembly of laparoscopic 
equipment used in gynecologic procedures before steam sterilization presents no risk for infection181.  
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 As with laparoscopes and other equipment that enter sterile body sites, arthroscopes ideally should 
be sterilized before used. Older studies demonstrated that these instruments were commonly (57%) only 
high-level disinfected in the United States 28, 86. A later survey (with a response rate of only 5%) reported 
that high-level disinfection was used by 31% and a sterilization process in the remainder of the health-
care facilities30 High-level disinfection rather than sterilization presumably has been used because the 
incidence of infection is low and the few infections identified probably are unrelated to the use of high-
level disinfection rather than sterilization. A retrospective study of 12,505 arthroscopic procedures found 
an infection rate of 0.04% (five infections) when arthroscopes were soaked in 2% glutaraldehyde for 15–
20 minutes. Four infections were caused by S. aureus; the fifth was an anaerobic streptococcal infection 
88. Because these organisms are very susceptible to high-level disinfectants, such as 2% glutaraldehyde, 
the infections most likely originated from the patient’s skin. Two cases of Clostridium perfringens arthritis 
have been reported when the arthroscope was disinfected with glutaraldehyde for an exposure time that 
is not effective against spores 182, 183. 
 
 Although only limited data are available, the evidence does not demonstrate that high-level 
disinfection of arthroscopes and laparoscopes poses an infection risk to the patient. For example, a 
prospective study that compared the reprocessing of arthroscopes and laparoscopes (per 1,000 
procedures) with EtO sterilization to high-level disinfection with glutaraldehyde found no statistically 
significant difference in infection risk between the two methods (i.e., EtO, 7.5/1,000 procedures; 
glutaraldehyde, 2.5/1,000 procedures)89. Although the debate for high-level disinfection versus 
sterilization of laparoscopes and arthroscopes will go unsettled until well-designed, randomized clinical 
trials are published, this guideline should be followed 1, 17. That is, laparoscopes, arthroscopes, and other 
scopes that enter normally sterile tissue should be sterilized before each use; if this is not feasible, they 
should receive at least high-level disinfection. 
 
 
Tonometers, Cervical Diaphragm Fitting Rings, Cryosurgical 
Instruments, and Endocavitary Probes  
 Disinfection strategies vary widely for other semicritical items (e.g., applanation tonometers, 
rectal/vaginal probes, cryosurgical instruments, and diaphragm fitting rings). FDA requests that device 
manufacturers include at least one validated cleaning and disinfection/sterilization protocol in the labeling 
for their devices. As with all medications and devices, users should be familiar with the label instructions. 
One study revealed that no uniform technique was in use for disinfection of applanation tonometers, with 
disinfectant contact times varying from <15 sec to 20 minutes 28. In view of the potential for transmission 
of viruses (e.g., herpes simplex virus [HSV], adenovirus 8, or HIV) 184 by tonometer tips, CDC 
recommended that the tonometer tips be wiped clean and disinfected for 5-10 minutes with either 3% 
hydrogen peroxide, 5000 ppm chlorine, 70% ethyl alcohol, or 70% isopropyl alcohol 95. However, more 
recent data suggest that 3% hydrogen peroxide and 70% isopropyl alcohol are not effective against 
adenovirus capable of causing epidemic keratoconjunctivitis and similar viruses and should not be used 
for disinfecting applanation tonometers 49, 185, 186. Structural damage to Schiotz tonometers has been 
observed with a 1:10 sodium hypochlorite (5,000 ppm chlorine) and 3% hydrogen peroxide187. After 
disinfection, the tonometer should be thoroughly rinsed in tapwater and air dried before use. Although 
these disinfectants and exposure times should kill pathogens that can infect the eyes, no studies directly 
support this 188, 189. The guidelines of the American Academy of Ophthalmology for preventing infections 
in ophthalmology focus on only one potential pathogen: HIV. 190 Because a short and simple 
decontamination procedure is desirable in the clinical setting, swabbing the tonometer tip with a 70% 
isopropyl alcohol wipe sometimes is practiced. 189 Preliminary reports suggest that wiping the tonometer 
tip with an alcohol swab and then allowing the alcohol to evaporate might be effective in eliminating HSV, 
HIV, and adenovirus189, 191, 192. However, because these studies involved only a few replicates and were 
conducted in a controlled laboratory setting, further studies are needed before this technique can be 
recommended. In addition, two reports have found that disinfection of pneumotonometer tips between 
uses with a 70% isopropyl alcohol wipe contributed to outbreaks of epidemic keratoconjunctivitis caused 
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by adenovirus type 8193, 194. 
 
 Limited studies have evaluated disinfection techniques for other items that contact mucous 
membranes, such as diaphragm fitting rings, cryosurgical probes, transesophageal echocardiography 
probes 195, flexible cystoscopes 196 or vaginal/rectal probes used in sonographic scanning. Lettau, Bond, 
and McDougal of CDC supported the recommendation of a diaphragm fitting ring manufacturer that 
involved using a soap-and-water wash followed by a 15-minute immersion in 70% alcohol96. This 
disinfection method should be adequate to inactivate HIV, HBV, and HSV even though alcohols are not 
classified as high-level disinfectants because their activity against picornaviruses is somewhat limited72. 
No data are available regarding inactivation of human papillomavirus (HPV) by alcohol or other 
disinfectants because in vitro replication of complete virions has not been achieved. Thus, even though 
alcohol for 15 minutes should kill pathogens of relevance in gynecology, no clinical studies directly 
support this practice. 
 
 Vaginal probes are used in sonographic scanning. A vaginal probe and all endocavitary probes 
without a probe cover are semicritical devices because they have direct contact with mucous membranes 
(e.g., vagina, rectum, pharynx). While use of the probe cover could be considered as changing the 
category, this guideline proposes use of a new condom/probe cover for the probe for each patient, and 
because condoms/probe covers can fail 195, 197-199, the probe also should be high-level disinfected. The 
relevance of this recommendation is reinforced with the findings that sterile transvaginal ultrasound probe 
covers have a very high rate of perforations even before use (0%, 25%, and 65% perforations from three 
suppliers). 199 One study found, after oocyte retrieval use, a very high rate of perforations in used 
endovaginal probe covers from two suppliers (75% and 81%) 199, other studies demonstrated a lower rate 
of perforations after use of condoms (2.0% and 0.9%) 197 200. Condoms have been found superior to 
commercially available probe covers for covering the ultrasound probe (1.7% for condoms versus 8.3% 
leakage for probe covers)201. These studies underscore the need for routine probe disinfection between 
examinations. Although most ultrasound manufacturers recommend use of 2% glutaraldehyde for high-
level disinfection of contaminated transvaginal transducers, the this agent has been questioned 202 
because it might shorten the life of the transducer and might have toxic effects on the gametes and 
embryos 203. An alternative procedure for disinfecting the vaginal transducer involves the mechanical 
removal of the gel from the transducer, cleaning the transducer in soap and water, wiping the transducer 
with 70% alcohol or soaking it for 2 minutes in 500 ppm chlorine, and rinsing with tap water and air 
drying204. The effectiveness of this and other methods 200 has not been validated in either rigorous 
laboratory experiments or in clinical use. High-level disinfection with a product (e.g., hydrogen peroxide) 
that is not toxic to staff, patients, probes, and retrieved cells should be used until the effectiveness of 
alternative procedures against microbes of importance at the cavitary site is demonstrated by well-
designed experimental scientific studies. Other probes such as rectal, cryosurgical, and transesophageal 
probes or devices also should be high-level disinfected between patients. 
 
 Ultrasound probes used during surgical procedures also can contact sterile body sites. These probes 
can be covered with a sterile sheath to reduce the level of contamination on the probe and reduce the risk 
for infection. However, because the sheath does not completely protect the probe, the probes should be 
sterilized between each patient use as with other critical items. If this is not possible, at a minimum the 
probe should be high-level disinfected and covered with a sterile probe cover. 
 
 Some cryosurgical probes are not fully immersible. During reprocessing, the tip of the probe should 
be immersed in a high-level disinfectant for the appropriate time; any other portion of the probe that could 
have mucous membrane contact can be disinfected by immersion or by wrapping with a cloth soaked in a 
high-level disinfectant to allow the recommended contact time. After disinfection, the probe should be 
rinsed with tap water and dried before use. Health-care facilities that use nonimmersible probes should 
replace them as soon as possible with fully immersible probes. 
 
 As with other high-level disinfection procedures, proper cleaning of probes is necessary to ensure 
the success of the subsequent disinfection 205. One study demonstrated that vegetative bacteria 
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inoculated on vaginal ultrasound probes decreased when the probes were cleaned with a towel 206. No 
information is available about either the level of contamination of such probes by potential viral 
pathogens such as HBV and HPV or their removal by cleaning (such as with a towel). Because these 
pathogens might be present in vaginal and rectal secretions and contaminate probes during use, high-




 Scientific articles and increased publicity about the potential for transmitting infectious agents in 
dentistry have focused attention on dental instruments as possible agents for pathogen transmission207, 208. 
The American Dental Association recommends that surgical and other instruments that normally penetrate 
soft tissue or bone (e.g., extraction forceps, scalpel blades, bone chisels, periodontal scalers, and surgical 
burs) be classified as critical devices that should be sterilized after each use or discarded. Instruments not 
intended to penetrate oral soft tissues or bone (e.g., amalgam condensers, and air/water syringes) but that 
could contact oral tissues are classified as semicritical, but sterilization after each use is recommended if the 
instruments are heat-tolerant 43, 209. If a semicritical item is heat–sensitive, it should, at a minimum, be 
processed with high-level disinfection 43, 210. Handpieces can be contaminated internally with patient material 
and should be heat sterilized after each patient. Handpieces that cannot be heat sterilized should not be 
used. 211 Methods of sterilization that can be used for critical or semicritical dental instruments and materials 
that are heat-stable include steam under pressure (autoclave), chemical (formaldehyde) vapor, and dry heat 
(e.g., 320ºF for 2 hours). Dental professionals most commonly use the steam sterilizer 212. All three 
sterilization procedures can damage some dental instruments, including steam-sterilized hand pieces 213. 
Heat-tolerant alternatives are available for most clinical dental applications and are preferred43.  
 
 CDC has divided noncritical surfaces in dental offices into clinical contact and housekeeping 
surfaces43. Clinical contact surfaces are surfaces that might be touched frequently with gloved hands 
during patient care or that might become contaminated with blood or other potentially infectious material 
and subsequently contact instruments, hands, gloves, or devices (e.g., light handles, switches, dental X-
ray equipment, chair-side computers). Barrier protective coverings (e.g., clear plastic wraps) can be used 
for these surfaces, particularly those that are difficult to clean (e.g., light handles, chair switches). The 
coverings should be changed when visibly soiled or damaged and routinely (e.g., between patients). 
Protected surfaces should be disinfected at the end of each day or if contamination is evident. If not 
barrier-protected, these surfaces should be disinfected between patients with an intermediate-disinfectant 
(i.e., EPA-registered hospital disinfectant with tuberculocidal claim) or low-level disinfectant (i.e., EPA-
registered hospital disinfectant with an HBV and HIV label claim) 43, 214, 215. 
 
 Most housekeeping surfaces need to be cleaned only with a detergent and water or an EPA-
registered hospital disinfectant, depending of the nature of the surface and the type and degree of 
contamination. When housekeeping surfaces are visibly contaminated by blood or body substances, 
however, prompt removal and surface disinfection is a sound infection control practice and required by 
the Occupational Safety and Health Administration (OSHA) 43, 214. 
 
 Several studies have demonstrated variability among dental practices while trying to meet these 
recommendations216, 217. For example, 68% of respondents believed they were sterilizing their instruments 
but did not use appropriate chemical sterilants or exposure times and 49% of respondents did not 
challenge autoclaves with biological indicators216. Other investigators using biologic indicators have found 
a high proportion (15%–65%) of positive spore tests after assessing the efficacy of sterilizers used in 
dental offices. In one study of Minnesota dental offices, operator error, rather than mechanical 
malfunction218, caused 87% of sterilization failures. Common factors in the improper use of sterilizers 
include chamber overload, low temperature setting, inadequate exposure time, failure to preheat the 
sterilizer, and interruption of the cycle. 
 
 Mail-return sterilization monitoring services use spore strips to test sterilizers in dental clinics, but 
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delay caused by mailing to the test laboratory could potentially cause false-negatives results. Studies 
revealed, however, that the post-sterilization time and temperature after a 7-day delay had no influence 
on the test results219. Delays (7 days at 27ºC and 37ºC, 3-day mail delay) did not cause any predictable 
pattern of inaccurate spore tests 220. 
 
 
Disinfection of HBV-, HCV-, HIV- or TB-Contaminated Devices 
 The CDC recommendation for high-level disinfection of HBV-, HCV-, HIV- or TB-contaminated 
devices is appropriate because experiments have demonstrated the effectiveness of high-level 
disinfectants to inactivate these and other pathogens that might contaminate semicritical devices 61, 62, 
73, 81, 105, 121, 125, 221-238. Nonetheless, some healthcare facilities have modified their disinfection 
procedures when endoscopes are used with a patient known or suspected to be infected with HBV, 
HIV, or M. tuberculosis 28, 239. This is inconsistent with the concept of Standard Precautions that 
presumes all patients are potentially infected with bloodborne pathogens228. Several studies have 
highlighted the inability to distinguish HBV- or HIV-infected patients from noninfected patients on clinical 
grounds240-242. In addition, mycobacterial infection is unlikely to be clinically apparent in many patients. 
In most instances, hospitals that altered their disinfection procedure used EtO sterilization on the 
endoscopic instruments because they believed this practice reduced the risk for infection 28, 239. EtO is 
not routinely used for endoscope sterilization because of the lengthy processing time. Endoscopes and 
other semicritical devices should be managed the same way regardless of whether the patient is known 
to be infected with HBV, HCV, HIV or M. tuberculosis. 
 
 An evaluation of a manual disinfection procedure to eliminate HCV from experimentally 
contaminated endoscopes provided some evidence that cleaning and 2% glutaraldehyde for 20 minutes 
should prevent transmission 236. A study that used experimentally contaminated hysteroscopes 
detected HCV by polymerase chain reaction (PCR) in one (3%) of 34 samples after cleaning with a 
detergent, but no samples were positive after treatment with a 2% glutaraldehyde solution for 20 
minutes 120. Another study demonstrated complete elimination of HCV (as detected by PCR) from 
endoscopes used on chronically infected patients after cleaning and disinfection for 3–5 minutes in 
glutaraldehyde 118. Similarly, PCR was used to demonstrate complete elimination of HCV after standard 
disinfection of experimentally contaminated endoscopes 236 and endoscopes used on HCV-antibody–
positive patients had no detectable HCV RNA after high-level disinfection 243. The inhibitory activity of a 
phenolic and a chlorine compound on HCV showed that the phenolic inhibited the binding and 
replication of HCV, but the chlorine was ineffective, probably because of its low concentration and its 
neutralization in the presence of organic matter 244.  
 
 
Disinfection in the Hemodialysis Unit 
 Hemodialysis systems include hemodialysis machines, water supply, water-treatment systems, and 
distribution systems. During hemodialysis, patients have acquired bloodborne viruses and pathogenic 
bacteria 245-247. Cleaning and disinfection are important components of infection control in a hemodialysis 
center. EPA and FDA regulate disinfectants used to reprocess hemodialyzers, hemodialysis machines, 
and water-treatment systems. 
 
Noncritical surfaces (e.g., dialysis bed or chair, countertops, external surfaces of dialysis 
machines, and equipment [scissors, hemostats, clamps, blood pressure cuffs, stethoscopes]) should be 
disinfected with an EPA-registered disinfectant unless the item is visibly contaminated with blood; in that 
case a tuberculocidal agent (or a disinfectant with specific label claims for HBV and HIV) or a 1:100 
dilution of a hypochlorite solution (500–600 ppm free chlorine) should be used 246, 248. This procedure 
accomplishes two goals: it removes soil on a regular basis and maintains an environment that is 
consistent with good patient care. Hemodialyzers are disinfected with peracetic acid, formaldehyde, 
glutaraldehyde, heat pasteurization with citric acid, and chlorine-containing compounds 249. Hemodialysis 
systems usually are disinfected by chlorine-based disinfectants (e.g., sodium hypochlorite), aqueous 
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formaldehyde, heat pasteurization, ozone, or peracetic acid 250, 251. All products must be used according 
to the manufacturers’ recommendations. Some dialysis systems use hot-water disinfection to control 
microbial contamination.  
 
 At its high point, 82% of U.S. chronic hemodialysis centers were reprocessing (i.e., reusing) 
dialyzers for the same patient using high-level disinfection 249. However, one of the large dialysis 
organizations has decided to phase out reuse and, by 2002 the percentage of dialysis facilities 
reprocessing hemodialyzers had decreased to 63% 252. The two commonly used disinfectants to 
reprocess dialyzers were peracetic acid and formaldehyde; 72% used peracetic acid and 20% used 
formaldehyde to disinfect hemodialyzers. Another 4% of the facilities used either glutaraldehyde or heat 
pasteurization in combination with citric acid 252. Infection-control recommendations, including 
disinfection and sterilization and the use of dedicated machines for hepatitis B surface antigen (HBsAg)-
positive patients, in the hemodialysis setting were detailed in two reviews 245, 246. The Association for the 




Inactivation of Clostridium difficile 
 The source of health-care–associated acquisition of Clostridium difficile in nonepidemic settings has 
not been determined. The environment and carriage on the hands of health-care personnel have been 
considered possible sources of infection 66, 254. Carpeted rooms occupied by a patient with C. difficile 
were more heavily contaminated with C. difficile than were noncarpeted rooms 255. Because C. difficile 
spore-production can increase when exposed to nonchlorine-based cleaning agents and the spores are 
more resistant than vegetative cells to commonly used surface disinfectants256, some investigators have 
recommended use of dilute solutions of hypochlorite (1,600 ppm available chlorine) for routine 
environmental disinfection of rooms of patients with C. difficile-associated diarrhea or colitis 257, to 
reduce the incidence of C. difficile diarrhea 258, or in units with high C. difficile rates. 259 Stool samples of 
patients with symptomatic C. difficile colitis contain spores of the organism, as demonstrated by ethanol 
treatment of the stool to reduce the overgrowth of fecal flora when isolating C. difficile in the 
laboratory260, 261. C. difficile-associated diarrhea rates were shown to have decreased markedly in a 
bone-marrow transplant unit (from 8.6 to 3.3 cases per 1,000 patient-days) during a period of bleach 
disinfection (1:10 dilution) of environmental surfaces compared with cleaning with a quaternary 
ammonium compound. Because no EPA-registered products exist that are specific for inactivating C. 
difficile spores, use of diluted hypochlorite should be considered in units with high C. difficile rates. 
Acidified bleach and regular bleach (5000 ppm chlorine) can inactivate 106 C. difficile spores in ≤10 
minutes 262. However, studies have shown that asymptomatic patients constitute an important reservoir 
within the health-care facility and that person-to-person transmission is the principal means of 
transmission between patients. Thus, combined use of hand washing, barrier precautions, and 
meticulous environmental cleaning with an EPA-registered disinfectant (e.g., germicidal detergent) 
should effectively prevent spread of the organism 263.  
 
 Contaminated medical devices, such as colonoscopes and thermometers,can be vehicles for 
transmission of C. difficile spores 264. For this reason, investigators have studied commonly used 
disinfectants and exposure times to assess whether current practices can place patients at risk. Data 
demonstrate that 2% glutaraldehyde 79, 265-267 and peracetic acid 267, 268 reliably kill C. difficile spores 
using exposure times of 5–20 minutes. ortho-Phthalaldehyde and ≥0.2% peracetic acid (WA Rutala, 
personal communication, April 2006) also can inactivate ≥104 C. difficile spores in 10–12 minutes at 20ºC 
268. Sodium dichloroisocyanurate at a concentration of 1000 ppm available chlorine achieved lower log10 
reduction factors against C. difficile spores at 10 min, ranging from 0.7 to 1.5, than 0.26% peracetic acid 
with log10 reduction factors ranging from 2.7 to 6.0268.  
 
 
OSHA Bloodborne Pathogen Standard 
 In December 1991, OSHA promulgated a standard entitled “Occupational Exposure to Bloodborne 
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Pathogens” to eliminate or minimize occupational exposure to bloodborne pathogens 214. One 
component of this requirement is that all equipment and environmental and working surfaces be cleaned 
and decontaminated with an appropriate disinfectant after contact with blood or other potentially 
infectious materials. Even though the OSHA standard does not specify the type of disinfectant or 
procedure, the OSHA original compliance document 269 suggested that a germicide must be 
tuberculocidal to kill the HBV. To follow the OSHA compliance document a tuberculocidal disinfectant 
(e.g., phenolic, and chlorine) would be needed to clean a blood spill. However, in February 1997, OSHA 
amended its policy and stated that EPA-registered disinfectants labeled as effective against HIV and 
HBV would be considered as appropriate disinfectants “. . . provided such surfaces have not become 
contaminated with agent(s) or volumes of or concentrations of agent(s) for which higher level disinfection 
is recommended.” When bloodborne pathogens other than HBV or HIV are of concern, OSHA continues 
to require use of EPA-registered tuberculocidal disinfectants or hypochlorite solution (diluted 1:10 or 
1:100 with water) 215, 228. Studies demonstrate that, in the presence of large blood spills, a 1:10 final 
dilution of EPA-registered hypochlorite solution initially should be used to inactivate bloodborne viruses 
63, 235 to minimize risk for infection to health-care personnel from percutaneous injury during cleanup. 
 
 
Emerging Pathogens (Cryptosporidium, Helicobacter pylori, 
Escherichia coli O157:H7, Rotavirus, Human Papilloma Virus, 
Norovirus, Severe Acute Respiratory Syndrome [SARS] Coronavirus) 
 Emerging pathogens are of growing concern to the general public and infection-control 
professionals. Relevant pathogens include Cryptosporidium parvum, Helicobacter pylori, E. coli 
O157:H7, HIV, HCV, rotavirus, norovirus, severe acute respiratory syndrome (SARS) coronavirus, 
multidrug-resistant M. tuberculosis, and nontuberculous mycobacteria (e.g., M. chelonae). The 
susceptibility of each of these pathogens to chemical disinfectants and sterilants has been studied. With 
the exceptions discussed below, all of these emerging pathogens are susceptible to currently available 
chemical disinfectants and sterilants 270. 
 
 Cryptosporidium is resistant to chlorine at concentrations used in potable water. C. parvum is not 
completely inactivated by most disinfectants used in healthcare including ethyl alcohol 271, 
glutaraldehyde 271, 272, 5.25% hypochlorite 271, peracetic acid 271, ortho-phthalaldehyde 271, phenol 271, 272, 
povidone-iodine 271, 272, and quaternary ammonium compounds271. The only chemical disinfectants and 
sterilants able to inactivate greater than 3 log10 of C. parvum were 6% and 7.5% hydrogen peroxide 271. 
Sterilization methods will fully inactivate C. parvum, including steam 271, EtO 271, 273, and hydrogen 
peroxide gas plasma271. Although most disinfectants are ineffective against C. parvum, current cleaning 
and disinfection practices appear satisfactory to prevent healthcare-associated transmission. For 
example, endoscopes are unlikely to be an important vehicle for transmitting C. parvum because the 
results of bacterial studies indicate mechanical cleaning will remove approximately 104 organisms, and 
drying results in rapid loss of C. parvum viability (e.g., 30 minutes, 2.9 log10 decrease; and 60 minutes, 
3.8 log10 decrease) 271. 
 
 Chlorine at ~1 ppm has been found capable of eliminating approximately 4 log10 of E. coli O157:H7 
within 1 minute in a suspension test64. Electrolyzed oxidizing water at 23°C was effective in 10 minutes in 
producing a 5-log10 decrease in E. coli O157:H7 inoculated onto kitchen cutting boards274. The following 
disinfectants eliminated >5 log10 of E. coli O157:H7 within 30 seconds: a quaternary ammonium 
compound, a phenolic, a hypochlorite (1:10 dilution of 5.25% bleach), and ethanol53. Disinfectants 
including chlorine compounds can reduce E. coli O157:H7 experimentally inoculated onto alfalfa seeds 
or sprouts 275, 276 or beef carcass surfaces277.  
 
 Data are limited on the susceptibility of H. pylori to disinfectants. Using a suspension test, one study 
assessed the effectiveness of a variety of disinfectants against nine strains of H. pylori 60. Ethanol (80%) 
and glutaraldehyde (0.5%) killed all strains within 15 seconds; chlorhexidine gluconate (0.05%, 1.0%), 
benzalkonium chloride (0.025%, 0.1%), alkyldiaminoethylglycine hydrochloride (0.1%), povidone-iodine 
(0.1%), and sodium hypochlorite (150 ppm) killed all strains within 30 seconds. Both ethanol (80%) and 
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glutaraldehyde (0.5%) retained similar bactericidal activity in the presence of organic matter; the other 
disinfectants showed reduced bactericidal activity. In particular, the bactericidal activity of povidone-
iodine (0.1%) and sodium hypochlorite (150 ppm) markedly decreased in the presence of dried yeast 
solution with killing times increased to 5 - 10 minutes and 5 - 30 minutes, respectively. 
 
 Immersing biopsy forceps in formalin before obtaining a specimen does not affect the ability to 
culture H. pylori from the biopsy specimen 278. The following methods are ineffective for eliminating H. 
pylori from endoscopes: cleaning with soap and water 119, 279, immersion in 70% ethanol for 3 
minutes280, instillation of 70% ethanol126, instillation of 30 ml of 83% methanol279, and instillation of 0.2% 
Hyamine solution281. The differing results with regard to the efficacy of ethyl alcohol against 
Helicobacter are unexplained. Cleaning followed by use of 2% alkaline glutaraldehyde (or automated 
peracetic acid) has been demonstrated by culture to be effective in eliminating H. pylori 119, 279, 282. 
Epidemiologic investigations of patients who had undergone endoscopy with endoscopes mechanically 
washed and disinfected with 2.0%–2.3% glutaraldehyde have revealed no evidence of person-to-
person transmission of H. pylori 126, 283. Disinfection of experimentally contaminated endoscopes using 
2% glutaraldehyde (10-minute, 20-minute, 45-minute exposure times) or the peracetic acid system (with 
and without active peracetic acid) has been demonstrated to be effective in eliminating H. pylori 119. H. 
pylori DNA has been detected by PCR in fluid flushed from endoscope channels after cleaning and 
disinfection with 2% glutaraldehyde 284. The clinical significance of this finding is unclear. In vitro 
experiments have demonstrated a >3.5-log10 reduction in H. pylori after exposure to 0.5 mg/L of free 
chlorine for 80 seconds285.  
 
 An outbreak of healthcare-associated rotavirus gastroenteritis on a pediatric unit has been reported 
286. Person to person through the hands of health-care workers was proposed as the mechanism of 
transmission. Prolonged survival of rotavirus on environmental surfaces (90 minutes to >10 days at room 
temperature) and hands (>4 hours) has been demonstrated. Rotavirus suspended in feces can survive 
longer 287, 288. Vectors have included hands, fomites, air, water, and food 288, 289. Products with 
demonstrated efficacy (>3 log10 reduction in virus) against rotavirus within 1 minute include: 95% ethanol, 
70% isopropanol, some phenolics, 2% glutaraldehyde, 0.35% peracetic acid, and some quaternary 
ammonium compounds 59, 290-293. In a human challenge study, a disinfectant spray (0.1% ortho-
phenylphenol and 79% ethanol), sodium hypochlorite (800 ppm free chlorine), and a phenol-based 
product (14.7% phenol diluted 1:256 in tapwater) when sprayed onto contaminated stainless steel disks, 
were effective in interrupting transfer of a human rotavirus from stainless steel disk to fingerpads of 
volunteers after an exposure time of 3- 10 minutes. A quaternary ammonium product (7.05% quaternary 
ammonium compound diluted 1:128 in tapwater) and tapwater allowed transfer of virus 52. 
 
 No data exist on the inactivation of HPV by alcohol or other disinfectants because in vitro replication 
of complete virions has not been achieved. Similarly, little is known about inactivation of noroviruses 
(members of the family Caliciviridae and important causes of gastroenteritis in humans) because they 
cannot be grown in tissue culture. Improper disinfection of environmental surfaces contaminated by 
feces or vomitus of infected patients is believed to play a role in the spread of noroviruses in some 
settings 294-296. Prolonged survival of a norovirus surrogate (i.e., feline calicivirus virus [FCV], a closely 
related cultivable virus) has been demonstrated (e.g., at room temperature, FCV in a dried state 
survived for 21–18 days) 297. Inactivation studies with FCV have shown the effectiveness of chlorine, 
glutaraldehyde, and iodine-based products whereas the quaternary ammonium compound, detergent, 
and ethanol failed to inactivate the virus completely. 297 An evaluation of the effectiveness of several 
disinfectants against the feline calicivirus found that bleach diluted to 1000 ppm of available chlorine 
reduced infectivity of FCV by 4.5 logs in 1 minute. Other effective (log10 reduction factor of >4 in virus) 
disinfectants included accelerated hydrogen peroxide, 5,000 ppm (3 min); chlorine dioxide, 1,000 ppm 
chlorine (1 min); a mixture of four quaternary ammonium compounds, 2,470 ppm (10 min); 79% ethanol 
with 0.1% quaternary ammonium compound (3 min); and 75% ethanol (10 min) 298. A quaternary 
ammonium compound exhibited activity against feline calicivirus supensions dried on hard surface 
carriers in 10 minutes 299. Seventy percent ethanol and 70% 1-propanol reduced FCV by a 3–4-log10 
reduction in 30 seconds 300.  
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 CDC announced that a previously unrecognized human virus from the coronavirus family is the 
leading hypothesis for the cause of a described syndrome of SARS 301. Two coronaviruses that are 
known to infect humans cause one third of common colds and can cause gastroenteritis. The virucidal 
efficacy of chemical germicides against coronavirus has been investigated. A study of disinfectants 
against coronavirus 229E found several that were effective after a 1-minute contact time; these included 
sodium hypochlorite (at a free chlorine concentration of 1,000 ppm and 5,000 ppm), 70% ethyl alcohol, 
and povidone-iodine (1% iodine) 186. In another study, 70% ethanol, 50% isopropanol, 0.05% 
benzalkonium chloride, 50 ppm iodine in iodophor, 0.23% sodium chlorite, 1% cresol soap and 0.7% 
formaldehyde inactivated >3 logs of two animal coronaviruses (mouse hepatitis virus, canine coronavirus) 
after a 10-minute exposure time 302. The activity of povidone-iodine has been demonstrated against 
human coronaviruses 229E and OC43 303. A study also showed complete inactivation of the SARS 
coronavirus by 70% ethanol and povidone-iodine with an exposure times of 1 minute and 2.5% 
glutaraldehyde with an exposure time of 5 minute 304. Because the SARS coronavirus is stable in feces 
and urine at room temperature for at least 1–2 days [The current version of this document may differ from 
original: First data on stability and resistance of SARS coronavirus compiled by members of WHO 
laboratory network (http://www.who.int/csr/sars/survival_2003_05_04/en/)], surfaces might be a possible 
source of contamination and lead to infection with the SARS coronavirus and should be disinfected. Until 
more precise information is available, environments in which SARS patients are housed should be 
considered heavily contaminated, and rooms and equipment should be thoroughly disinfected daily and 
after the patient is discharged. EPA-registered disinfectants or 1:100 dilution of household bleach and 
water should be used for surface disinfection and disinfection on noncritical patient-care equipment. High-
level disinfection and sterilization of semicritical and critical medical devices, respectively, does not need 
to be altered for patients with known or suspected SARS.  
 
 Free-living amoeba can be pathogenic and can harbor agents of pneumonia such as Legionella 
pneumophila. Limited studies have shown that 2% glutaraldehyde and peracetic acid do not completely 
inactivate Acanthamoeba polyphaga in a 20-minute exposure time for high-level disinfection. If amoeba 
are found to contaminate instruments and facilitate infection, longer immersion times or other 
disinfectants may need to be considered 305.  
 
 
Inactivation of Bioterrorist Agents 
 Publications have highlighted concerns about the potential for biological terrorism306, 307. CDC has 
categorized several agents as “high priority” because they can be easily disseminated or transmitted from 
person to person, cause high mortality, and are likely to cause public panic and social disruption 308. 
These agents include Bacillus anthracis (the cause of anthrax), Yersinia pestis (plague), variola major 
(smallpox), Clostridium botulinum toxin (botulism), Francisella tularensis (tularemia), filoviruses (Ebola 
hemorrhagic fever, Marburg hemorrhagic fever); and arenaviruses (Lassa [Lassa fever], Junin [Argentine 
hemorrhagic fever]), and related viruses308.  
 
 A few comments can be made regarding the role of sterilization and disinfection of potential agents 
of bioterrorism309. First, the susceptibility of these agents to germicides in vitro is similar to that of other 
related pathogens. For example, variola is similar to vaccinia 72, 310, 311 and B. anthracis is similar to B. 
atrophaeus (formerly B. subtilis)312, 313. B. subtilis spores, for instance, proved as resistant as, if not more 
resistant than, B. anthracis spores (>6 log10 reduction of B. anthracis spores in 5 minutes with acidified 
bleach [5,250 ppm chlorine])313. Thus, one can extrapolate from the larger database available on the 
susceptibility of genetically similar organisms314. Second, many of the potential bioterrorist agents are 
stable enough in the environment that contaminated environmental surfaces or fomites could lead to 
transmission of agents such as B. anthracis, F. tularensis, variola major, C. botulinum toxin, and C. 
burnetti 315. Third, data suggest that current disinfection and sterilization practices are appropriate for 
managing patient-care equipment and environmental surfaces when potentially contaminated patients 
are evaluated and/or admitted in a health-care facility after exposure to a bioterrorist agent. For example, 
sodium hypochlorite can be used for surface disinfection (see [This link is no longer active: 
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http://www.epa.gov/pesticides/factsheets/chemicals/bleachfactsheet.htm.]). In instances where the 
health-care facility is the site of a bioterrorist attack, environmental decontamination might require 
special decontamination procedures (e.g., chlorine dioxide gas for B. anthracis spores). Because no 
antimicrobial products are registered for decontamination of biologic agents after a bioterrorist attack, 
EPA has granted a crises exemption for each product (see [This link is no longer active: 
http://www.epa.gov/pesticides/factsheets/chemicals/bleachfactsheet.htm.]). Of only theoretical concern 
is the possibility that a bioterrorist agent could be engineered to be less susceptible to disinfection and 
sterilization processes 309.  
 
 
Toxicological, Environmental and Occupational Concerns 
 Health hazards associated with the use of germicides in healthcare vary from mucous membrane 
irritation to death, with the latter involving accidental injection by mentally disturbed patients316. 
Although their degrees of toxicity vary 317-320, all disinfectants should be used with the proper safety 
precautions 321 and only for the intended purpose. 
 
 Key factors associated with assessing the health risk of a chemical exposure include the duration, 
intensity (i.e., how much chemical is involved), and route (e.g., skin, mucous membranes, and 
inhalation) of exposure. Toxicity can be acute or chronic. Acute toxicity usually results from an 
accidental spill of a chemical substance. Exposure is sudden and often produces an emergency 
situation. Chronic toxicity results from repeated exposure to low levels of the chemical over a prolonged 
period. Employers are responsible for informing workers about the chemical hazards in the workplace 
and implementing control measures. The OSHA Hazard Communication Standard (29 CFR 1910.1200, 
1915.99, 1917.28, 1918.90, 1926.59, and 1928.21) requires manufacturers and importers of hazardous 
chemicals to develop Material Safety Data Sheets (MSDS) for each chemical or mixture of chemicals. 
Employers must have these data sheets readily available to employees who work with the products to 
which they could be exposed. 
 
 Exposure limits have been published for many chemicals used in health care to help provide a safe 
environment and, as relevant, are discussed in each section of this guideline. Only the exposure limits 
published by OSHA carry the legal force of regulations. OSHA publishes a limit as a time-weighted 
average (TWA), that is, the average concentration for a normal 8-hour work day and a 40-hour work 
week to which nearly all workers can be repeatedly exposed to a chemical without adverse health 
effects. For example, the permissible exposure limit (PEL) for EtO is 1.0 ppm, 8 hour TWA. The CDC 
National Institute for Occupational Safety and Health (NIOSH) develops recommended exposure limits 
(RELs). RELs are occupational exposure limits recommended by NIOSH as being protective of worker 
health and safety over a working lifetime. This limit is frequently expressed as a 40-hour TWA exposure 
for up to 10 hours per day during a 40-hour work week. These exposure limits are designed for 
inhalation exposures. Irritant and allergic effects can occur below the exposure limits, and skin contact 
can result in dermal effects or systemic absorption without inhalation. The American Conference on 
Governmental Industrial Hygienists (ACGIN) also provides guidelines on exposure limits 322. Information 
about workplace exposures and methods to reduce them (e.g., work practices, engineering controls, 
PPE) is available on the OSHA (https://www.osha.gov/) and NIOSH (https://www.cdc.gov/niosh/) 
websites. 
 
 Some states have excluded or limited concentrations of certain chemical germicides (e.g., 
glutaraldehyde, formaldehyde, and some phenols) from disposal through the sewer system. These 
rules are intended to minimize environmental harm. If health-care facilities exceed the maximum 
allowable concentration of a chemical (e.g., ≥5.0 mg/L), they have three options. First, they can switch 
to alternative products; for example, they can change from glutaraldehyde to another disinfectant for 
high-level disinfection or from phenolics to quaternary ammonium compounds for low-level disinfection. 
Second, the health-care facility can collect the disinfectant and dispose of it as a hazardous chemical. 
Third, the facility can use a commercially available small-scale treatment method (e.g., neutralize 
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glutaraldehyde with glycine). 
 
 Safe disposal of regulated chemicals is important throughout the medical community. For disposal of 
large volumes of spent solutions, users might decide to neutralize the microbicidal activity before disposal 
(e.g., glutaraldehyde). Solutions can be neutralized by reaction with chemicals such as sodium bisulfite 
323, 324 or glycine 325. 
 
 European authors have suggested that instruments and ventilation therapy equipment should be 
disinfected by heat rather than by chemicals. The concerns for chemical disinfection include toxic side 
effects for the patient caused by chemical residues on the instrument or object, occupational exposure to 
toxic chemicals, and recontamination by rinsing the disinfectant with microbially contaminated tap water 326. 
 
 
Disinfection in Ambulatory Care, Home Care, and the Home 
 With the advent of managed healthcare, increasing numbers of patients are now being cared for in 
ambulatory-care and home settings. Many patients in these settings might have communicable diseases, 
immunocompromising conditions, or invasive devices. Therefore, adequate disinfection in these settings 
is necessary to provide a safe patient environment. Because the ambulatory-care setting (i.e., outpatient 
facility) provides the same risk for infection as the hospital, the Spaulding classification scheme described 
in this guideline should be followed (Table 1).17 
 
 The home environment should be much safer than hospitals or ambulatory care. Epidemics should 
not be a problem, and cross-infection should be rare. The healthcare provider is responsible for providing 
the responsible family member information about infection-control procedures to follow in the home, 
including hand hygiene, proper cleaning and disinfection of equipment, and safe storage of cleaned and 
disinfected devices. Among the products recommended for home disinfection of reusable objects are 
bleach, alcohol, and hydrogen peroxide. APIC recommends that reusable objects (e.g., tracheostomy 
tubes) that touch mucous membranes be disinfected by immersion in 70% isopropyl alcohol for 5 minutes 
or in 3% hydrogen peroxide for 30 minutes. Additionally, a 1:50 dilution of 5.25%–6.15% sodium 
hypochlorite (household bleach) for 5 minutes should be effective 327-329. Noncritical items (e.g., blood 
pressure cuffs, crutches) can be cleaned with a detergent. Blood spills should be handled according to 
OSHA regulations as previously described (see section on OSHA Bloodborne Pathogen Standard). In 
general, sterilization of critical items is not practical in homes but theoretically could be accomplished by 
chemical sterilants or boiling. Single-use disposable items can be used or reusable items sterilized in a 
hospital 330, 331. 
 
 Some environmental groups advocate “environmentally safe” products as alternatives to commercial 
germicides in the home-care setting. These alternatives (e.g., ammonia, baking soda, vinegar, Borax, 
liquid detergent) are not registered with EPA and should not be used for disinfecting because they are 
ineffective against S. aureus. Borax, baking soda, and detergents also are ineffective against Salmonella 
Typhi and E.coli; however, undiluted vinegar and ammonia are effective against S. Typhi and E.coli 53, 332, 
333. Common commercial disinfectants designed for home use also are effective against selected 
antibiotic-resistant bacteria 53. 
 
 Public concerns have been raised that the use of antimicrobials in the home can promote 
development of antibiotic-resistant bacteria 334, 335. This issue is unresolved and needs to be considered 
further through scientific and clinical investigations. The public health benefits of using disinfectants in 
the home are unknown. However, some facts are known: many sites in the home kitchen and bathroom 
are microbially contaminated 336, use of hypochlorites markedly reduces bacteria 337, and good 
standards of hygiene (e.g., food hygiene, hand hygiene) can help reduce infections in the home 338, 339. 
In addition, laboratory studies indicate that many commercially prepared household disinfectants are 
effective against common pathogens 53 and can interrupt surface-to-human transmission of pathogens 
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48. The “targeted hygiene concept”—which means identifying situations and areas (e.g., food-
preparation surfaces and bathroom) where risk exists for transmission of pathogens—may be a 
reasonable way to identify when disinfection might be appropriate 340.  
 
 
Susceptibility of Antibiotic-Resistant Bacteria to Disinfectants 
 As with antibiotics, reduced susceptibility (or acquired “resistance”) of bacteria to disinfectants can 
arise by either chromosomal gene mutation or acquisition of genetic material in the form of plasmids or 
transposons 338, 341-343, 344 , 345, 346. When changes occur in bacterial susceptibility that renders an 
antibiotic ineffective against an infection previously treatable by that antibiotic, the bacteria are referred 
to as “resistant.” In contrast, reduced susceptibility to disinfectants does not correlate with failure of the 
disinfectant because concentrations used in disinfection still greatly exceed the cidal level. Thus, the 
word "resistance" when applied to these changes is incorrect, and the preferred term is “reduced 
susceptibility” or “increased tolerance”344, 347. No data are available that show that antibiotic-resistant 
bacteria are less sensitive to the liquid chemical germicides than antibiotic-sensitive bacteria at 
currently used germicide contact conditions and concentrations. 
 
 MRSA and vancomycin-resistant Enterococcus (VRE) are important health-care–associated 
agents. Some antiseptics and disinfectants have been known for years to be, because of MICs, 
somewhat less inhibitory to S. aureus strains that contain a plasmid-carrying gene encoding resistance 
to the antibiotic gentamicin 344. For example, gentamicin resistance has been shown to also encode 
reduced susceptibility to propamidine, quaternary ammonium compounds, and ethidium bromide 348, 
and MRSA strains have been found to be less susceptible than methicillin-sensitive S. aureus (MSSA) 
strains to chlorhexidine, propamidine, and the quaternary ammonium compound cetrimide 349. In other 
studies, MRSA and MSSA strains have been equally sensitive to phenols and chlorhexidine, but MRSA 
strains were slightly more tolerant to quaternary ammonium compounds 350. Two gene families (qacCD 
[now referred to as smr] and qacAB) are involved in providing protection against agents that are 
components of disinfectant formulations such as quaternary ammonium compounds. Staphylococci 
have been proposed to evade destruction because the protein specified by the qacA determinant is a 
cytoplasmic-membrane–associated protein involved in an efflux system that actively reduces 
intracellular accumulation of toxicants, such as quaternary ammonium compounds, to intracellular 
targets. 351 
 
 Other studies demonstrated that plasmid-mediated formaldehyde tolerance is transferable from 
Serratia marcescens to E. coli 352 and plasmid-mediated quaternary ammonium tolerance is transferable 
from S. aureus to E. coli.353. Tolerance to mercury and silver also is plasmid borne. 341, 343-346 
 
 Because the concentrations of disinfectants used in practice are much higher than the MICs 
observed, even for the more tolerant strains, the clinical relevance of these observations is 
questionable. Several studies have found antibiotic-resistant hospital strains of common healthcare-
associated pathogens (i.e., Enterococcus, P. aeruginosa, Klebsiella pneumoniae, E. coli, S. aureus, 
and S. epidermidis) to be equally susceptible to disinfectants as antibiotic-sensitive strains 53, 354-356. The 
susceptibility of glycopeptide-intermediate S. aureus was similar to vancomycin-susceptible, MRSA 357. 
On the basis of these data, routine disinfection and housekeeping protocols do not need to be altered 
because of antibiotic resistance provided the disinfection method is effective 358, 359. A study that 
evaluated the efficacy of selected cleaning methods (e.g., QUAT-sprayed cloth, and QUAT-immersed 
cloth) for eliminating VRE found that currently used disinfection processes most likely are highly 
effective in eliminating VRE. However, surface disinfection must involve contact with all contaminated 
surfaces 358. A new method using an invisible flurorescent marker to objectively evaluate the 
thoroughness of cleaning activities in patient rooms might lead to improvement in cleaning of all objects 
and surfaces but needs further evaluation. 360 
 
 Lastly, does the use of antiseptics or disinfectants facilitate the development of disinfectant-tolerant 
organisms? Evidence and reviews indicate enhanced tolerance to disinfectants can be developed in 
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response to disinfectant exposure 334, 335, 346, 347, 361. However, the level of tolerance is not important in 
clinical terms because it is low and unlikely to compromise the effectiveness of disinfectants of which 
much higher concentrations are used 347, 362. 
 
 The issue of whether low-level tolerance to germicides selects for antibiotic-resistant strains is 
unsettled but might depend on the mechanism by which tolerance is attained. For example, changes in 
the permeability barrier or efflux mechanisms might affect susceptibility to both antibiotics and germicides, 
but specific changes to a target site might not. Some researchers have suggested that use of 
disinfectants or antiseptics (e.g., triclosan) could facilitate development of antibiotic-resistant 
microorganisms 334, 335, 363. Although evidence in laboratory studies indicates low-level resistance to 
triclosan, the concentrations of triclosan in these studies were low (generally <1 μg/mL) and dissimilar 
from the higher levels used in antimicrobial products (2,000–20,000 μg/mL) 364, 365. Thus, researchers can 
create laboratory-derived mutants that demonstrate reduced susceptibility to antiseptics or disinfectants. 
In some experiments, such bacteria have demonstrated reduced susceptibility to certain antibiotics 335. 
There is no evidence that using antiseptics or disinfectants selects for antibiotic-resistant organisms in 
nature or that such mutants survive in nature366. ). In addition, the action of antibiotics and the action of 
disinfectants differ fundamentally. Antibiotics are selectively toxic and generally have a single target site 
in bacteria, thereby inhibiting a specific biosynthetic process. Germicides generally are considered 
nonspecific antimicrobials because of a multiplicity of toxic-effect mechanisms or target sites and are 
broader spectrum in the types of microorganisms against which they are effective 344, 347.  
 
 The rotational use of disinfectants in some environments (e.g., pharmacy production units) has been 
recommended and practiced in an attempt to prevent development of resistant microbes 367, 368. There 
have been only rare case reports that appropriately used disinfectants have resulted in a clinical problem 




 The effective use of disinfectants is part of a multibarrier strategy to prevent health-care–associated 
infections. Surfaces are considered noncritical items because they contact intact skin. Use of noncritical 
items or contact with noncritical surfaces carries little risk of causing an infection in patients or staff. Thus, 
the routine use of germicidal chemicals to disinfect hospital floors and other noncritical items is 
controversial 370-375. A 1991 study expanded the Spaulding scheme by dividing the noncritical 
environmental surfaces into housekeeping surfaces and medical equipment surfaces 376. The classes of 
disinfectants used on housekeeping and medical equipment surfaces can be similar. However, the 
frequency of decontaminating can vary (see Recommendations). Medical equipment surfaces (e.g., blood 
pressure cuffs, stethoscopes, hemodialysis machines, and X-ray machines) can become contaminated 
with infectious agents and contribute to the spread of health-care–associated infections 248, 375. For this 
reason, noncritical medical equipment surfaces should be disinfected with an EPA-registered low- or 
intermediate-level disinfectant. Use of a disinfectant will provide antimicrobial activity that is likely to be 
achieved with minimal additional cost or work. 
 
 Environmental surfaces (e.g., bedside table) also could potentially contribute to cross-transmission by 
contamination of health-care personnel from hand contact with contaminated surfaces, medical 
equipment, or patients 50, 375, 377. A paper reviews the epidemiologic and microbiologic data (Table 3) 
regarding the use of disinfectants on noncritical surfaces 378.  
 
 Of the seven reasons to usie a disinfectant on noncritical surfaces, five are particularly noteworthy 
and support the use of a germicidal detergent. First, hospital floors become contaminated with 
microorganisms from settling airborne bacteria: by contact with shoes, wheels, and other objects; and 
occasionally by spills. The removal of microbes is a component in controling health-care–associated 
infections. In an investigation of the cleaning of hospital floors, the use of soap and water (80% 
reduction) was less effective in reducing the numbers of bacteria than was a phenolic disinfectant (94%–
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99.9% reduction) 379. However, a few hours after floor disinfection, the bacterial count was nearly back to 
the pretreatment level. Second, detergents become contaminated and result in seeding the patient’s 
environment with bacteria. Investigators have shown that mop water becomes increasingly dirty during 
cleaning and becomes contaminated if soap and water is used rather than a disinfectant. For example, 
in one study, bacterial contamination in soap and water without a disinfectant increased from 10 CFU/mL 
to 34,000 CFU/mL after cleaning a ward, whereas contamination in a disinfectant solution did not 
change (20 CFU/mL) 380. Contamination of surfaces close to the patient that are frequently touched by 
the patient or staff (e.g., bed rails) could result in patient exposures0 381. In a study, using of detergents 
on floors and patient room furniture, increased bacterial contamination of the patients’ environmental 
surfaces was found after cleaning (average increase = 103.6 CFU/24cm2) 382. In addition, a P. 
aeruginosa outbreak was reported in a hematology-oncology unit associated with contamination of the 
surface cleaning equipment when nongermicidal cleaning solutions instead of disinfectants were used to 
decontaminate the patients’ environment 383 and another study demonstrated the role of environmental 
cleaning in controlling an outbreak of Acinetobacter baumannii 384. Studies also have shown that, in 
situations where the cleaning procedure failed to eliminate contamination from the surface and the cloth 
is used to wipe another surface, the contamination is transferred to that surface and the hands of the 
person holding the cloth381, 385. Third, the CDC Isolation Guideline recommends that noncritical 
equipment contaminated with blood, body fluids, secretions, or excretions be cleaned and disinfected 
after use. The same guideline recommends that, in addition to cleaning, disinfection of the bedside 
equipment and environmental surfaces (e.g., bedrails, bedside tables, carts, commodes, door-knobs, 
and faucet handles) is indicated for certain pathogens, e.g., enterococci, which can survive in the 
inanimate environment for prolonged periods 386. Fourth, OSHA requires that surfaces contaminated with 
blood and other potentially infectious materials (e.g., amniotic, pleural fluid) be disinfected. Fifth, using a 
single product throughout the facility can simplify both training and appropriate practice. 
 
 Reasons also exist for using a detergent alone on floors because noncritical surfaces contribute 
minimally to endemic health-care–associated infections 387, and no differences have been found in 
healthcare–associated infections rates when floors are cleaned with detergent rather than disinfectant 
382, 388, 389. However, these studies have been small and of short duration and suffer from low statistical 
power because the outcome—healthcare–associated infections—is of low frequency. The low rate of 
infections makes the efficacy of an intervention statistically difficult to demonstrate. Because 
housekeeping surfaces are associated with the lowest risk for disease transmission, some researchers 
have suggested that either detergents or a disinfectant/detergent could be used 376. No data exist that 
show reduced healthcare–associated infection rates with use of surface disinfection of floors, but some 
data demonstrate reduced microbial load associated with the use of disinfectants. Given this information; 
other information showing that environmental surfaces (e.g., bedside table, bed rails) close to the patient 
and in outpatient settings 390 can be contaminated with epidemiologically important microbes (such as 
VRE and MRSA)47, 390-394; and data showing these organisms survive on various hospital surfaces 395, 396; 
some researchers have suggested that such surfaces should be disinfected on a regular schedule 378. 
Spot decontamination on fabrics that remain in hospitals or clinic rooms while patients move in and out 
(e.g., privacy curtains) also should be considered. One study demonstrated the effectiveness of spraying 
the fabric with 3% hydrogen peroxide 397. Future studies should evaluate the level of contamination on 
noncritical environmental surfaces as a function of high and low hand contact and whether some 
surfaces (e.g., bed rails) near the patient with high contact frequencies require more frequent 
disinfection. Regardless of whether a detergent or disinfectant is used on surfaces in a health-care 
facility, surfaces should be cleaned routinely and when dirty or soiled to provide an aesthetically pleasing 
environment and to prevent potentially contaminated objects from serving as a source for health-care–
associated infections. 398 The value of designing surfaces (e.g. hexyl-polyvinylpyridine) that kill bacteria 
on contact 399 or have sustained antimicrobial activity 400 should be further evaluated.  
 
 Several investigators have recognized heavy microbial contamination of wet mops and cleaning 
cloths and the potential for spread of such contamination 68, 401. They have shown that wiping hard 
surfaces with contaminated cloths can contaminate hands, equipment, and other surfaces 68, 402. Data 
have been published that can be used to formulate effective policies for decontamination and 
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maintenance of reusable cleaning cloths. For example, heat was the most reliable treatment of cleaning 
cloths as a detergent washing followed by drying at 80°C for 2 hours produced elimination of 
contamination. However, the dry heating process might be a fire hazard if the mop head contains 
petroleum-based products or lint builds up within the equipment or vent hose (American Health Care 
Association, personal communication, March 2003). Alternatively, immersing the cloth in hypochlorite 
(4,000 ppm) for 2 minutes produced no detectable surviving organisms in 10 of 13 cloths 403. If reusable 
cleaning cloths or mops are used, they should be decontaminated regularly to prevent surface 
contamination during cleaning with subsequent transfer of organisms from these surfaces to patients or 
equipment by the hands of health-care workers. Some hospitals have begun using a new mopping 
technique involving microfiber materials to clean floors. Microfibers are densely constructed, polyester 
and polyamide (nylon) fibers, that are approximately 1/16 the thickness of a human hair. The positively 
charged microfibers attract dust (which has a negative charge) and are more absorbent than a 
conventional, cotton-loop mop. Microfiber materials also can be wet with disinfectants, such as 
quaternary ammonium compounds. In one study, the microfiber system tested demonstrated superior 
microbial removal compared with conventional string mops when used with a detergent cleaner (94% vs 
68%). The use of a disinfectant did not improve the microbial elimination demonstrated by the microfiber 
system (95% vs 94%). However, use of disinfectant significantly improved microbial removal when a 
conventional string mop was used (95% vs 68%) (WA Rutala, unpublished data, August 2006). The 
microfiber system also prevents the possibility of transferring microbes from room to room because a 
new microfiber pad is used in each room. 
 
 An important issue concerning use of disinfectants for noncritical surfaces in health-care settings is 
that the contact time specified on the label of the product is often too long to be practically followed. The 
labels of most products registered by EPA for use against HBV, HIV, or M. tuberculosis specify a contact 
time of 10 minutes. Such a long contact time is not practical for disinfection of environmental surfaces in a 
health-care setting because most health-care facilities apply a disinfectant and allow it to dry (~1 minute). 
Multiple scientific papers have demonstrated significant microbial reduction with contact times of 30 to 60 
seconds46-56, 58-64. In addition, EPA will approve a shortened contact time for any product for which the 
manufacturers will submit confirmatory efficacy data.  
 
 Currently, some EPA-registered disinfectants have contact times of one to three minutes. By law, 
users must follow all applicable label instructions for EPA-registered products. Ideally, product users 
should consider and use products that have the shortened contact time. However, disinfectant 
manufacturers also need to obtain EPA approval for shortened contact times so these products will be 




 Disinfectant spray-fog techniques for antimicrobial control in hospital rooms has been used. This 
technique of spraying of disinfectants is an unsatisfactory method of decontaminating air and surfaces 
and is not recommended for general infection control in routine patient-care areas386. Disinfectant fogging 
is rarely, if ever, used in U.S. healthcare facilities for air and surface disinfection in patient-care areas. 
Methods (e.g., filtration, ultraviolet germicidal irradiation, chlorine dioxide) to reduce air contamination in 
the healthcare setting are discussed in another guideline 23. 
 
 
Microbial Contamination of Disinfectants 
 Contaminated disinfectants and antiseptics have been occasional vehicles of health-care infections 
and pseudoepidemics for more than 50 years. Published reports describing contaminated disinfectants 
and antiseptic solutions leading to health-care-associated infections have been summarized 404. Since 
this summary additional reports have been published 405-408. An examination of reports of disinfectants 
contaminated with microorganisms revealed noteworthy observations. Perhaps most importantly, high-
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level disinfectants/liquid chemical sterilants have not been associated with outbreaks due to intrinsic or 
extrinsic contamination.Members of the genus Pseudomonas (e.g., P. aeruginosa) are the most frequent 
isolates from contaminated disinfectants—recovered from 80% of contaminated products. Their ability to 
remain viable or grow in use-dilutions of disinfectants is unparalleled. This survival advantage for 
Pseudomonas results presumably from their nutritional versatility, their unique outer membrane that 
constitutes an effective barrier to the passage of germicides, and/or efflux systems 409. Although the 
concentrated solutions of the disinfectants have not been demonstrated to be contaminated at the point of 
manufacture, an undiluted phenolic can be contaminated by a Pseudomonas sp. during use 410. In most 
of the reports that describe illness associated with contaminated disinfectants, the product was used to 
disinfect patient-care equipment, such as cystoscopes, cardiac catheters, and thermometers. Germicides 
used as disinfectants that were reported to have been contaminated include chlorhexidine, quaternary 
ammonium compounds, phenolics, and pine oil. 
 
 The following control measures should be instituted to reduce the frequency of bacterial growth in 
disinfectants and the threat of serious healthcare–associated infections from the use of such 
contaminated products 404. First, some disinfectants should not be diluted; those that are diluted must 
be prepared correctly to achieve the manufacturers’ recommended use-dilution. Second, infection-control 
professionals must learn from the literature what inappropriate activities result in extrinsic contamination 
(i.e., at the point of use) of germicides and train users to prevent recurrence. Common sources of 
extrinsic contamination of germicides in the reviewed literature are the water to make working dilutions, 
contaminated containers, and general contamination of the hospital areas where the germicides are 
prepared and/or used. Third, stock solutions of germicides must be stored as indicated on the product 
label. EPA verifies manufacturers’ efficacy claims against microorganisms. These measures should 
provide assurance that products meeting the EPA registration requirements can achieve a certain level of 
antimicrobial activity when used as directed. 
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Factors Affecting the Efficacy of  
Disinfection and Sterilization 
 
 The activity of germicides against microorganisms depends on a number of factors, some of which 
are intrinsic qualities of the organism, others of which are the chemical and external physical 
environment. Awareness of these factors should lead to better use of disinfection and sterilization 
processes and will be briefly reviewed. More extensive consideration of these and other factors is 
available elsewhere 13, 14, 16, 411-413. 
 
 
Number and Location of Microorganisms 
 All other conditions remaining constant, the larger the number of microbes, the more time a germicide 
needs to destroy all of them. Spaulding illustrated this relation when he employed identical test conditions 
and demonstrated that it took 30 minutes to kill 10 B. atrophaeus (formerly Bacillus subtilis) spores but 3 
hours to kill 100,000 Bacillus atrophaeus spores. This reinforces the need for scrupulous cleaning of 
medical instruments before disinfection and sterilization. Reducing the number of microorganisms that 
must be inactivated through meticulous cleaning, increases the margin of safety when the germicide is 
used according to the labeling and shortens the exposure time required to kill the entire microbial load. 
Researchers also have shown that aggregated or clumped cells are more difficult to inactivate than 
monodispersed cells 414. 
 
 The location of microorganisms also must be considered when factors affecting the efficacy of 
germicides are assessed. Medical instruments with multiple pieces must be disassembled and equipment 
such as endoscopes that have crevices, joints, and channels are more difficult to disinfect than are flat- 
surface equipment because penetration of the disinfectant of all parts of the equipment is more difficult. 
Only surfaces that directly contact the germicide will be disinfected, so there must be no air pockets and 
the equipment must be completely immersed for the entire exposure period. Manufacturers should be 
encouraged to produce equipment engineered for ease of cleaning and disinfection. 
 
 
Innate Resistance of Microorganisms  
 Microorganisms vary greatly in their resistance to chemical germicides and sterilization processes 
(Figure 1) 342 Intrinsic resistance mechanisms in microorganisms to disinfectants vary. For example, 
spores are resistant to disinfectants because the spore coat and cortex act as a barrier, mycobacteria 
have a waxy cell wall that prevents disinfectant entry, and gram-negative bacteria possess an outer 
membrane that acts as a barrier to the uptake of disinfectants 341, 343-345. Implicit in all disinfection 
strategies is the consideration that the most resistant microbial subpopulation controls the sterilization or 
disinfection time. That is, to destroy the most resistant types of microorganisms (i.e., bacterial spores), the 
user needs to employ exposure times and a concentration of germicide needed to achieve complete 
destruction. Except for prions, bacterial spores possess the highest innate resistance to chemical 
germicides, followed by coccidia (e.g., Cryptosporidium), mycobacteria (e.g., M. tuberculosis), nonlipid or 
small viruses (e.g., poliovirus, and coxsackievirus), fungi (e.g., Aspergillus, and Candida), vegetative 
bacteria (e.g., Staphylococcus, and Pseudomonas) and lipid or medium-size viruses (e.g., herpes, and 
HIV). The germicidal resistance exhibited by the gram-positive and gram-negative bacteria is similar with 
some exceptions (e.g., P. aeruginosa which shows greater resistance to some disinfectants) 369, 415, 416. P. 
aeruginosa also is significantly more resistant to a variety of disinfectants in its “naturally occurring” state 
than are cells subcultured on laboratory media 415, 417. Rickettsiae, Chlamydiae, and mycoplasma cannot 
be placed in this scale of relative resistance because information about the efficacy of germicides against 
these agents is limited 418. Because these microorganisms contain lipid and are similar in structure and 
composition to other bacteria, they can be predicted to be inactivated by the same germicides that 
destroy lipid viruses and vegetative bacteria. A known exception to this supposition is Coxiella burnetti, 
which has demonstrated resistance to disinfectants 419. 
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Concentration and Potency of Disinfectants 
 With other variables constant, and with one exception (iodophors), the more concentrated the 
disinfectant, the greater its efficacy and the shorter the time necessary to achieve microbial kill. Generally 
not recognized, however, is that all disinfectants are not similarly affected by concentration adjustments. 
For example, quaternary ammonium compounds and phenol have a concentration exponent of 1 and 6, 
respectively; thus, halving the concentration of a quaternary ammonium compound requires doubling its 
disinfecting time, but halving the concentration of a phenol solution requires a 64-fold (i.e., 26) increase in 
its disinfecting time 365, 413, 420. 
 
 Considering the length of the disinfection time, which depends on the potency of the germicide, also 
is important. This was illustrated by Spaulding who demonstrated using the mucin-loop test that 70% 
isopropyl alcohol destroyed 104 M. tuberculosis in 5 minutes, whereas a simultaneous test with 3% 
phenolic required 2–3 hours to achieve the same level of microbial kill 14. 
 
 
Physical and Chemical Factors 
 Several physical and chemical factors also influence disinfectant procedures: temperature, pH, 
relative humidity, and water hardness. For example, the activity of most disinfectants increases as the 
temperature increases, but some exceptions exist. Furthermore, too great an increase in temperature 
causes the disinfectant to degrade and weakens its germicidal activity and thus might produce a potential 
health hazard. 
 
 An increase in pH improves the antimicrobial activity of some disinfectants (e.g., glutaraldehyde, 
quaternary ammonium compounds) but decreases the antimicrobial activity of others (e.g., phenols, 
hypochlorites, and iodine). The pH influences the antimicrobial activity by altering the disinfectant 
molecule or the cell surface 413. 
 
 Relative humidity is the single most important factor influencing the activity of gaseous 
disinfectants/sterilants, such as EtO, chlorine dioxide, and formaldehyde. 
 
 Water hardness (i.e., high concentration of divalent cations) reduces the rate of kill of certain 
disinfectants because divalent cations (e.g., magnesium, calcium) in the hard water interact with the 
disinfectant to form insoluble precipitates 13, 421. 
 
 
Organic and Inorganic Matter 
 Organic matter in the form of serum, blood, pus, or fecal or lubricant material can interfere with the 
antimicrobial activity of disinfectants in at least two ways. Most commonly, interference occurs by a 
chemical reaction between the germicide and the organic matter resulting in a complex that is less 
germicidal or nongermicidal, leaving less of the active germicide available for attacking microorganisms. 
Chlorine and iodine disinfectants, in particular, are prone to such interaction. Alternatively, organic 
material can protect microorganisms from attack by acting as a physical barrier 422, 423.  
 
 The effects of inorganic contaminants on the sterilization process were studied during the 1950s and 
1960s 424, 425. These and other studies show the protection by inorganic contaminants of microorganisms 
to all sterilization processes results from occlusion in salt crystals 426, 427. This further emphasizes the 
importance of meticulous cleaning of medical devices before any sterilization or disinfection procedure 
because both organic and inorganic soils are easily removed by washing 426. 
 
 
Duration of Exposure 
 Items must be exposed to the germicide for the appropriate minimum contact time. Multiple 
investigators have demonstrated the effectiveness of low-level disinfectants against vegetative bacteria 
(e.g., Listeria, E. coli, Salmonella, VRE, MRSA), yeasts (e.g., Candida), mycobacteria (e.g., M. 
tuberculosis), and viruses (e.g., poliovirus) at exposure times of 30–60 seconds 46-64. By law, all 
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applicable label instructions on EPA-registered products must be followed. If the user selects exposure 
conditions that differ from those on the EPA-registered product label, the user assumes liability for any 
injuries resulting from off-label use and is potentially subject to enforcement action under the Federal 
Insecticide, Fungicide, and Rodenticide Act (FIFRA). 
 
 All lumens and channels of endoscopic instruments must contact the disinfectant. Air pockets 
interfere with the disinfection process, and items that float on the disinfectant will not be disinfected. The 
disinfectant must be introduced reliably into the internal channels of the device. The exact times for 
disinfecting medical items are somewhat elusive because of the effect of the aforementioned factors on 
disinfection efficacy. Certain contact times have proved reliable (Table 1), but, in general, longer contact 




 Microorganisms may be protected from disinfectants by production of thick masses of cells 428 and 
extracellular materials, or biofilms 429-435. Biofilms are microbial communities that are tightly attached to 
surfaces and cannot be easly removed. Once these masses form, microbes within them can be resistant 
to disinfectants by multiple mechanisms, including physical characteristics of older biofilms, genotypic 
variation of the bacteria, microbial production of neutralizing enzymes, and physiologic gradients within 
the biofilm (e.g., pH). Bacteria within biofilms are up to 1,000 times more resistant to antimicrobials than 
are the same bacteria in suspension 436. Although new decontamination methods 437 are being 
investigated for removing biofilms, chlorine and monochloramines can effectively inactivate biofilm 
bacteria 431 438. Investigators have hypothesized that the glycocalyx-like cellular masses on the interior 
walls of polyvinyl chloride pipe would protect embedded organisms from some disinfectants and be a 
reservoir for continuous contamination 429, 430, 439. Biofilms have been found in whirlpools 440, dental unit 
waterlines441, and numerous medical devices (e.g., contact lenses, pacemakers, hemodialysis systems, 
urinary catheters, central venous catheters, endoscopes) 434, 436, 438, 442. Their presence can have serious 
implications for immunocompromised patients and patients who have indwelling medical devices. Some 
enzymes 436, 443, 444 and detergents 436 can degrade biofilms or reduce numbers of viable bacteria within a 
biofilm, but no products are EPA-registered or FDA-cleared for this purpose. 
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 Cleaning is the removal of foreign material (e.g., soil, and organic material) from objects and is 
normally accomplished using water with detergents or enzymatic products. Thorough cleaning is required 
before high-level disinfection and sterilization because inorganic and organic materials that remain on the 
surfaces of instruments interfere with the effectiveness of these processes. Also, if soiled materials dry or 
bake onto the instruments, the removal process becomes more difficult and the disinfection or sterilization 
process less effective or ineffective. Surgical instruments should be presoaked or rinsed to prevent drying 
of blood and to soften or remove blood from the instruments. 
 
 Cleaning is done manually in use areas without mechanical units (e.g., ultrasonic cleaners or washer-
disinfectors) or for fragile or difficult-to-clean instruments. With manual cleaning, the two essential 
components are friction and fluidics. Friction (e.g., rubbing/scrubbing the soiled area with a brush) is an 
old and dependable method. Fluidics (i.e., fluids under pressure) is used to remove soil and debris from 
internal channels after brushing and when the design does not allow passage of a brush through a 
channel 445. When a washer-disinfector is used, care should be taken in loading instruments: hinged 
instruments should be opened fully to allow adequate contact with the detergent solution; stacking of 
instruments in washers should be avoided; and instruments should be disassembled as much as 
possible.  
 
 The most common types of mechanical or automatic cleaners are ultrasonic cleaners, washer-
decontaminators, washer-disinfectors, and washer-sterilizers. Ultrasonic cleaning removes soil by 
cavitation and implosion in which waves of acoustic energy are propagated in aqueous solutions to 
disrupt the bonds that hold particulate matter to surfaces. Bacterial contamination can be present in used 
ultrasonic cleaning solutions (and other used detergent solutions) because these solutions generally do 
not make antibacterial label claims 446. Even though ultrasound alone does not significantly inactivate 
bacteria, sonication can act synergistically to increase the cidal efficacy of a disinfectant 447. Users of 
ultrasonic cleaners should be aware that the cleaning fluid could result in endotoxin contamination of 
surgical instruments, which could cause severe inflammatory reactions 448. Washer-sterilizers are 
modified steam sterilizers that clean by filling the chamber with water and detergent through which steam 
passes to provide agitation. Instruments are subsequently rinsed and subjected to a short steam-
sterilization cycle. Another washer-sterilizer employs rotating spray arms for a wash cycle followed by a 
steam sterilization cycle at 285°F 449, 450. Washer-decontaminators/disinfectors act like a dishwasher that 
uses a combination of water circulation and detergents to remove soil. These units sometimes have a 
cycle that subjects the instruments to a heat process (e.g., 93ºC for 10 minutes) 451. Washer-disinfectors 
are generally computer-controlled units for cleaning, disinfecting, and drying solid and hollow surgical and 
medical equipment. In one study, cleaning (measured as 5–6 log10 reduction) was achieved on surfaces 
that had adequate contact with the water flow in the machine 452. Detailed information about cleaning and 
preparing supplies for terminal sterilization is provided by professional organizations 453, 454 and books 455. 
Studies have shown that manual and mechanical cleaning of endoscopes achieves approximately a 4-
log10 reduction of contaminating organisms 83, 104, 456, 457. Thus, cleaning alone effectively reduces the 
number of microorganisms on contaminated equipment. In a quantitative analysis of residual protein 
contamination of reprocessed surgical instruments, median levels of residual protein contamination per 
instrument for five trays were 267, 260, 163, 456, and 756 µg 458. In another study, the median amount of 
protein from reprocessed surgical instruments from different hospitals ranged from 8 µg to 91 µg 459. 
When manual methods were compared with automated methods for cleaning reusable accessory devices 
used for minimally invasive surgical procedures, the automated method was more efficient for cleaning 
biopsy forceps and ported and nonported laparoscopic devices and achieved a >99% reduction in soil 
parameters (i.e., protein, carbohydrate, hemoglobin) in the ported and nonported laparoscopic devices 460, 
461 
 
 For instrument cleaning, a neutral or near-neutral pH detergent solution commonly is used because 
such solutions generally provide the best material compatibility profile and good soil removal. Enzymes, 
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usually proteases, sometimes are added to neutral pH solutions to assist in removing organic material. 
Enzymes in these formulations attack proteins that make up a large portion of common soil (e.g., blood, 
pus). Cleaning solutions also can contain lipases (enzymes active on fats) and amylases (enzymes active 
on starches). Enzymatic cleaners are not disinfectants, and proteinaceous enzymes can be inactivated by 
germicides. As with all chemicals, enzymes must be rinsed from the equipment or adverse reactions (e.g., 
fever, residual amounts of high-level disinfectants, proteinaceous residue) could result 462, 463. Enzyme 
solutions should be used in accordance with manufacturer’s instructions, which include proper dilution of 
the enzymatic detergent and contact with equipment for the amount of time specified on the label 463. 
Detergent enzymes can result in asthma or other allergic effects in users. Neutral pH detergent solutions 
that contain enzymes are compatible with metals and other materials used in medical instruments and are 
the best choice for cleaning delicate medical instruments, especially flexible endoscopes 457. Alkaline-
based cleaning agents are used for processing medical devices because they efficiently dissolve protein 
and fat residues 464; however, they can be corrosive 457. Some data demonstrate that enzymatic cleaners 
are more effective than neutral detergents 465, 466 in removing microorganisms from surfaces but two more 
recent studies found no difference in cleaning efficiency between enzymatic and alkaline-based cleaners 
443, 464. Another study found no significant difference between enzymatic and non-enzymatic cleaners in 
terms of microbial cleaning efficacy 467. A new non-enzyme, hydrogen peroxide-based formulation (not 
FDA-cleared) was as effective as enzymatic cleaners in removing protein, blood, carbohydrate, and 
endotoxin from surface test carriers468 In addition, this product effected a 5-log10 reduction in microbial 
loads with a 3-minute exposure at room temperature 468.  
 
 Although the effectiveness of high-level disinfection and sterilization mandates effective cleaning, no 
“real-time” tests exist that can be employed in a clinical setting to verify cleaning. If such tests were 
commercially available they could be used to ensure an adequate level of cleaning.469-472 The only way to 
ensure adequate cleaning is to conduct a reprocessing verification test (e.g., microbiologic sampling), but 
this is not routinely recommended 473. Validation of the cleaning processes in a laboratory-testing program 
is possible by microorganism detection, chemical detection for organic contaminants, radionuclide 
tagging, and chemical detection for specific ions 426, 471. During the past few years, data have been 
published describing use of an artificial soil, protein, endotoxin, X-ray contrast medium, or blood to verify 
the manual or automated cleaning process 169, 452, 474-478 and adenosine triphosphate bioluminescence and 
microbiologic sampling to evaluate the effectiveness of environmental surface cleaning170, 479. At a 
minimum, all instruments should be individually inspected and be visibly clean. 
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 Many disinfectants are used alone or in combinations (e.g., hydrogen peroxide and peracetic acid) in 
the health-care setting. These include alcohols, chlorine and chlorine compounds, formaldehyde, 
glutaraldehyde, ortho-phthalaldehyde, hydrogen peroxide, iodophors, peracetic acid, phenolics, and 
quaternary ammonium compounds. Commercial formulations based on these chemicals are considered 
unique products and must be registered with EPA or cleared by FDA. In most instances, a given product 
is designed for a specific purpose and is to be used in a certain manner. Therefore, users should read 
labels carefully to ensure the correct product is selected for the intended use and applied efficiently. 
 
 Disinfectants are not interchangeable, and incorrect concentrations and inappropriate disinfectants 
can result in excessive costs. Because occupational diseases among cleaning personnel have been 
associated with use of several disinfectants (e.g., formaldehyde, glutaraldehyde, and chlorine), 
precautions (e.g., gloves and proper ventilation) should be used to minimize exposure 318, 480, 481. Asthma 
and reactive airway disease can occur in sensitized persons exposed to any airborne chemical, including 
germicides. Clinically important asthma can occur at levels below ceiling levels regulated by OSHA or 
recommended by NIOSH. The preferred method of control is elimination of the chemical (through 
engineering controls or substitution) or relocation of the worker. 
 
 The following overview of the performance characteristics of each provides users with sufficient 





 Overview. In the healthcare setting, “alcohol” refers to two water-soluble chemical compounds—ethyl 
alcohol and isopropyl alcohol—that have generally underrated germicidal characteristics 482. FDA has not 
cleared any liquid chemical sterilant or high-level disinfectant with alcohol as the main active ingredient. 
These alcohols are rapidly bactericidal rather than bacteriostatic against vegetative forms of bacteria; 
they also are tuberculocidal, fungicidal, and virucidal but do not destroy bacterial spores. Their cidal 
activity drops sharply when diluted below 50% concentration, and the optimum bactericidal concentration 
is 60%–90% solutions in water (volume/volume) 483, 484.  
 
 Mode of Action. The most feasible explanation for the antimicrobial action of alcohol is denaturation 
of proteins. This mechanism is supported by the observation that absolute ethyl alcohol, a dehydrating 
agent, is less bactericidal than mixtures of alcohol and water because proteins are denatured more 
quickly in the presence of water 484, 485. Protein denaturation also is consistent with observations that 
alcohol destroys the dehydrogenases of Escherichia coli 486, and that ethyl alcohol increases the lag 
phase of Enterobacter aerogenes 487 and that the lag phase effect could be reversed by adding certain 
amino acids. The bacteriostatic action was believed caused by inhibition of the production of metabolites 
essential for rapid cell division. 
 
 Microbicidal Activity. Methyl alcohol (methanol) has the weakest bactericidal action of the alcohols 
and thus seldom is used in healthcare 488. The bactericidal activity of various concentrations of ethyl 
alcohol (ethanol) was examined against a variety of microorganisms in exposure periods ranging from 10 
seconds to 1 hour 483. Pseudomonas aeruginosa was killed in 10 seconds by all concentrations of ethanol 
from 30% to 100% (v/v), and Serratia marcescens, E, coli and Salmonella typhosa were killed in 10 
seconds by all concentrations of ethanol from 40% to 100%. The gram-positive organisms 
Staphylococcus aureus and Streptococcus pyogenes were slightly more resistant, being killed in 10 
seconds by ethyl alcohol concentrations of 60%–95%. Isopropyl alcohol (isopropanol) was slightly more 
bactericidal than ethyl alcohol for E. coli and S. aureus 489. 
 
 Ethyl alcohol, at concentrations of 60%–80%, is a potent virucidal agent inactivating all of the 
lipophilic viruses (e.g., herpes, vaccinia, and influenza virus) and many hydrophilic viruses (e.g., 
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adenovirus, enterovirus, rhinovirus, and rotaviruses but not hepatitis A virus (HAV) 58 or poliovirus) 49. 
Isopropyl alcohol is not active against the nonlipid enteroviruses but is fully active against the lipid viruses 
72. Studies also have demonstrated the ability of ethyl and isopropyl alcohol to inactivate the hepatitis B 
virus(HBV) 224, 225 and the herpes virus, 490 and ethyl alcohol to inactivate human immunodeficiency virus 
(HIV) 227, rotavirus, echovirus, and astrovirus 491. 
 
 In tests of the effect of ethyl alcohol against M. tuberculosis, 95% ethanol killed the tubercle bacilli 
in sputum or water suspension within 15 seconds 492. In 1964, Spaulding stated that alcohols were 
the germicide of choice for tuberculocidal activity, and they should be the standard by which all other 
tuberculocides are compared. For example, he compared the tuberculocidal activity of iodophor (450 
ppm), a substituted phenol (3%), and isopropanol (70%/volume) using the mucin-loop test (106 M. 
tuberculosis per loop) and determined the contact times needed for complete destruction were 120–
180 minutes, 45–60 minutes, and 5 minutes, respectively. The mucin-loop test is a severe test 
developed to produce long survival times. Thus, these figures should not be extrapolated to the 
exposure times needed when these germicides are used on medical or surgical material 482. 
 
 Ethyl alcohol (70%) was the most effective concentration for killing the tissue phase of 
Cryptococcus neoformans, Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma 
capsulatum and the culture phases of the latter three organisms aerosolized onto various surfaces. 
The culture phase was more resistant to the action of ethyl alcohol and required about 20 minutes to 
disinfect the contaminated surface, compared with <1 minute for the tissue phase 493, 494. 
 
 Isopropyl alcohol (20%) is effective in killing the cysts of Acanthamoeba culbertsoni (560) as are 
chlorhexidine, hydrogen peroxide, and thimerosal 496.  
 
 Uses. Alcohols are not recommended for sterilizing medical and surgical materials principally 
because they lack sporicidal action and they cannot penetrate protein-rich materials. Fatal 
postoperative wound infections with Clostridium have occurred when alcohols were used to sterilize 
surgical instruments contaminated with bacterial spores 497. Alcohols have been used effectively to 
disinfect oral and rectal thermometers498, 499, hospital pagers 500, scissors 501, and stethoscopes 502. 
Alcohols have been used to disinfect fiberoptic endoscopes 503, 504 but failure of this disinfectant have 
lead to infection 280, 505. Alcohol towelettes have been used for years to disinfect small surfaces such 
as rubber stoppers of multiple-dose medication vials or vaccine bottles. Furthermore, alcohol 
occasionally is used to disinfect external surfaces of equipment (e.g., stethoscopes, ventilators, 
manual ventilation bags) 506, CPR manikins 507, ultrasound instruments 508 or medication preparation 
areas. Two studies demonstrated the effectiveness of 70% isopropyl alcohol to disinfect reusable 
transducer heads in a controlled environment 509, 510. In contrast, three bloodstream infection 
outbreaks have been described when alcohol was used to disinfect transducer heads in an intensive-
care setting 511.  
 
 The documented shortcomings of alcohols on equipment are that they damage the shellac 
mountings of lensed instruments, tend to swell and harden rubber and certain plastic tubing after 
prolonged and repeated use, bleach rubber and plastic tiles 482 and damage tonometer tips (by 
deterioration of the glue) after the equivalent of 1 working year of routine use 512. Tonometer biprisms 
soaked in alcohol for 4 days developed rough front surfaces that potentially could cause corneal 
damage; this appeared to be caused by weakening of the cementing substances used to fabricate the 
biprisms 513. Corneal opacification has been reported when tonometer tips were swabbed with alcohol 
immediately before measurement of intraocular pressure 514. Alcohols are flammable and 
consequently must be stored in a cool, well-ventilated area. They also evaporate rapidly, making 
extended exposure time difficult to achieve unless the items are immersed. 
 
Chlorine and Chlorine Compounds 
 Overview. Hypochlorites, the most widely used of the chlorine disinfectants, are available as liquid 
(e.g., sodium hypochlorite) or solid (e.g., calcium hypochlorite). The most prevalent chlorine products in 
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the United States are aqueous solutions of 5.25%–6.15% sodium hypochlorite (see glossary), usually 
called household bleach. They have a broad spectrum of antimicrobial activity, do not leave toxic 
residues, are unaffected by water hardness, are inexpensive and fast acting 328, remove dried or fixed 
organisms and biofilms from surfaces465, and have a low incidence of serious toxicity 515-517. Sodium 
hypochlorite at the concentration used in household bleach (5.25-6.15%) can produce ocular irritation or 
oropharyngeal, esophageal, and gastric burns 318, 518-522. Other disadvantages of hypochlorites include 
corrosiveness to metals in high concentrations (>500 ppm), inactivation by organic matter, discoloring or 
“bleaching” of fabrics, release of toxic chlorine gas when mixed with ammonia or acid (e.g., household 
cleaning agents) 523-525, and relative stability 327. The microbicidal activity of chlorine is attributed largely to 
undissociated hypochlorous acid (HOCl). The dissociation of HOCI to the less microbicidal form 
(hypochlorite ion OCl-) depends on pH. The disinfecting efficacy of chlorine decreases with an increase in 
pH that parallels the conversion of undissociated HOCI to OCl- 329, 526. A potential hazard is production of 
the carcinogen bis(chloromethyl) ether when hypochlorite solutions contact formaldehyde 527 and the 
production of the animal carcinogen trihalomethane when hot water is hyperchlorinated 528. After 
reviewing environmental fate and ecologic data, EPA has determined the currently registered uses of 
hypochlorites will not result in unreasonable adverse effects to the environment 529.  
 
 Alternative compounds that release chlorine and are used in the health-care setting include demand-
release chlorine dioxide, sodium dichloroisocyanurate, and chloramine-T. The advantage of these 
compounds over the hypochlorites is that they retain chlorine longer and so exert a more prolonged 
bactericidal effect. Sodium dichloroisocyanurate tablets are stable, and for two reasons, the microbicidal 
activity of solutions prepared from sodium dichloroisocyanurate tablets might be greater than that of 
sodium hypochlorite solutions containing the same total available chlorine. First, with sodium 
dichloroisocyanurate, only 50% of the total available chlorine is free (HOCl and OCl-), whereas the 
remainder is combined (monochloroisocyanurate or dichloroisocyanurate), and as free available chlorine 
is used up, the latter is released to restore the equilibrium. Second, solutions of sodium 
dichloroisocyanurate are acidic, whereas sodium hypochlorite solutions are alkaline, and the more 
microbicidal type of chlorine (HOCl) is believed to predominate 530-533. Chlorine dioxide-based 
disinfectants are prepared fresh as required by mixing the two components (base solution [citric acid 
with preservatives and corrosion inhibitors] and the activator solution [sodium chlorite]). In vitro 
suspension tests showed that solutions containing about 140 ppm chlorine dioxide achieved a reduction 
factor exceeding 106 of S. aureus in 1 minute and of Bacillus atrophaeus spores in 2.5 minutes in the 
presence of 3 g/L bovine albumin. The potential for damaging equipment requires consideration because 
long-term use can damage the outer plastic coat of the insertion tube 534. In another study, chlorine 
dioxide solutions at either 600 ppm or 30 ppm killed Mycobacterium avium-intracellulare within 60 
seconds after contact but contamination by organic material significantly affected the microbicidal 
properties535.  
 
 The microbicidal activity of a new disinfectant, “superoxidized water,” has been examined The 
concept of electrolyzing saline to create a disinfectant or antiseptics is appealing because the basic 
materials of saline and electricity are inexpensive and the end product (i.e., water) does not damage the 
environment. The main products of this water are hypochlorous acid (e.g., at a concentration of about 
144 mg/L) and chlorine. As with any germicide, the antimicrobial activity of superoxidized water is 
strongly affected by the concentration of the active ingredient (available free chlorine) 536. One 
manufacturer generates the disinfectant at the point of use by passing a saline solution over coated 
titanium electrodes at 9 amps. The product generated has a pH of 5.0–6.5 and an oxidation-reduction 
potential (redox) of >950 mV. Although superoxidized water is intended to be generated fresh at the 
point of use, when tested under clean conditions the disinfectant was effective within 5 minutes when 48 
hours old 537. Unfortunately, the equipment required to produce the product can be expensive because 
parameters such as pH, current, and redox potential must be closely monitored. The solution is nontoxic 
to biologic tissues. Although the United Kingdom manufacturer claims the solution is noncorrosive and 
nondamaging to endoscopes and processing equipment, one flexible endoscope manufacturer 
(Olympus Key-Med, United Kingdom) has voided the warranty on the endoscopes if superoxidized water 
is used to disinfect them 538. As with any germicide formulation, the user should check with the device 
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manufacturer for compatibility with the germicide. Additional studies are needed to determine whether 
this solution could be used as an alternative to other disinfectants or antiseptics for hand washing, skin 
antisepsis, room cleaning, or equipment disinfection (e.g., endoscopes, dialyzers) 400, 539, 540. In October 
2002, the FDA cleared superoxidized water as a high-level disinfectant (FDA, personal communication, 
September 18, 2002). 
 
 Mode of Action. The exact mechanism by which free chlorine destroys microorganisms has not been 
elucidated. Inactivation by chlorine can result from a number of factors: oxidation of sulfhydryl enzymes 
and amino acids; ring chlorination of amino acids; loss of intracellular contents; decreased uptake of 
nutrients; inhibition of protein synthesis; decreased oxygen uptake; oxidation of respiratory components; 
decreased adenosine triphosphate production; breaks in DNA; and depressed DNA synthesis 329, 347. The 
actual microbicidal mechanism of chlorine might involve a combination of these factors or the effect of 
chlorine on critical sites 347. 
 
 Microbicidal Activity. Low concentrations of free available chlorine (e.g., HOCl, OCl-, and elemental 
chlorine-Cl2) have a biocidal effect on mycoplasma (25 ppm) and vegetative bacteria (<5 ppm) in seconds 
in the absence of an organic load 329, 418. Higher concentrations (1,000 ppm) of chlorine are required to kill 
M. tuberculosis using the Association of Official Analytical Chemists (AOAC) tuberculocidal test 73. A 
concentration of 100 ppm will kill ≥99.9% of B. atrophaeus spores within 5 minutes 541, 542 and destroy 
mycotic agents in <1 hour 329. Acidified bleach and regular bleach (5,000 ppm chlorine) can inactivate 106 
Clostridium difficile spores in ≤10 minutes 262. One study reported that 25 different viruses were 
inactivated in 10 minutes with 200 ppm available chlorine 72. Several studies have demonstrated the 
effectiveness of diluted sodium hypochlorite and other disinfectants to inactivate HIV 61. Chlorine (500 
ppm) showed inhibition of Candida after 30 seconds of exposure 54. In experiments using the AOAC Use-
Dilution Method, 100 ppm of free chlorine killed 106–107 S. aureus, Salmonella choleraesuis, and P. 
aeruginosa in <10 minutes 327. Because household bleach contains 5.25%–6.15% sodium hypochlorite, 
or 52,500–61,500 ppm available chlorine, a 1:1,000 dilution provides about 53–62 ppm available chlorine, 
and a 1:10 dilution of household bleach provides about 5250–6150 ppm. 
 
 Data are available for chlorine dioxide that support manufacturers' bactericidal, fungicidal, sporicidal, 
tuberculocidal, and virucidal label claims 543-546. A chlorine dioxide generator has been shown effective for 
decontaminating flexible endoscopes 534 but it is not currently FDA-cleared for use as a high-level 
disinfectant 85. Chlorine dioxide can be produced by mixing solutions, such as a solution of chlorine with a 
solution of sodium chlorite 329. In 1986, a chlorine dioxide product was voluntarily removed from the 
market when its use caused leakage of cellulose-based dialyzer membranes, which allowed bacteria to 
migrate from the dialysis fluid side of the dialyzer to the blood side 547. 
 
 Sodium dichloroisocyanurate at 2,500 ppm available chlorine is effective against bacteria in the 
presence of up to 20% plasma, compared with 10% plasma for sodium hypochlorite at 2,500 ppm 548. 
 
 “Superoxidized water” has been tested against bacteria, mycobacteria, viruses, fungi, and spores 537, 
539, 549. Freshly generated superoxidized water is rapidly effective (<2 minutes) in achieving a 5-log10 
reduction of pathogenic microorganisms (i.e., M. tuberculosis, M. chelonae, poliovirus, HIV, multidrug-
resistant S. aureus, E. coli, Candida albicans, Enterococcus faecalis, P. aeruginosa) in the absence of 
organic loading. However, the biocidal activity of this disinfectant decreased substantially in the presence 
of organic material (e.g., 5% horse serum) 537, 549, 550. No bacteria or viruses were detected on artificially 
contaminated endoscopes after a 5-minute exposure to superoxidized water 551 and HBV-DNA was not 
detected from any endoscope experimentally contaminated with HBV-positive mixed sera after a 
disinfectant exposure time of 7 minutes552.  
 
 Uses. Hypochlorites are widely used in healthcare facilities in a variety of settings. 328 Inorganic 
chlorine solution is used for disinfecting tonometer heads 188 and for spot-disinfection of countertops and 
floors. A 1:10–1:100 dilution of 5.25%–6.15% sodium hypochlorite (i.e., household bleach) 22, 228, 553, 554 or 
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an EPA-registered tuberculocidal disinfectant 17has been recommended for decontaminating blood spills. 
For small spills of blood (i.e., drops of blood) on noncritical surfaces, the area can be disinfected with a 
1:100 dilution of 5.25%-6.15% sodium hypochlorite or an EPA-registered tuberculocidal disinfectant. 
Because hypochlorites and other germicides are substantially inactivated in the presence of blood 63, 548, 
555, 556, large spills of blood require that the surface be cleaned before an EPA-registered disinfectant or a 
1:10 (final concentration) solution of household bleach is applied 557. If a sharps injury is possible, the 
surface initially should be decontaminated 69, 318, then cleaned and disinfected (1:10 final concentration) 
63. Extreme care always should be taken to prevent percutaneous injury. At least 500 ppm available 
chlorine for 10 minutes is recommended for decontaminating CPR training manikins 558. Full-strength 
bleach has been recommended for self-disinfection of needles and syringes used for illicit-drug injection 
when needle-exchange programs are not available. The difference in the recommended concentrations of 
bleach reflects the difficulty of cleaning the interior of needles and syringes and the use of needles and 
syringes for parenteral injection 559. Clinicians should not alter their use of chlorine on environmental 
surfaces on the basis of testing methodologies that do not simulate actual disinfection practices 560, 561. 
Other uses in healthcare include as an irrigating agent in endodontic treatment 562 and as a disinfectant 
for manikins, laundry, dental appliances, hydrotherapy tanks 23, 41, regulated medical waste before 
disposal 328, and the water distribution system in hemodialysis centers and hemodialysis machines 563.  
 
 Chlorine long has been used as the disinfectant in water treatment. Hyperchlorination of a Legionella-
contaminated hospital water system 23 resulted in a dramatic decrease (from 30% to 1.5%) in the isolation 
of L. pneumophila from water outlets and a cessation of healthcare-associated Legionnaires' disease in 
an affected unit 528, 564. Water disinfection with monochloramine by municipal water-treatment plants 
substantially reduced the risk for healthcare–associated Legionnaires disease 565, 566. Chlorine dioxide 
also has been used to control Legionella in a hospital water supply. 567 Chloramine T 568 and 
hypochlorites 41 have been used to disinfect hydrotherapy equipment.  
 
 Hypochlorite solutions in tap water at a pH >8 stored at room temperature (23ºC) in closed, opaque 
plastic containers can lose up to 40%–50% of their free available chlorine level over 1 month. Thus, if a 
user wished to have a solution containing 500 ppm of available chlorine at day 30, he or she should 
prepare a solution containing 1,000 ppm of chlorine at time 0. Sodium hypochlorite solution does not 
decompose after 30 days when stored in a closed brown bottle 327. 
 
 The use of powders, composed of a mixture of a chlorine-releasing agent with highly absorbent resin, 
for disinfecting spills of body fluids has been evaluated by laboratory tests and hospital ward trials. The 
inclusion of acrylic resin particles in formulations markedly increases the volume of fluid that can be 
soaked up because the resin can absorb 200–300 times its own weight of fluid, depending on the fluid 
consistency. When experimental formulations containing 1%, 5%, and 10% available chlorine were 
evaluated by a standardized surface test, those containing 10% demonstrated bactericidal activity. One 





 Overview. Formaldehyde is used as a disinfectant and sterilant in both its liquid and gaseous states. 
Liquid formaldehyde will be considered briefly in this section, and the gaseous form is reviewed 
elsewhere 570. Formaldehyde is sold and used principally as a water-based solution called formalin, which 
is 37% formaldehyde by weight. The aqueous solution is a bactericide, tuberculocide, fungicide, virucide 
and sporicide 72, 82, 571-573. OSHA indicated that formaldehyde should be handled in the workplace as a 
potential carcinogen and set an employee exposure standard for formaldehyde that limits an 8-hour time-
weighted average exposure concentration of 0.75 ppm 574, 575. The standard includes a second 
permissible exposure limit in the form of a short-term exposure limit (STEL) of 2 ppm that is the maximum 
exposure allowed during a 15-minute period 576. Ingestion of formaldehyde can be fatal, and long-term 
exposure to low levels in the air or on the skin can cause asthma-like respiratory problems and skin 
irritation, such as dermatitis and itching. For these reasons, employees should have limited direct contact 
Guideline for Disinfection and Sterilization in Healthcare Facilities (2008) 
 
Last update: Feburary 15, 2017 43 of 161 
  
with formaldehyde, and these considerations limit its role in sterilization and disinfection processes. Key 
provisions of the OSHA standard that protects workers from exposure to formaldehyde appear in Title 29 
of the Code of Federal Regulations (CFR) Part 1910.1048 (and equivalent regulations in states with 
OSHA-approved state plans) 577. 
 
 Mode of Action. Formaldehyde inactivates microorganisms by alkylating the amino and sulfhydral 
groups of proteins and ring nitrogen atoms of purine bases 376. 
 
 Microbicidal Activity. Varying concentrations of aqueous formaldehyde solutions destroy a wide 
range of microorganisms. Inactivation of poliovirus in 10 minutes required an 8% concentration of 
formalin, but all other viruses tested were inactivated with 2% formalin 72. Four percent formaldehyde is a 
tuberculocidal agent, inactivating 104 M. tuberculosis in 2 minutes 82, and 2.5% formaldehyde inactivated 
about 107 Salmonella Typhi in 10 minutes in the presence of organic matter 572. The sporicidal action of 
formaldehyde was slower than that of glutaraldehyde in comparative tests with 4% aqueous 
formaldehyde and 2% glutaraldehyde against the spores of B. anthracis 82. The formaldehyde solution 
required 2 hours of contact to achieve an inactivation factor of 104, whereas glutaraldehyde required only 
15 minutes. 
 
 Uses. Although formaldehyde-alcohol is a chemical sterilant and formaldehyde is a high-level 
disinfectant, the health-care uses of formaldehyde are limited by its irritating fumes and its pungent odor 
even at very low levels (<1 ppm). For these reasons and others—such as its role as a suspected human 
carcinogen linked to nasal cancer and lung cancer 578, this germicide is excluded from Table 1. When it is 
used, , direct exposure to employees generally is limited; however, excessive exposures to formaldehyde 
have been documented for employees of renal transplant units 574, 579, and students in a gross anatomy 
laboratory 580. Formaldehyde is used in the health-care setting to prepare viral vaccines (e.g., poliovirus 
and influenza); as an embalming agent; and to preserve anatomic specimens; and historically has been 
used to sterilize surgical instruments, especially when mixed with ethanol. A 1997 survey found that 
formaldehyde was used for reprocessing hemodialyzers by 34% of U.S. hemodialysis centers—a 60% 
decrease from 1983 249, 581. If used at room temperature, a concentration of 4% with a minimum exposure 
of 24 hours is required to disinfect disposable hemodialyzers reused on the same patient 582, 583. Aqueous 
formaldehyde solutions (1%–2%) also have been used to disinfect the internal fluid pathways of dialysis 
machines 583. To minimize a potential health hazard to dialysis patients, the dialysis equipment must be 
thoroughly rinsed and tested for residual formaldehyde before use. 
 
 Paraformaldehyde, a solid polymer of formaldehyde, can be vaporized by heat for the gaseous 
decontamination of laminar flow biologic safety cabinets when maintenance work or filter changes require 




 Overview. Glutaraldehyde is a saturated dialdehyde that has gained wide acceptance as a high-level 
disinfectant and chemical sterilant 107. Aqueous solutions of glutaraldehyde are acidic and generally in this 
state are not sporicidal. Only when the solution is “activated” (made alkaline) by use of alkalinating agents 
to pH 7.5–8.5 does the solution become sporicidal. Once activated, these solutions have a shelf-life of 
minimally 14 days because of the polymerization of the glutaraldehyde molecules at alkaline pH levels. 
This polymerization blocks the active sites (aldehyde groups) of the glutaraldehyde molecules that are 
responsible for its biocidal activity. 
 
 Novel glutaraldehyde formulations (e.g., glutaraldehyde-phenol-sodium phenate, potentiated acid 
glutaraldehyde, stabilized alkaline glutaraldehyde) produced in the past 30 years have overcome the 
problem of rapid loss of activity (e.g., use-life 28–30 days) while generally maintaining excellent 
microbicidal activity 584-588. However, antimicrobial activity depends not only on age but also on use 
conditions, such as dilution and organic stress. Manufacturers' literature for these preparations suggests 
the neutral or alkaline glutaraldehydes possess microbicidal and anticorrosion properties superior to 
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those of acid glutaraldehydes, and a few published reports substantiate these claims 542, 589, 590. However, 
two studies found no difference in the microbicidal activity of alkaline and acid glutaraldehydes 73, 591. The 
use of glutaraldehyde-based solutions in health-care facilities is widespread because of their advantages, 
including excellent biocidal properties; activity in the presence of organic matter (20% bovine serum); and 
noncorrosive action to endoscopic equipment, thermometers, rubber, or plastic equipment (Tables 4 and 
5). 
 
 Mode of Action. The biocidal activity of glutaraldehyde results from its alkylation of sulfhydryl, 
hydroxyl, carboxyl, and amino groups of microorganisms, which alters RNA, DNA, and protein synthesis. 
The mechanism of action of glutaraldehydes are reviewed extensively elsewhere 592, 593. 
 
 Microbicidal Activity. The in vitro inactivation of microorganisms by glutaraldehydes has been 
extensively investigated and reviewed 592, 593. Several investigators showed that ≥2% aqueous solutions 
of glutaraldehyde, buffered to pH 7.5–8.5 with sodium bicarbonate effectively killed vegetative bacteria in 
<2 minutes; M. tuberculosis, fungi, and viruses in <10 minutes; and spores of Bacillus and Clostridium 
species in 3 hours 542, 592-597. Spores of C. difficile are more rapidly killed by 2% glutaraldehyde than are 
spores of other species of Clostridium and Bacillus 79, 265, 266. Microorganisms with substantial resistance 
to glutaraldehyde have been reported, including some mycobacteria (M. chelonae, Mycobacterium avium-
intracellulare, M. xenopi) 598-601, Methylobacterium mesophilicum 602, Trichosporon, fungal ascospores 
(e.g., Microascus cinereus, Cheatomium globosum), and Cryptosporidium271, 603. M. chelonae persisted in 
a 0.2% glutaraldehyde solution used to store porcine prosthetic heart valves 604.  
 
 Two percent alkaline glutaraldehyde solution inactivated 105 M. tuberculosis cells on the surface of 
penicylinders within 5 minutes at 18ºC 589. However, subsequent studies82 questioned the 
mycobactericidal prowess of glutaraldehydes. Two percent alkaline glutaraldehyde has slow action (20 to 
>30 minutes) against M. tuberculosis and compares unfavorably with alcohols, formaldehydes, iodine, 
and phenol 82. Suspensions of M. avium, M. intracellulare, and M. gordonae were more resistant to 
inactivation by a 2% alkaline glutaraldehyde (estimated time to complete inactivation: ~60 minutes) than 
were virulent M. tuberculosis (estimated time to complete inactivation ~25 minutes) 605. The rate of kill 
was directly proportional to the temperature, and a standardized suspension of M. tuberculosis could not 
be sterilized within 10 minutes 84. An FDA-cleared chemical sterilant containing 2.5% glutaraldehyde uses 
increased temperature (35ºC) to reduce the time required to achieve high-level disinfection (5 minutes) 85, 
606, but its use is limited to automatic endoscope reprocessors equipped with a heater. In another study 
employing membrane filters for measurement of mycobactericidal activity of 2% alkaline glutaraldehyde, 
complete inactivation was achieved within 20 minutes at 20ºC when the test inoculum was 106 M. 
tuberculosis per membrane 81. Several investigators 55, 57, 73, 76, 80, 81, 84, 605 have demonstrated that 
glutaraldehyde solutions inactivate 2.4 to >5.0 log10 of M. tuberculosis in 10 minutes (including multidrug-
resistant M. tuberculosis) and 4.0–6.4 log10 of M. tuberculosis in 20 minutes. On the basis of these data 
and other studies, 20 minutes at room temperature is considered the minimum exposure time needed to 
reliably kill Mycobacteria and other vegetative bacteria with ≥2% glutaraldehyde 17, 19, 27, 57, 83, 94, 108, 111, 117-
121, 607.  
 
 Glutaraldehyde is commonly diluted during use, and studies showed a glutaraldehyde concentration 
decline after a few days of use in an automatic endoscope washer 608, 609. The decline occurs because 
instruments are not thoroughly dried and water is carried in with the instrument, which increases the 
solution’s volume and dilutes its effective concentration 610. This emphasizes the need to ensure that 
semicritical equipment is disinfected with an acceptable concentration of glutaraldehyde. Data suggest 
that 1.0%–1.5% glutaraldehyde is the minimum effective concentration for >2% glutaraldehyde solutions 
when used as a high-level disinfectant 76, 589, 590, 609. Chemical test strips or liquid chemical monitors 610, 611 
are available for determining whether an effective concentration of glutaraldehyde is present despite 
repeated use and dilution. The frequency of testing should be based on how frequently the solutions are 
used (e.g., used daily, test daily; used weekly, test before use; used 30 times per day, test each 10th 
use), but the strips should not be used to extend the use life beyond the expiration date. Data suggest the 
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chemicals in the test strip deteriorate with time 612 and a manufacturer’s expiration date should be placed 
on the bottles. The bottle of test strips should be dated when opened and used for the period of time 
indicated on the bottle (e.g., 120 days). The results of test strip monitoring should be documented. The 
glutaraldehyde test kits have been preliminarily evaluated for accuracy and range 612 but the reliability has 
been questioned 613. To ensure the presence of minimum effective concentration of the high-level 
disinfectant, manufacturers of some chemical test strips recommend the use of quality-control procedures 
to ensure the strips perform properly. If the manufacturer of the chemical test strip recommends a quality-
control procedure, users should comply with the manufacturer’s recommendations. The concentration 
should be considered unacceptable or unsafe when the test indicates a dilution below the product’s 
minimum effective concentration (MEC) (generally to ≤1.0%–1.5% glutaraldehyde) by the indicator not 
changing color. 
 
 A 2.0% glutaraldehyde–7.05% phenol–1.20% sodium phenate product that contained 0.125% 
glutaraldehyde–0.44% phenol–0.075% sodium phenate when diluted 1:16 is not recommended as a high-
level disinfectant because it lacks bactericidal activity in the presence of organic matter and lacks 
tuberculocidal, fungicidal, virucidal, and sporicidal activity 49, 55, 56, 71, 73-79, 614. In December 1991, EPA 
issued an order to stop the sale of all batches of this product because of efficacy data showing the product 
is not effective against spores and possibly other microorganisms or inanimate objects as claimed on the 
label 615. FDA has cleared a glutaraldehyde–phenol/phenate concentrate as a high-level disinfectant that 
contains 1.12% glutaraldehyde with 1.93% phenol/phenate at its use concentration. Other FDA cleared 
glutaraldehyde sterilants that contain 2.4%–3.4% glutaraldehyde are used undiluted 606. 
 
 
 Uses. Glutaraldehyde is used most commonly as a high-level disinfectant for medical equipment 
such as endoscopes 69, 107, 504, spirometry tubing, dialyzers 616, transducers, anesthesia and respiratory 
therapy equipment 617, hemodialysis proportioning and dialysate delivery systems 249, 618, and reuse of 
laparoscopic disposable plastic trocars 619. Glutaraldehyde is noncorrosive to metal and does not damage 
lensed instruments, rubber. or plastics. Glutaraldehyde should not be used for cleaning noncritical 
surfaces because it is too toxic and expensive.  
 
 Colitis believed caused by glutaraldehyde exposure from residual disinfecting solution in endoscope 
solution channels has been reported and is preventable by careful endoscope rinsing 318, 620-630. One 
study found that residual glutaraldehyde levels were higher and more variable after manual disinfection 
(<0.2 mg/L to 159.5 mg/L) than after automatic disinfection (0.2–6.3 mg/L)631. Similarly, keratopathy and 
corneal decompensation were caused by ophthalmic instruments that were inadequately rinsed after 
soaking in 2% glutaraldehyde 632, 633.  
 
 Healthcare personnel can be exposed to elevated levels of glutaraldehyde vapor when equipment is 
processed in poorly ventilated rooms, when spills occur, when glutaraldehyde solutions are activated or 
changed,634, or when open immersion baths are used. Acute or chronic exposure can result in skin 
irritation or dermatitis, mucous membrane irritation (eye, nose, mouth), or pulmonary symptoms 318, 635-639. 
Epistaxis, allergic contact dermatitis, asthma, and rhinitis also have been reported in healthcare workers 
exposed to glutaraldehyde 636, 640-647.  
 
 Glutaraldehyde exposure should be monitored to ensure a safe work environment. Testing can be 
done by four techniques: a silica gel tube/gas chromatography with a flame ionization detector, 
dinitrophenylhydrazine (DNPH)-impregnated filter cassette/high-performance liquid chromatography 
(HPLC) with an ultraviolet (UV) detector, a passive badge/HPLC, or a handheld glutaraldehyde air 
monitor 648. The silica gel tube and the DNPH-impregnated cassette are suitable for monitoring the 0.05 
ppm ceiling limit. The passive badge, with a 0.02 ppm limit of detection, is considered marginal at the 
Americal Council of Governmental Industrial Hygienists (ACGIH) ceiling level. The ceiling level is 
considered too close to the glutaraldehyde meter’s 0.03 ppm limit of detection to provide confidence in 
the readings 648. ACGIH does not require a specific monitoring schedule for glutaraldehyde; however, a 
monitoring schedule is needed to ensure the level is less than the ceiling limit. For example, monitoring 
Guideline for Disinfection and Sterilization in Healthcare Facilities (2008) 
 
Last update: Feburary 15, 2017 46 of 161 
  
should be done initially to determine glutaraldehyde levels, after procedural or equipment changes, and in 
response to worker complaints 649. In the absence of an OSHA permissible exposure limit, if the 
glutaraldehyde level is higher than the ACGIH ceiling limit of 0.05 ppm, corrective action and repeat 
monitoring would be prudent 649.  
 
 Engineering and work-practice controls that can be used to resolve these problems include ducted 
exhaust hoods, air systems that provide 7–15 air exchanges per hour, ductless fume hoods with 
absorbents for the glutaraldehyde vapor, tight-fitting lids on immersion baths, personal protection (e.g., 
nitrile or butyl rubber gloves but not natural latex gloves, goggles) to minimize skin or mucous membrane 
contact, and automated endoscope processors 7, 650. If engineering controls fail to maintain levels below 
the ceiling limit, institutions can consider the use of respirators (e.g., a half-face respirator with organic 
vapor cartridge 640 or a type "C" supplied air respirator with a full facepiece operated in a positive pressure 
mode) 651. In general, engineering controls are preferred over work-practice and administrative controls 
because they do not require active participation by the health-care worker. Even though enforcement of 
the OSHA ceiling limit was suspended in 1993 by the U.S. Court of Appeals 577, limiting employee 
exposure to 0.05 ppm (according to ACGIH) is prudent because, at this level, glutaraldehyde can irritate 
the eyes, throat, and nose 318, 577, 639, 652. If glutaraldehyde disposal through the sanitary sewer system is 




 Overview. The literature contains several accounts of the properties, germicidal effectiveness, and 
potential uses for stabilized hydrogen peroxide in the health-care setting. Published reports ascribe good 
germicidal activity to hydrogen peroxide and attest to its bactericidal, virucidal, sporicidal, and fungicidal 
properties 653-655. (Tables 4 and 5) The FDA website lists cleared liquid chemical sterilants and high-level 
disinfectants containing hydrogen peroxide and their cleared contact conditions. 
 
 Mode of Action. Hydrogen peroxide works by producing destructive hydroxyl free radicals that can 
attack membrane lipids, DNA, and other essential cell components. Catalase, produced by aerobic 
organisms and facultative anaerobes that possess cytochrome systems, can protect cells from 
metabolically produced hydrogen peroxide by degrading hydrogen peroxide to water and oxygen. This 
defense is overwhelmed by the concentrations used for disinfection 653, 654. 
 
 Microbicidal Activity. Hydrogen peroxide is active against a wide range of microorganisms, 
including bacteria, yeasts, fungi, viruses, and spores 78, 654. A 0.5% accelerated hydrogen peroxide 
demonstrated bactericidal and virucidal activity in 1 minute and mycobactericidal and fungicidal activity in 
5 minutes 656. Bactericidal effectiveness and stability of hydrogen peroxide in urine has been 
demonstrated against a variety of health-care–associated pathogens; organisms with high cellular 
catalase activity (e.g., S. aureus, S. marcescens, and Proteus mirabilis) required 30–60 minutes of 
exposure to 0.6% hydrogen peroxide for a 108 reduction in cell counts, whereas organisms with lower 
catalase activity (e.g., E. coli, Streptococcus species, and Pseudomonas species) required only 15 
minutes’ exposure 657. In an investigation of 3%, 10%, and 15% hydrogen peroxide for reducing 
spacecraft bacterial populations, a complete kill of 106 spores (i.e., Bacillus species) occurred with a 10% 
concentration and a 60-minute exposure time. A 3% concentration for 150 minutes killed 106 spores in six 
of seven exposure trials 658. A 10% hydrogen peroxide solution resulted in a 103 decrease in B. 
atrophaeus spores, and a ≥105 decrease when tested against 13 other pathogens in 30 minutes at 20ºC 
659, 660. A 3.0% hydrogen peroxide solution was ineffective against VRE after 3 and 10 minutes exposure 
times 661 and caused only a 2-log10 reduction in the number of Acanthamoeba cysts in approximately 2 
hours 662. A 7% stabilized hydrogen peroxide proved to be sporicidal (6 hours of exposure), 
mycobactericidal (20 minutes), fungicidal (5 minutes) at full strength, virucidal (5 minutes) and bactericidal 
(3 minutes) at a 1:16 dilution when a quantitative carrier test was used 655. The 7% solution of hydrogen 
peroxide, tested after 14 days of stress (in the form of germ-loaded carriers and respiratory therapy 
equipment), was sporicidal (>7 log10 reduction in 6 hours), mycobactericidal (>6.5 log10 reduction in 25 
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minutes), fungicidal (>5 log10 reduction in 20 minutes), bactericidal (>6 log10 reduction in 5 minutes) and 
virucidal (5 log10 reduction in 5 minutes) 663. Synergistic sporicidal effects were observed when spores 
were exposed to a combination of hydrogen peroxide (5.9%–23.6%) and peracetic acid 664. Other studies 
demonstrated the antiviral activity of hydrogen peroxide against rhinovirus 665. The time required for 
inactivating three serotypes of rhinovirus using a 3% hydrogen peroxide solution was 6–8 minutes; this 
time increased with decreasing concentrations (18-20 minutes at 1.5%, 50–60 minutes at 0.75%). 
 
 Concentrations of hydrogen peroxide from 6% to 25% show promise as chemical sterilants. The 
product marketed as a sterilant is a premixed, ready-to-use chemical that contains 7.5% hydrogen 
peroxide and 0.85% phosphoric acid (to maintain a low pH) 69. The mycobactericidal activity of 7.5% 
hydrogen peroxide has been corroborated in a study showing the inactivation of >105 multidrug-resistant 
M. tuberculosis after a 10-minute exposure 666. Thirty minutes were required for >99.9% inactivation of 
poliovirus and HAV 667. Three percent and 6% hydrogen peroxide were unable to inactivate HAV in 1 
minute in a carrier test 58. When the effectiveness of 7.5% hydrogen peroxide at 10 minutes was 
compared with 2% alkaline glutaraldehyde at 20 minutes in manual disinfection of endoscopes, no 
significant difference in germicidal activity was observed 668. ). No complaints were received from the 
nursing or medical staff regarding odor or toxicity. In one study, 6% hydrogen peroxide (unused product 
was 7.5%) was more effective in the high-level disinfection of flexible endoscopes than was the 2% 
glutaraldehyde solution 456. A new, rapid-acting 13.4% hydrogen peroxide formulation (that is not yet 
FDA-cleared) has demonstrated sporicidal, mycobactericidal, fungicidal, and virucidal efficacy. 
Manufacturer data demonstrate that this solution sterilizes in 30 minutes and provides high-level 
disinfection in 5 minutes669. This product has not been used long enough to evaluate material 
compatibility to endoscopes and other semicritical devices, and further assessment by instrument 
manufacturers is needed. 
 
 Under normal conditions, hydrogen peroxide is extremely stable when properly stored (e.g., in dark 
containers). The decomposition or loss of potency in small containers is less than 2% per year at ambient 
temperatures 670.  
 
 Uses. Commercially available 3% hydrogen peroxide is a stable and effective disinfectant when used 
on inanimate surfaces. It has been used in concentrations from 3% to 6% for disinfecting soft contact 
lenses (e.g., 3% for 2–3 hrs) 653, 671, 672, tonometer biprisms 513, ventilators 673, fabrics 397, and endoscopes 
456. Hydrogen peroxide was effective in spot-disinfecting fabrics in patients’ rooms 397. Corneal damage 
from a hydrogen peroxide-soaked tonometer tip that was not properly rinsed has been reported 674. 
Hydrogen peroxide also has been instilled into urinary drainage bags in an attempt to eliminate the bag 
as a source of bladder bacteriuria and environmental contamination 675. Although the instillation of 
hydrogen peroxide into the bag reduced microbial contamination of the bag, this procedure did not reduce 
the incidence of catheter-associated bacteriuria 675.  
 
 A chemical irritation resembling pseudomembranous colitis caused by either 3% hydrogen peroxide 
or a 2% glutaraldehyde has been reported 621. An epidemic of pseudomembrane-like enteritis and colitis 
in seven patients in a gastrointestinal endoscopy unit also has been associated with inadequate rinsing of 
3% hydrogen peroxide from the endoscope 676. 
 
 As with other chemical sterilants, dilution of the hydrogen peroxide must be monitored by regularly 
testing the minimum effective concentration (i.e., 7.5%–6.0%). Compatibility testing by Olympus America 
of the 7.5% hydrogen peroxide found both cosmetic changes (e.g., discoloration of black anodized metal 
finishes) 69 and functional changes with the tested endoscopes (Olympus, written communication, 




 Overview. Iodine solutions or tinctures long have been used by health professionals primarily as 
antiseptics on skin or tissue. Iodophors, on the other hand, have been used both as antiseptics and 
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disinfectants. FDA has not cleared any liquid chemical sterilant or high-level disinfectants with iodophors as 
the main active ingredient. An iodophor is a combination of iodine and a solubilizing agent or carrier; the 
resulting complex provides a sustained-release reservoir of iodine and releases small amounts of free iodine 
in aqueous solution. The best-known and most widely used iodophor is povidone-iodine, a compound of 
polyvinylpyrrolidone with iodine. This product and other iodophors retain the germicidal efficacy of iodine but 
unlike iodine generally are nonstaining and relatively free of toxicity and irritancy 677, 678. 
 
 Several reports that documented intrinsic microbial contamination of antiseptic formulations of 
povidone-iodine and poloxamer-iodine 679-681 caused a reappraisal of the chemistry and use of 
iodophors682. “Free” iodine (I2) contributes to the bactericidal activity of iodophors and dilutions of 
iodophors demonstrate more rapid bactericidal action than does a full-strength povidone-iodine solution. 
The reason for the observation that dilution increases bactericidal activity is unclear, but dilution of 
povidone-iodine might weaken the iodine linkage to the carrier polymer with an accompanying increase of 
free iodine in solution 680. Therefore, iodophors must be diluted according to the manufacturers' directions 
to achieve antimicrobial activity. 
 
 Mode of Action. Iodine can penetrate the cell wall of microorganisms quickly, and the lethal effects 
are believed to result from disruption of protein and nucleic acid structure and synthesis. 
 
 Microbicidal Activity. Published reports on the in vitro antimicrobial efficacy of iodophors 
demonstrate that iodophors are bactericidal, mycobactericidal, and virucidal but can require prolonged 
contact times to kill certain fungi and bacterial spores 14, 71-73, 290, 683-686. Three brands of povidone-iodine 
solution have demonstrated more rapid kill (seconds to minutes) of S. aureus and M. chelonae at a 1:100 
dilution than did the stock solution 683. The virucidal activity of 75–150 ppm available iodine was 
demonstrated against seven viruses 72. Other investigators have questioned the efficacy of iodophors 
against poliovirus in the presence of organic matter 685and rotavirus SA-11 in distilled or tapwater 290. 
Manufacturers' data demonstrate that commercial iodophors are not sporicidal, but they are 
tuberculocidal, fungicidal, virucidal, and bactericidal at their recommended use-dilution. 
 
 Uses. Besides their use as an antiseptic, iodophors have been used for disinfecting blood culture 
bottles and medical equipment, such as hydrotherapy tanks, thermometers, and endoscopes. Antiseptic 
iodophors are not suitable for use as hard-surface disinfectants because of concentration differences. 
Iodophors formulated as antiseptics contain less free iodine than do those formulated as disinfectants 376. 
Iodine or iodine-based antiseptics should not be used on silicone catheters because they can adversely 




 Overview. Ortho-phthalaldehyde is a high-level disinfectant that received FDA clearance in October 
1999. It contains 0.55% 1,2-benzenedicarboxaldehyde (OPA). OPA solution is a clear, pale-blue liquid 
with a pH of 7.5. (Tables 4 and 5) 
 
 Mode of Action. Preliminary studies on the mode of action of OPA suggest that both OPA and 
glutaraldehyde interact with amino acids, proteins, and microorganisms. However, OPA is a less potent 
cross-linking agent. This is compensated for by the lipophilic aromatic nature of OPA that is likely to assist 
its uptake through the outer layers of mycobacteria and gram-negative bacteria 688-690. OPA appears to kill 
spores by blocking the spore germination process 691. 
 
 Microbicidal Activity. Studies have demonstrated excellent microbicidal activity in vitro 69, 100, 271, 400, 
692-703. For example, OPA has superior mycobactericidal activity (5-log10 reduction in 5 minutes) to 
glutaraldehyde. The mean times required to produce a 6-log10 reduction for M. bovis using 0.21% OPA 
was 6 minutes, compared with 32 minutes using 1.5% glutaraldehyde 693. OPA showed good activity 
against the mycobacteria tested, including the glutaraldehyde-resistant strains, but 0.5% OPA was not 
sporicidal with 270 minutes of exposure. Increasing the pH from its unadjusted level (about 6.5) to pH 8 
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improved the sporicidal activity of OPA 694. The level of biocidal activity was directly related to the 
temperature. A greater than 5-log10 reduction of B. atrophaeus spores was observed in 3 hours at 35ºC, 
than in 24 hours at 20ºC. Also, with an exposure time ≤5 minutes, biocidal activity decreased with 
increasing serum concentration. However, efficacy did not differ when the exposure time was ≥10 
minutes 697. In addition, OPA is effective (>5-log10 reduction) against a wide range of microorganisms, 
including glutaraldehyde-resistant mycobacteria and B. atrophaeus spores 694. 
 
 The influence of laboratory adaptation of test strains, such as P. aeruginosa, to 0.55% OPA has 
been evaluated. Resistant and multiresistant strains increased substantially in susceptibility to OPA after 
laboratory adaptation (log10 reduction factors increased by 0.54 and 0.91 for resistant and multiresistant 
strains, respectively) 704. Other studies have found naturally occurring cells of P. aeurginosa were more 
resistant to a variety of disinfectants than were subcultured cells 705.  
 
 Uses. OPA has several potential advantages over glutaraldehyde. It has excellent stability over a wide 
pH range (pH 3–9), is not a known irritant to the eyes and nasal passages 706, does not require exposure 
monitoring, has a barely perceptible odor, and requires no activation. OPA, like glutaraldehyde, has 
excellent material compatibility. A potential disadvantage of OPA is that it stains proteins gray (including 
unprotected skin) and thus must be handled with caution 69. However, skin staining would indicate 
improper handling that requires additional training and/or personal protective equipment (e.g., gloves, eye 
and mouth protection, and fluid-resistant gowns). OPA residues remaining on inadequately water-rinsed 
transesophageal echo probes can stain the patient’s mouth 707. Meticulous cleaning, using the correct 
OPA exposure time (e.g., 12 minutes) and copious rinsing of the probe with water should eliminate this 
problem. The results of one study provided a basis for a recommendation that rinsing of instruments 
disinfected with OPA will require at least 250 mL of water per channel to reduce the chemical residue to a 
level that will not compromise patient or staff safety (<1 ppm) 708. Personal protective equipment should 
be worn when contaminated instruments, equipment, and chemicals are handled 400. In addition, 
equipment must be thoroughly rinsed to prevent discoloration of a patient’s skin or mucous membrane.  
 
 In April 2004, the manufacturer of OPA disseminated information to users about patients who 
reportedly experienced an anaphylaxis-like reaction after cystoscopy where the scope had been 
reprocessed using OPA. Of approximately 1 million urologic procedures performed using instruments 
reprocessed using OPA, 24 cases (17 cases in the United States, six in Japan, one in the United Kingdom) 
of anaphylaxis-like reactions have been reported after repeated cystoscopy (typically after four to nine 
treatments). Preventive measures include removal of OPA residues by thorough rinsing and not using 
OPA for reprocessing urologic instrumentation used to treat patients with a history of bladder cancer 
(Nevine Erian, personal communication, June 4, 2004; Product Notification, Advanced Sterilization 
Products, April 23, 2004) 709.  
 
 A few OPA clinical studies are available. In a clinical-use study, OPA exposure of 100 endoscopes 
for 5 minutes resulted in a >5-log10 reduction in bacterial load. Furthermore, OPA was effective over a 
14-day use cycle 100. Manufacturer data show that OPA will last longer in an automatic endoscope 
reprocessor before reaching its MEC limit (MEC after 82 cycles) than will glutaraldehyde (MEC after 40 
cycles) 400. High-pressure liquid chromatography confirmed that OPA levels are maintained above 0.3% 
for at least 50 cycles 706, 710. OPA must be disposed in accordance with local and state regulations. If 
OPA disposal through the sanitary sewer system is restricted, glycine (25 grams/gallon) can be used to 
neutralize the OPA and make it safe for disposal. 
 
 The high-level disinfectant label claims for OPA solution at 20ºC vary worldwide (e.g., 5 minutes in 
Europe, Asia, and Latin America; 10 minutes in Canada and Australia; and 12 minutes in the United 
States). These label claims differ worldwide because of differences in the test methodology and 
requirements for licensure. In an automated endoscope reprocessor with an FDA-cleared capability to 
maintain solution temperatures at 25°C, the contact time for OPA is 5 minutes.  
 
Guideline for Disinfection and Sterilization in Healthcare Facilities (2008) 
 
Last update: Feburary 15, 2017 50 of 161 
  
Peracetic Acid 
 Overview. Peracetic, or peroxyacetic, acid is characterized by rapid action against all 
microorganisms. Special advantages of peracetic acid are that it lacks harmful decomposition products 
(i.e., acetic acid, water, oxygen, hydrogen peroxide), enhances removal of organic material 711, and 
leaves no residue. It remains effective in the presence of organic matter and is sporicidal even at low 
temperatures (Tables 4 and 5). Peracetic acid can corrode copper, brass, bronze, plain steel, and 
galvanized iron but these effects can be reduced by additives and pH modifications. It is considered 
unstable, particularly when diluted; for example, a 1% solution loses half its strength through hydrolysis in 
6 days, whereas 40% peracetic acid loses 1%–2% of its active ingredients per month 654. 
 
 Mode of Action. Little is known about the mechanism of action of peracetic acid, but it is believed to 
function similarly to other oxidizing agents—that is, it denatures proteins, disrupts the cell wall 
permeability, and oxidizes sulfhydryl and sulfur bonds in proteins, enzymes, and other metabolites 654. 
 
 Microbicidal Activity. Peracetic acid will inactivate gram-positive and gram-negative bacteria, fungi, 
and yeasts in ≤5 minutes at <100 ppm. In the presence of organic matter, 200–500 ppm is required. For 
viruses, the dosage range is wide (12–2250 ppm), with poliovirus inactivated in yeast extract in 15 
minutes with 1,500–2,250 ppm. In one study, 3.5% peracetic acid was ineffective against HAV after 1-
minute exposure using a carrier test 58. Peracetic acid (0.26%) was effective (log10 reduction factor >5) 
against all test strains of mycobacteria (M. tuberculosis, M. avium-intracellulare, M. chelonae, and M. 
fortuitum) within 20–30 minutes in the presence or absence of an organic load 607, 712. With bacterial 
spores, 500–10,000 ppm (0.05%–1%) inactivates spores in 15 seconds to 30 minutes using a spore 
suspension test 654, 659, 713-715. 
 
 Uses. An automated machine using peracetic acid to chemically sterilize medical (e.g., endoscopes, 
arthroscopes), surgical, and dental instruments is used in the United States716-718. As previously noted, 
dental handpieces should be steam sterilized. The sterilant, 35% peracetic acid, is diluted to 0.2% with 
filtered water at 50ºC. Simulated-use trials have demonstrated excellent microbicidal activity 111, 718-722, 
and three clinical trials have demonstrated both excellent microbial killing and no clinical failures leading 
to infection90, 723, 724. The high efficacy of the system was demonstrated in a comparison of the efficacies 
of the system with that of ethylene oxide. Only the peracetic acid system completely killed 6 log10 of M. 
chelonae, E. faecalis, and B. atrophaeus spores with both an organic and inorganic challenge722. An 
investigation that compared the costs, performance, and maintenance of urologic endoscopic equipment 
processed by high-level disinfection (with glutaraldehyde) with those of the peracetic acid system 
reported no clinical differences between the two systems. However, the use of this system led to higher 
costs than the high-level disinfection, including costs for processing ($6.11 vs. $0.45 per cycle), 
purchasing and training ($24,845 vs. $16), installation ($5,800 vs. $0), and endoscope repairs ($6,037 vs. 
$445) 90. Furthermore, three clusters of infection using the peracetic acid automated endoscope 
reprocessor were linked to inadequately processed bronchoscopes when inappropriate channel 
connectors were used with the system 725. These clusters highlight the importance of training, proper 
model-specific endoscope connector systems, and quality-control procedures to ensure compliance with 
endoscope manufacturer recommendations and professional organization guidelines. An alternative high-
level disinfectant available in the United Kingdom contains 0.35% peracetic acid. Although this product is 
rapidly effective against a broad range of microorganisms 466, 726, 727, it tarnishes the metal of endoscopes 
and is unstable, resulting in only a 24-hour use life 727.  
 
 
Peracetic Acid and Hydrogen Peroxide 
 Overview. Two chemical sterilants are available that contain peracetic acid plus hydrogen peroxide 
(i.e., 0.08% peracetic acid plus 1.0% hydrogen peroxide [no longer marketed]; and 0.23% peracetic acid 
plus 7.35% hydrogen peroxide (Tables 4 and 5). 
 
 Microbicidal Activity. The bactericidal properties of peracetic acid and hydrogen peroxide have 
been demonstrated 728. Manufacturer data demonstrated this combination of peracetic acid and hydrogen 
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peroxide inactivated all microorganisms except bacterial spores within 20 minutes. The 0.08% peracetic 
acid plus 1.0% hydrogen peroxide product effectively inactivated glutaraldehyde-resistant 
mycobacteria729.  
 
 Uses. The combination of peracetic acid and hydrogen peroxide has been used for disinfecting 
hemodialyzers 730. The percentage of dialysis centers using a peracetic acid-hydrogen peroxide-based 
disinfectant for reprocessing dialyzers increased from 5% in 1983 to 56% in 1997249. Olympus America 
does not endorse use of 0.08% peracetic acid plus 1.0% hydrogen peroxide (Olympus America, personal 
communication, April 15, 1998) on any Olympus endoscope because of cosmetic and functional damage 
and will not assume liability for chemical damage resulting from use of this product. This product is not 
currently available. FDA has cleared a newer chemical sterilant with 0.23% peracetic acid and 7.35% 
hydrogen peroxide (Tables 4 and 5). After testing the 7.35% hydrogen peroxide and 0.23% peracetic acid 
product, Olympus America concluded it was not compatible with the company’s flexible gastrointestinal 
endoscopes; this conclusion was based on immersion studies where the test insertion tubes had failed 
because of swelling and loosening of the black polymer layer of the tube (Olympus America, personal 




 Overview. Phenol has occupied a prominent place in the field of hospital disinfection since its initial 
use as a germicide by Lister in his pioneering work on antiseptic surgery. In the past 30 years, however, 
work has concentrated on the numerous phenol derivatives or phenolics and their antimicrobial 
properties. Phenol derivatives originate when a functional group (e.g., alkyl, phenyl, benzyl, halogen) 
replaces one of the hydrogen atoms on the aromatic ring. Two phenol derivatives commonly found as 
constituents of hospital disinfectants are ortho-phenylphenol and ortho-benzyl-para-chlorophenol. The 
antimicrobial properties of these compounds and many other phenol derivatives are much improved over 
those of the parent chemical. Phenolics are absorbed by porous materials, and the residual disinfectant 
can irritate tissue. In 1970, depigmentation of the skin was reported to be caused by phenolic germicidal 
detergents containing para-tertiary butylphenol and para-tertiary amylphenol 731. 
 
 Mode of Action. In high concentrations, phenol acts as a gross protoplasmic poison, penetrating and 
disrupting the cell wall and precipitating the cell proteins. Low concentrations of phenol and higher 
molecular-weight phenol derivatives cause bacterial death by inactivation of essential enzyme systems 
and leakage of essential metabolites from the cell wall 732. 
 
 Microbicidal Activity. Published reports on the antimicrobial efficacy of commonly used phenolics 
showed they were bactericidal, fungicidal, virucidal, and tuberculocidal 14, 61, 71, 73, 227, 416, 573, 732-738. One 
study demonstrated little or no virucidal effect of a phenolic against coxsackie B4, echovirus 11, and 
poliovirus 1 736. Similarly, 12% ortho-phenylphenol failed to inactivate any of the three hydrophilic viruses 
after a 10-minute exposure time, although 5% phenol was lethal for these viruses 72. A 0.5% dilution of a 
phenolic (2.8% ortho-phenylphenol and 2.7% ortho-benzyl-para-chlorophenol) inactivated HIV 227 and a 
2% solution of a phenolic (15% ortho-phenylphenol and 6.3% para-tertiary-amylphenol) inactivated all but 
one of 11 fungi tested 71.  
 
 Manufacturers’ data using the standardized AOAC methods demonstrate that commercial phenolics 
are not sporicidal but are tuberculocidal, fungicidal, virucidal, and bactericidal at their recommended use-
dilution. Attempts to substantiate the bactericidal label claims of phenolics using the AOAC Use-Dilution 
Method occasionally have failed 416, 737. However, results from these same studies have varied 
dramatically among laboratories testing identical products. 
  
Uses. Many phenolic germicides are EPA-registered as disinfectants for use on environmental surfaces 
(e.g., bedside tables, bedrails, and laboratory surfaces) and noncritical medical devices. Phenolics are 
not FDA-cleared as high-level disinfectants for use with semicritical items but could be used to preclean 
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or decontaminate critical and semicritical devices before terminal sterilization or high-level disinfection. 
 
 The use of phenolics in nurseries has been questioned because of hyperbilirubinemia in infants 
placed in bassinets where phenolic detergents were used 739. In addition, bilirubin levels were reported to 
increase in phenolic-exposed infants, compared with nonphenolic-exposed infants, when the phenolic 
was prepared according to the manufacturers' recommended dilution 740. If phenolics are used to clean 
nursery floors, they must be diluted as recommended on the product label. Phenolics (and other 
disinfectants) should not be used to clean infant bassinets and incubators while occupied. If phenolics are 
used to terminally clean infant bassinets and incubators, the surfaces should be rinsed thoroughly with 
water and dried before reuse of infant bassinets and incubators 17.  
 
 
Quaternary Ammonium Compounds 
 Overview. The quaternary ammonium compounds are widely used as disinfectants. Health-care–
associated infections have been reported from contaminated quaternary ammonium compounds used to 
disinfect patient-care supplies or equipment, such as cystoscopes or cardiac catheters 741, 742. The 
quaternaries are good cleaning agents, but high water hardness 743 and materials such as cotton and 
gauze pads can make them less microbicidal because of insoluble precipitates or cotton and gauze pads 
absorb the active ingredients, respectively. One study showed a significant decline (~40%–50% lower at 
1 hour) in the concentration of quaternaries released when cotton rags or cellulose-based wipers were 
used in the open-bucket system, compared with the nonwoven spunlace wipers in the closed-bucket 
system 744 As with several other disinfectants (e.g., phenolics, iodophors) gram-negative bacteria can 
survive or grow in them 404.  
 
 Chemically, the quaternaries are organically substituted ammonium compounds in which the nitrogen 
atom has a valence of 5, four of the substituent radicals (R1-R4) are alkyl or heterocyclic radicals of a 
given size or chain length, and the fifth (X-) is a halide, sulfate, or similar radical 745. Each compound 
exhibits its own antimicrobial characteristics, hence the search for one compound with outstanding 
antimicrobial properties. Some of the chemical names of quaternary ammonium compounds used in 
healthcare are alkyl dimethyl benzyl ammonium chloride, alkyl didecyl dimethyl ammonium chloride, and 
dialkyl dimethyl ammonium chloride. The newer quaternary ammonium compounds (i.e., fourth 
generation), referred to as twin-chain or dialkyl quaternaries (e.g. didecyl dimethyl ammonium bromide 
and dioctyl dimethyl ammonium bromide), purportedly remain active in hard water and are tolerant of 
anionic residues 746.  
 
 A few case reports have documented occupational asthma as a result of exposure to benzalkonium 
chloride 747. 
 
 Mode of Action. The bactericidal action of the quaternaries has been attributed to the inactivation of 
energy-producing enzymes, denaturation of essential cell proteins, and disruption of the cell 
membrane746. Evidence exists that supports these and other possibilities 745 748. 
 
 Microbicidal Activity. Results from manufacturers' data sheets and from published scientific 
literature indicate that the quaternaries sold as hospital disinfectants are generally fungicidal, bactericidal, 
and virucidal against lipophilic (enveloped) viruses; they are not sporicidal and generally not 
tuberculocidal or virucidal against hydrophilic (nonenveloped) viruses14, 54-56, 58, 59, 61, 71, 73, 186, 297, 748, 749. The 
poor mycobactericidal activities of quaternary ammonium compounds have been demonstrated 55, 73. 
Quaternary ammonium compounds (as well as 70% isopropyl alcohol, phenolic, and a chlorine-containing 
wipe [80 ppm]) effectively (>95%) remove and/or inactivate contaminants (i.e., multidrug-resistant S. 
aureus, vancomycin-resistant Entercoccus, P. aeruginosa) from computer keyboards with a 5-second 
application time. No functional damage or cosmetic changes occurred to the computer keyboards after 
300 applications of the disinfectants 45. 
 
Attempts to reproduce the manufacturers' bactericidal and tuberculocidal claims using the AOAC tests 
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with a limited number of quaternary ammonium compounds occasionally have failed 73, 416, 737. However, 
test results have varied extensively among laboratories testing identical products 416, 737. 
 
 Uses. The quaternaries commonly are used in ordinary environmental sanitation of noncritical 
surfaces, such as floors, furniture, and walls. EPA-registered quaternary ammonium compounds are 
appropriate to use for disinfecting medical equipment that contacts intact skin (e.g., blood pressure cuffs). 
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Miscellaneous Inactivating Agents   
 
Other Germicides 
 Several compounds have antimicrobial activity but for various reasons have not been incorporated 
into the armamentarium of health-care disinfectants. These include mercurials, sodium hydroxide, β-
propiolactone, chlorhexidine gluconate, cetrimide-chlorhexidine, glycols (triethylene and propylene), and 
the Tego disinfectants. Two authoritative references examine these agents in detail 16, 412. 
 
 A peroxygen-containing formulation had marked bactericidal action when used as a 1% 
weight/volume solution and virucidal activity at 3% 49, but did not have mycobactericidal activity at 
concentrations of 2.3% and 4% and exposure times ranging from 30 to 120 minutes 750. It also required 
20 hours to kill B. atrophaeus spores 751. A powder-based peroxygen compound for disinfecting 
contaminated spill was strongly and rapidly bactericidal 752.  
 
 In preliminary studies, nanoemulsions (composed of detergents and lipids in water) showed activity 
against vegetative bacteria, enveloped viruses and Candida. This product represents a potential agent for 
use as a topical biocidal agent. 753-755. 
 
 New disinfectants that require further evaluation include glucoprotamin756, tertiary amines 703. and a 
light-activated antimicrobial coating 757. Several other disinfection technologies might have potential 
applications in the healthcare setting 758.  
 
Metals as Microbicides 
 Comprehensive reviews of antisepsis 759, disinfection421, and anti-infective chemotherapy 760 barely 
mention the antimicrobial activity of heavy metals761, 762. Nevertheless, the anti-infective activity of some 
heavy metals has been known since antiquity. Heavy metals such as silver have been used for 
prophylaxis of conjunctivitis of the newborn, topical therapy for burn wounds, and bonding to indwelling 
catheters, and the use of heavy metals as antiseptics or disinfectants is again being explored 763. 
Inactivation of bacteria on stainless steel surfaces by zeolite ceramic coatings containing silver and zinc 
ions has also been demonstrated 764, 765. 
 
 Metals such as silver, iron, and copper could be used for environmental control, disinfection of water, 
or reusable medical devices or incorporated into medical devices (e.g., intravascular catheters) 400, 761-763, 
766-770. A comparative evaluation of six disinfectant formulations for residual antimicrobial activity 
demonstrated that only the silver disinfectant demonstrated significant residual activity against S. aureus 
and P. aeruginosa 763. Preliminary data suggest metals are effective against a wide variety of 
microorganisms.  
 
 Clinical uses of other heavy metals include copper-8-quinolinolate as a fungicide against Aspergillus, 
copper-silver ionization for Legionella disinfection 771-774, organic mercurials as an antiseptic (e.g., 
mercurochrome) and preservative/disinfectant (e.g., thimerosal [currently being removed from vaccines]) 
in pharmaceuticals and cosmetics 762.  
 
Ultraviolet Radiation (UV)  
 The wavelength of UV radiation ranges from 328 nm to 210 nm (3280 A to 2100 A). Its maximum 
bactericidal effect occurs at 240–280 nm. Mercury vapor lamps emit more than 90% of their radiation at 
253.7 nm, which is near the maximum microbicidal activity 775. Inactivation of microorganisms results from 
destruction of nucleic acid through induction of thymine dimers. UV radiation has been employed in the 
disinfection of drinking water 776, air 775, titanium implants 777, and contact lenses778. Bacteria and viruses 
are more easily killed by UV light than are bacterial spores 775. UV radiation has several potential 
applications, but unfortunately its germicidal effectiveness and use is influenced by organic matter; 
wavelength; type of suspension; temperature; type of microorganism; and UV intensity, which is affected 
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by distance and dirty tubes779. The application of UV radiation in the health-care environment (i.e., 
operating rooms, isolation rooms, and biologic safety cabinets) is limited to destruction of airborne 
organisms or inactivation of microorganisms on surfaces. The effect of UV radiation on postoperative 
wound infections was investigated in a double-blind, randomized study in five university medical centers. 
After following 14,854 patients over a 2-year period, the investigators reported the overall wound infection 
rate was unaffected by UV radiation, although postoperative infection in the “refined clean” surgical 
procedures decreased significantly (3.8%–2.9%) 780. No data support the use of UV lamps in isolation 
rooms, and this practice has caused at least one epidemic of UV-induced skin erythema and 
keratoconjunctivitis in hospital patients and visitors 781.  
 
Pasteurization 
 Pasteurization is not a sterilization process; its purpose is to destroy all pathogenic microorganisms. 
However, pasteurization does not destroy bacterial spores. The time-temperature relation for hot-water 
pasteurization is generally ~70°C (158°F) for 30 minutes. The water temperature and time should be 
monitored as part of a quality-assurance program 782. Pasteurization of respiratory therapy 783, 784 and 
anesthesia equipment 785 is a recognized alternative to chemical disinfection. The efficacy of this process 
has been tested using an inoculum that the authors believed might simulate contamination by an infected 
patient. Use of a large inoculum (107) of P. aeruginosa or Acinetobacter calcoaceticus in sets of 
respiratory tubing before processing demonstrated that machine-assisted chemical processing was more 
efficient than machine-assisted pasteurization with a disinfection failure rate of 6% and 83%, respectively 
783. Other investigators found hot water disinfection to be effective (inactivation factor >5 log10) against 
multiple bacteria, including multidrug-resistant bacteria, for disinfecting reusable anesthesia or respiratory 
therapy equipment 784-786. 
 
Flushing- and Washer-Disinfectors 
 Flushing- and washer-disinfectors are automated and closed equipment that clean and disinfect 
objects from bedpans and washbowls to surgical instruments and anesthesia tubes. Items such as 
bedpans and urinals can be cleaned and disinfected in flushing-disinfectors. They have a short cycle of a 
few minutes. They clean by flushing with warm water, possibly with a detergent, and then disinfect by 
flushing the items with hot water or with steam. Because this machine empties, cleans, and disinfects, 
manual cleaning is eliminated, fewer disposable items are needed, and fewer chemical germicides are 
used. A microbiologic evaluation of one washer/disinfector demonstrated complete inactivation of 
suspensions of E. faecalis or poliovirus 787. Other studies have shown that strains of Enterococcus 
faecium can survive the British Standard for heat disinfection of bedpans (80ºC for 1 minute). The 
significance of this finding with reference to the potential for enterococci to survive and disseminate in the 
health-care environment is debatable 788-790. These machines are available and used in many European 
countries.  
 
 Surgical instruments and anesthesia equipment are more difficult to clean. They are run in washer-
disinfectors on a longer cycle of approximately 20–30 minutes with a detergent. These machines also 
disinfect by hot water at approximately 90°C 791.  
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The Regulatory Framework for Disinfectants and Sterilants 
 
 Before using the guidance provided in this document, health-care workers should be aware of the 
federal laws and regulations that govern the sale, distribution, and use of disinfectants and sterilants. In 
particular, health-care workers need to know what requirements pertain to them when they apply these 
products. Finally, they should understand the relative roles of EPA, FDA, and CDC so the context for the 
guidance provided in this document is clear. 
 
EPA and FDA 
 In the United States, chemical germicides formulated as sanitizers, disinfectants, or sterilants are 
regulated in interstate commerce by the Antimicrobials Division, Office of Pesticides Program, EPA, under 
the authority of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) of 1947, as amended 792. 
Under FIFRA, any substance or mixture of substances intended to prevent, destroy, repel, or mitigate any 
pest (including microorganisms but excluding those in or on living humans or animals) must be registered 
before sale or distribution. To obtain a registration, a manufacturer must submit specific data about the 
safety and effectiveness of each product. For example, EPA requires manufacturers of sanitizers, 
disinfectants, or chemical sterilants to test formulations by using accepted methods for microbiocidal 
activity, stability, and toxicity to animals and humans. The manufacturers submit these data to EPA along 
with proposed labeling. If EPA concludes the product can be used without causing “unreasonable 
adverse effects,” then the product and its labeling are registered, and the manufacturer can sell and 
distribute the product in the United States. 
 
 FIFRA also requires users of products to follow explicitly the labeling directions on each product. The 
following standard statement appears on all labels under the “Directions for Use” heading: “It is a violation 
of federal law to use this product in a manner inconsistent with its labeling.” This statement means a 
health-care worker must follow the safety precautions and use directions on the labeling of each 
registered product. Failure to follow the specified use-dilution, contact time, method of application, or any 
other condition of use is considered a misuse of the product and potentially subject to enforcement action 
under FIFRA. 
 
 In general, EPA regulates disinfectants and sterilants used on environmental surfaces, and not those 
used on critical or semicritical medical devices; the latter are regulated by FDA. In June 1993, FDA and 
EPA issued a “Memorandum of Understanding” that divided responsibility for review and surveillance of 
chemical germicides between the two agencies. Under the agreement, FDA regulates liquid chemical 
sterilants used on critical and semicritical devices, and EPA regulates disinfectants used on noncritical 
surfaces and gaseous sterilants 793. In 1996, Congress passed the Food Quality Protection Act (FQPA). 
This act amended FIFRA in regard to several types of products regulated by both EPA and FDA. One 
provision of FQPA removed regulation of liquid chemical sterilants used on critical and semicritical 
medical devices from EPA’s jurisdiction, and it now rests solely with FDA 792, 794. EPA continues to register 
nonmedical chemical sterilants. FDA and EPA have considered the impact of FQPA, and in January 
2000, FDA published its final guidance document on product submissions and labeling. Antiseptics are 
considered antimicrobial drugs used on living tissue and thus are regulated by FDA under the Food, Drug 
and Cosmetic Act. FDA regulates liquid chemical sterilants and high-level disinfectants intended to 
process critical and semicritical devices. FDA has published recommendations on the types of test 
methods that manufacturers should submit to FDA for 510[k] clearance for such agents. 
 
CDC 
 At CDC, the mission of the Coordinating Center for Infections Diseases is to guide the public on how 
to prevent and respond to infectious diseases in both health-care settings and at home. With respect to 
disinfectants and sterilants, part of CDC’s role is to inform the public (in this case healthcare personnel) of 
current scientific evidence pertaining to these products, to comment about their safety and efficacy, and 
to recommend which chemicals might be most appropriate or effective for specific microorganisms and 
settings. 
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 The methods EPA has used for registration are standardized by the AOAC International; however, a 
survey of scientific literature reveals a number of problems with these tests that were reported during 
1987–1990 58, 76, 80, 428, 736, 737, 795-800 that cause them to be neither accurate nor reproducible 416, 737. As part 
of their regulatory authority, EPA and FDA support development and validation of methods for assessing 
disinfection claims 801-803. For example, EPA has supported the work of Dr. Syed Sattar and coworkers 
who have developed a two-tier quantitative carrier test to assess sporicidal, mycobactericidal, 
bactericidal, fungicidal, virucidal, and protozoacidal activity of chemical germicides 701, 803. EPA is 
accepting label claims against hepatitis B virus (HBV) using a surrogate organism, the duck HBV, to 
quantify disinfectant activity 124, 804. EPA also is accepting labeling claims against hepatitis C virus using 
the bovine viral diarrhea virus as a surrogate. 
 
 For nearly 30 years, EPA also performed intramural preregistration and postregistration efficacy 
testing of some chemical disinfectants in its own laboratories. In 1982, this was stopped, reportedly for 
budgetary reasons. At that time, manufacturers did not need to have microbiologic activity claims verified 
by EPA or an independent testing laboratory when registering a disinfectant or chemical sterilant 805. This 
occurred when the frequency of contaminated germicides and infections secondary to their use had 
increased 404. Investigations demonstrating that interlaboratory reproducibility of test results was poor and 
manufacturers' label claims were not verifiable 416, 737 and symposia sponsored by the American Society 
for Microbiology 800 heightened awareness of these problems and reconfirmed the need to improve the 
AOAC methods and reinstate a microbiologic activity verification program. A General Accounting Office 
report entitled Disinfectants: EPA Lacks Assurance They Work 806 seemed to provide the necessary 
impetus for EPA to initiate corrective measures, including cooperative agreements to improve the AOAC 
methods and independent verification testing for all products labeled as sporicidal and disinfectants 
labeled as tuberculocidal. For example, of 26 sterilant products tested by EPA, 15 were canceled 
because of product failure. A list of products registered with EPA and labeled for use as sterilants or 
tuberculocides or against HIV and/or HBV is available through EPA’s website at [This link is no longer 
active: http://www.epa.gov/oppad001/chemregindex.htm. The current version of this document may differ 
from original version: Selected EPA-registered Disinfectants (https://www.epa.gov/pesticide-
registration/selected-epa-registered-disinfectants).]. Organizations (e.g., Organization for Economic 
Cooperation and Development) are working to standardize requirements for germicide testing and 
registration. 
 
Neutralization of Germicides  
 One of the difficulties associated with evaluating the bactericidal activity of disinfectants is prevention 
of bacteriostasis from disinfectant residues carried over into the subculture media. Likewise, small 
amounts of disinfectants on environmental surfaces can make an accurate bacterial count difficult to get 
when sampling of the health-care environment as part of an epidemiologic or research investigation. One 
way these problems may be overcome is by employing neutralizers that inactivate residual disinfectants 
807-809. Two commonly used neutralizing media for chemical disinfectants are Letheen Media and D/E 
Neutralizing Media. The former contains lecithin to neutralize quaternaries and polysorbate 80 (Tween 
80) to neutralize phenolics, hexachlorophene, formalin, and, with lecithin, ethanol. The D/E Neutralizing 
media will neutralize a broad spectrum of antiseptic and disinfectant chemicals, including quaternary 
ammonium compounds, phenols, iodine and chlorine compounds, mercurials, formaldehyde, and 
glutaraldehyde 810. A review of neutralizers used in germicide testing has been published808. 
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 Most medical and surgical devices used in healthcare facilities are made of materials that are heat 
stable and therefore undergo heat, primarily steam, sterilization. However, since 1950, there has been an 
increase in medical devices and instruments made of materials (e.g., plastics) that require low-
temperature sterilization. Ethylene oxide gas has been used since the 1950s for heat- and moisture-
sensitive medical devices. Within the past 15 years, a number of new, low-temperature sterilization 
systems (e.g., hydrogen peroxide gas plasma, peracetic acid immersion, ozone) have been developed 
and are being used to sterilize medical devices. This section reviews sterilization technologies used in 
healthcare and makes recommendations for their optimum performance in the processing of medical 
devices 1, 18, 811-820. 
 
 Sterilization destroys all microorganisms on the surface of an article or in a fluid to prevent disease 
transmission associated with the use of that item. While the use of inadequately sterilized critical items 
represents a high risk of transmitting pathogens, documented transmission of pathogens associated with 
an inadequately sterilized critical item is exceedingly rare 821, 822. This is likely due to the wide margin of 
safety associated with the sterilization processes used in healthcare facilities. The concept of what 
constitutes "sterile" is measured as a probability of sterility for each item to be sterilized. This probability is 
commonly referred to as the sterility assurance level (SAL) of the product and is defined as the probability 
of a single viable microorganism occurring on a product after sterilization. SAL is normally expressed a 
10-n. For example, if the probability of a spore surviving were one in one million, the SAL would be 10-6 823, 
824. In short, a SAL is an estimate of lethality of the entire sterilization process and is a conservative 
calculation. Dual SALs (e.g., 10-3 SAL for blood culture tubes, drainage bags; 10-6 SAL for scalpels, 
implants) have been used in the United States for many years and the choice of a 10-6 SAL was strictly 
arbitrary and not associated with any adverse outcomes (e.g., patient infections) 823.  
 
 Medical devices that have contact with sterile body tissues or fluids are considered critical items. 
These items should be sterile when used because any microbial contamination could result in disease 
transmission. Such items include surgical instruments, biopsy forceps, and implanted medical devices. If 
these items are heat resistant, the recommended sterilization process is steam sterilization, because it 
has the largest margin of safety due to its reliability, consistency, and lethality. However, reprocessing 
heat- and moisture-sensitive items requires use of a low-temperature sterilization technology (e.g., 
ethylene oxide, hydrogen peroxide gas plasma, peracetic acid) 825. A summary of the advantages and 
disadvantages for commonly used sterilization technologies is presented in Table 6. 
 
Steam Sterilization 
 Overview. Of all the methods available for sterilization, moist heat in the form of saturated steam 
under pressure is the most widely used and the most dependable. Steam sterilization is nontoxic, 
inexpensive 826, rapidly microbicidal, sporicidal, and rapidly heats and penetrates fabrics (Table 6) 827. 
Like all sterilization processes, steam sterilization has some deleterious effects on some materials, 
including corrosion and combustion of lubricants associated with dental handpieces212; reduction in ability 
to transmit light associated with laryngoscopes828; and increased hardening time (5.6 fold) with plaster-
cast 829. 
 
 The basic principle of steam sterilization, as accomplished in an autoclave, is to expose each item to 
direct steam contact at the required temperature and pressure for the specified time. Thus, there are four 
parameters of steam sterilization: steam, pressure, temperature, and time. The ideal steam for 
sterilization is dry saturated steam and entrained water (dryness fraction ≥97%)813, 819. Pressure serves as 
a means to obtain the high temperatures necessary to quickly kill microorganisms. Specific temperatures 
must be obtained to ensure the microbicidal activity. The two common steam-sterilizing temperatures are 
121°C (250°F) and 132°C (270°F). These temperatures (and other high temperatures) 830 must be 
maintained for a minimal time to kill microorganisms. Recognized minimum exposure periods for 
sterilization of wrapped healthcare supplies are 30 minutes at 121°C (250°F) in a gravity displacement 
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sterilizer or 4 minutes at 132°C (270°C) in a prevacuum sterilizer (Table 7). At constant temperatures, 
sterilization times vary depending on the type of item (e.g., metal versus rubber, plastic, items with 
lumens), whether the item is wrapped or unwrapped, and the sterilizer type. 
 
 The two basic types of steam sterilizers (autoclaves) are the gravity displacement autoclave and the 
high-speed prevacuum sterilizer. In the former, steam is admitted at the top or the sides of the sterilizing 
chamber and, because the steam is lighter than air, forces air out the bottom of the chamber through the 
drain vent. The gravity displacement autoclaves are primarily used to process laboratory media, water, 
pharmaceutical products, regulated medical waste, and nonporous articles whose surfaces have direct 
steam contact. For gravity displacement sterilizers the penetration time into porous items is prolonged 
because of incomplete air elimination. This point is illustrated with the decontamination of 10 lbs of 
microbiological waste, which requires at least 45 minutes at 121°C because the entrapped air remaining 
in a load of waste greatly retards steam permeation and heating efficiency831, 832. The high-speed 
prevacuum sterilizers are similar to the gravity displacement sterilizers except they are fitted with a 
vacuum pump (or ejector) to ensure air removal from the sterilizing chamber and load before the steam is 
admitted. The advantage of using a vacuum pump is that there is nearly instantaneous steam penetration 
even into porous loads. The Bowie-Dick test is used to detect air leaks and inadequate air removal and 
consists of folded 100% cotton surgical towels that are clean and preconditioned. A commercially 
available Bowie-Dick-type test sheet should be placed in the center of the pack. The test pack should be 
placed horizontally in the front, bottom section of the sterilizer rack, near the door and over the drain, in 
an otherwise empty chamber and run at 134°C for 3.5 minutes813, 819. The test is used each day the 
vacuum-type steam sterilizer is used, before the first processed load. Air that is not removed from the 
chamber will interfere with steam contact. Smaller disposable test packs (or process challenge devices) 
have been devised to replace the stack of folded surgical towels for testing the efficacy of the vacuum 
system in a prevacuum sterilizer. 833 These devices are “designed to simulate product to be sterilized and 
to constitute a defined challenge to the sterilization process”819, 834. They should be representative of the 
load and simulate the greatest challenge to the load835. Sterilizer vacuum performance is acceptable if the 
sheet inside the test pack shows a uniform color change. Entrapped air will cause a spot to appear on the 
test sheet, due to the inability of the steam to reach the chemical indicator. If the sterilizer fails the Bowie-
Dick test, do not use the sterilizer until it is inspected by the sterilizer maintenance personnel and passes 
the Bowie-Dick test813, 819, 836.  
 
 Another design in steam sterilization is a steam flush-pressure pulsing process, which removes air 
rapidly by repeatedly alternating a steam flush and a pressure pulse above atmospheric pressure. Air is 
rapidly removed from the load as with the prevacuum sterilizer, but air leaks do not affect this process 
because the steam in the sterilizing chamber is always above atmospheric pressure. Typical sterilization 
temperatures and times are 132°C to 135°C with 3 to 4 minutes exposure time for porous loads and 
instruments827, 837. 
 
 Like other sterilization systems, the steam cycle is monitored by mechanical, chemical, and biological 
monitors. Steam sterilizers usually are monitored using a printout (or graphically) by measuring 
temperature, the time at the temperature, and pressure. Typically, chemical indicators are affixed to the 
outside and incorporated into the pack to monitor the temperature or time and temperature. The 
effectiveness of steam sterilization is monitored with a biological indicator containing spores of 
Geobacillus stearothermophilus (formerly Bacillus stearothermophilus). Positive spore test results are a 
relatively rare event 838 and can be attributed to operator error, inadequate steam delivery839, or 
equipment malfunction.  
 
 Portable (table-top) steam sterilizers are used in outpatient, dental, and rural clinics840. These 
sterilizers are designed for small instruments, such as hypodermic syringes and needles and dental 
instruments. The ability of the sterilizer to reach physical parameters necessary to achieve sterilization 
should be monitored by mechanical, chemical, and biological indicators. 
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 Microbicidal Activity. The oldest and most recognized agent for inactivation of microorganisms is 
heat. D-values (time to reduce the surviving population by 90% or 1 log10) allow a direct comparison of 
the heat resistance of microorganisms. Because a D-value can be determined at various temperatures, a 
subscript is used to designate the exposure temperature (i.e., D121C). D121C-values for Geobacillus 
stearothermophilus used to monitor the steam sterilization process range from 1 to 2 minutes. Heat-
resistant nonspore-forming bacteria, yeasts, and fungi have such low D121C values that they cannot be 
experimentally measured841. 
 
 Mode of Action. Moist heat destroys microorganisms by the irreversible coagulation and 
denaturation of enzymes and structural proteins. In support of this fact, it has been found that the 
presence of moisture significantly affects the coagulation temperature of proteins and the temperature at 
which microorganisms are destroyed. 
 
 Uses. Steam sterilization should be used whenever possible on all critical and semicritical items that 
are heat and moisture resistant (e.g., steam sterilizable respiratory therapy and anesthesia equipment), 
even when not essential to prevent pathogen transmission. Steam sterilizers also are used in healthcare 
facilities to decontaminate microbiological waste and sharps containers 831, 832, 842 but additional exposure 
time is required in the gravity displacement sterilizer for these items. 
 
Flash Sterilization 
 Overview. “Flash” steam sterilization was originally defined by Underwood and Perkins as 
sterilization of an unwrapped object at 132°C for 3 minutes at 27-28 lbs. of pressure in a gravity 
displacement sterilizer843. Currently, the time required for flash sterilization depends on the type of 
sterilizer and the type of item (i.e., porous vs non-porous items)(see Table 8). Although the wrapped 
method of sterilization is preferred for the reasons listed below, correctly performed flash sterilization is an 
effective process for the sterilization of critical medical devices844, 845. Flash sterilization is a modification 
of conventional steam sterilization (either gravity, prevacuum, or steam-flush pressure-pulse) in which the 
flashed item is placed in an open tray or is placed in a specially designed, covered, rigid container to 
allow for rapid penetration of steam. Historically, it is not recommended as a routine sterilization method 
because of the lack of timely biological indicators to monitor performance, absence of protective 
packaging following sterilization, possibility for contamination of processed items during transportation to 
the operating rooms, and the sterilization cycle parameters (i.e., time, temperature, pressure) are minimal. 
To address some of these concerns, many healthcare facilities have done the following: placed 
equipment for flash sterilization in close proximity to operating rooms to facilitate aseptic delivery to the 
point of use (usually the sterile field in an ongoing surgical procedure); extended the exposure time to 
ensure lethality comparable to sterilized wrapped items (e.g., 4 minutes at 132°C)846, 847; used biological 
indicators that provide results in 1 hour for flash-sterilized items846, 847; and used protective packaging that 
permits steam penetration812, 817-819, 845, 848. Further, some rigid, reusable sterilization container systems 
have been designed and validated by the container manufacturer for use with flash cycles. When sterile 
items are open to air, they will eventually become contaminated. Thus, the longer a sterile item is 
exposed to air, the greater the number of microorganisms that will settle on it. Sterilization cycle 
parameters for flash sterilization are shown in Table 8.  
 
 A few adverse events have been associated with flash sterilization. When evaluating an increased 
incidence of neurosurgical infections, the investigators noted that surgical instruments were flash 
sterilized between cases and 2 of 3 craniotomy infections involved plate implants that were flash 
sterilized849. A report of two patients who received burns during surgery from instruments that had been 
flash sterilized reinforced the need to develop policies and educate staff to prevent the use of instruments 
hot enough to cause clinical burns850. Staff should use precautions to prevent burns with potentially hot 
instruments (e.g., transport tray using heat-protective gloves). Patient burns may be prevented by either 
air-cooling the instruments or immersion in sterile liquid (e.g., saline). 
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 Uses. Flash sterilization is considered acceptable for processing cleaned patient-care items that 
cannot be packaged, sterilized, and stored before use. It also is used when there is insufficient time to 
sterilize an item by the preferred package method. Flash sterilization should not be used for reasons of 
convenience, as an alternative to purchasing additional instrument sets, or to save time817. Because of 
the potential for serious infections, flash sterilization is not recommended for implantable devices (i.e., 
devices placed into a surgically or naturally formed cavity of the human body); however, flash sterilization 
may be unavoidable for some devices (e.g., orthopedic screw, plates). If flash sterilization of an 
implantable device is unavoidable, recordkeeping (i.e., load identification, patient’s name/hospital 
identifier, and biological indicator result) is essential for epidemiological tracking (e.g., of surgical site 
infection, tracing results of biological indicators to patients who received the item to document sterility), 
and for an assessment of the reliability of the sterilization process (e.g., evaluation of biological 
monitoring records and sterilization maintenance records noting preventive maintenance and repairs with 
dates).  
 
Low-Temperature Sterilization Technologies 
 Ethylene oxide (ETO) has been widely used as a low-temperature sterilant since the 1950s. It has 
been the most commonly used process for sterilizing temperature- and moisture-sensitive medical 
devices and supplies in healthcare institutions in the United States. Two types of ETO sterilizers are 
available, mixed gas and 100% ETO. Until 1995, ethylene oxide sterilizers combined ETO with a 
chloroflourocarbon (CFC) stabilizing agent, most commonly in a ratio of 12% ETO mixed with 88% CFC 
(referred to as 12/88 ETO). 
 
 For several reasons, healthcare personnel have been exploring the use of new low-temperature 
sterilization technologies825, 851. First, CFCs were phased out in December 1995 under provisions of the 
Clean Air Act 852. CFCs were classified as a Class I substance under the Clean Air Act because of 
scientific evidence linking them to destruction of the earth’s ozone layer. Second, some states (e.g., 
California, New York, Michigan) require the use of ETO abatement technology to reduce the amount of 
ETO being released into ambient air from 90 to 99.9% depending on the state. Third, OSHA regulates the 
acceptable vapor levels of ETO (i.e., 1 ppm averaged over 8 hours) due to concerns that ETO exposure 
represents an occupational hazard318. These constraints have led to the development of alternative 
technologies for low-temperature sterilization in the healthcare setting.  
 
 Alternative technologies to ETO with chlorofluorocarbon that are currently available and cleared by 
the FDA for medical equipment include 100% ETO; ETO with a different stabilizing gas, such as carbon 
dioxide or hydrochlorofluorocarbons (HCFC); immersion in peracetic acid; hydrogen peroxide gas plasma; 
and ozone. Technologies under development for use in healthcare facilities, but not cleared by the FDA, 
include vaporized hydrogen peroxide, vapor phase peracetic acid, gaseous chlorine dioxide, ionizing 
radiation, or pulsed light 400, 758, 853. However, there is no guarantee that these new sterilization 
technologies will receive FDA clearance for use in healthcare facilities. 
 
 These new technologies should be compared against the characteristics of an ideal low-temperature 
(<60°C) sterilant (Table 9). 851 While it is apparent that all technologies will have limitations (Table 9), 
understanding the limitations imposed by restrictive device designs (e.g., long, narrow lumens) is critical 
for proper application of new sterilization technology854. For example, the development of increasingly 
small and complex endoscopes presents a difficult challenge for current sterilization processes. This 
occurs because microorganisms must be in direct contact with the sterilant for inactivation to occur. 
Several peer-reviewed scientific publications have data demonstrating concerns about the efficacy of 
several of the low-temperature sterilization processes (i.e., gas plasma, vaporized hydrogen peroxide, 
ETO, peracetic acid), particularly when the test organisms are challenged in the presence of serum and 
salt and a narrow lumen vehicle469, 721, 825, 855, 856. Factors shown to affect the efficacy of sterilization are 
shown in Table 10. 
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Ethylene Oxide "Gas" Sterilization 
 Overview. ETO is a colorless gas that is flammable and explosive. The four essential parameters 
(operational ranges) are: gas concentration (450 to 1200 mg/l); temperature (37 to 63°C); relative 
humidity (40 to 80%)(water molecules carry ETO to reactive sites); and exposure time (1 to 6 hours). 
These influence the effectiveness of ETO sterilization814, 857, 858. Within certain limitations, an increase in 
gas concentration and temperature may shorten the time necessary for achieving sterilization. 
 
 The main disadvantages associated with ETO are the lengthy cycle time, the cost, and its potential 
hazards to patients and staff; the main advantage is that it can sterilize heat- or moisture-sensitive 
medical equipment without deleterious effects on the material used in the medical devices (Table 6). 
Acute exposure to ETO may result in irritation (e.g., to skin, eyes, gastrointestinal or respiratory tracts) 
and central nervous system depression859-862. Chronic inhalation has been linked to the formation of 
cataracts, cognitive impairment, neurologic dysfunction, and disabling polyneuropathies860, 861, 863-866. 
Occupational exposure in healthcare facilities has been linked to hematologic changes 867 and an 
increased risk of spontaneous abortions and various cancers318, 868-870. ETO should be considered a 
known human carcinogen871. 
 
 The basic ETO sterilization cycle consists of five stages (i.e., preconditioning and humidification, gas 
introduction, exposure, evacuation, and air washes) and takes approximately 2 1/2 hrs excluding aeration 
time. Mechanical aeration for 8 to 12 hours at 50 to 60°C allows desorption of the toxic ETO residual 
contained in exposed absorbent materials. Most modern ETO sterilizers combine sterilization and 
aeration in the same chamber as a continuous process. These ETO models minimize potential ETO 
exposure during door opening and load transfer to the aerator. Ambient room aeration also will achieve 
desorption of the toxic ETO but requires 7 days at 20°C. There are no federal regulations for ETO 
sterilizer emission; however, many states have promulgated emission-control regulations814.  
 
 The use of ETO evolved when few alternatives existed for sterilizing heat- and moisture-sensitive 
medical devices; however, favorable properties (Table 6) account for its continued widespread use872. 
Two ETO gas mixtures are available to replace ETO-chlorofluorocarbon (CFC) mixtures for large 
capacity, tank-supplied sterilizers. The ETO-carbon dioxide (CO2) mixture consists of 8.5% ETO and 
91.5% CO2. This mixture is less expensive than ETO-hydrochlorofluorocarbons (HCFC), but a 
disadvantage is the need for pressure vessels rated for steam sterilization, because higher pressures (28-
psi gauge) are required. The other mixture, which is a drop-in CFC replacement, is ETO mixed with 
HCFC. HCFCs are approximately 50-fold less damaging to the earth’s ozone layer than are CFCs. The 
EPA will begin regulation of HCFC in the year 2015 and will terminate production in the year 2030. Two 
companies provide ETO-HCFC mixtures as drop-in replacement for CFC-12; one mixture consists of 
8.6% ETO and 91.4% HCFC, and the other mixture is composed of 10% ETO and 90% HCFC872. An 
alternative to the pressurized mixed gas ETO systems is 100% ETO. The 100% ETO sterilizers using 
unit-dose cartridges eliminate the need for external tanks.  
 
 ETO is absorbed by many materials. For this reason, following sterilization the item must undergo 
aeration to remove residual ETO. Guidelines have been promulgated regarding allowable ETO limits for 
devices that depend on how the device is used, how often, and how long in order to pose a minimal risk 
to patients in normal product use814.  
 
 ETO toxicity has been established in a variety of animals. Exposure to ETO can cause eye pain, sore 
throat, difficulty breathing and blurred vision. Exposure can also cause dizziness, nausea, headache, 
convulsions, blisters and vomiting and coughing873. In a variety of in vitro and animal studies, ETO has 
been demonstrated to be carcinogenic. ETO has been linked to spontaneous abortion, genetic damage, 
nerve damage, peripheral paralysis, muscle weakness, and impaired thinking and memory873. 
Occupational exposure in healthcare facilities has been linked to an increased risk of spontaneous 
abortions and various cancers318. Injuries (e.g., tissue burns) to patients have been associated with ETO 
residues in implants used in surgical procedures874. Residual ETO in capillary flow dialysis membranes 
has been shown to be neurotoxic in vitro875. OSHA has established a PEL of 1 ppm airborne ETO in the 
workplace, expressed as a TWA for an 8-hour work shift in a 40-hour work week. The “action level” for 
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ETO is 0.5 ppm, expressed as an 8-hour TWA, and the short-term excursion limit is 5 ppm, expressed as 
a 15-minute TWA814. For details of the requirements in OSHA’s ETO standard for occupational 
exposures, see Title 29 of the Code of Federal Regulations (CFR) Part 1910.1047873. Several personnel 
monitoring methods (e.g., charcoal tubes and passive sampling devices) are in use814. OSHA has 
established a PEL of 5 ppm for ethylene chlorohydrin (a toxic by-product of ETO) in the workplace876. 
Additional information regarding use of ETO in health care facilities is available from NIOSH.  
 
 Mode of Action. The microbicidal activity of ETO is considered to be the result of alkylation of 
protein, DNA, and RNA. Alkylation, or the replacement of a hydrogen atom with an alkyl group, within 
cells prevents normal cellular metabolism and replication877. 
 
 Microbicidal Activity. The excellent microbicidal activity of ETO has been demonstrated in several 
studies 469, 721, 722, 856, 878, 879 and summarized in published reports877. ETO inactivates all microorganisms 
although bacterial spores (especially B. atrophaeus) are more resistant than other microorganisms. For 
this reason B. atrophaeus is the recommended biological indicator.  
 
 Like all sterilization processes, the effectiveness of ETO sterilization can be altered by lumen length, 
lumen diameter, inorganic salts, and organic materials469, 721, 722, 855, 856, 879. For example, although ETO is 
not used commonly for reprocessing endoscopes28, several studies have shown failure of ETO in 
inactivating contaminating spores in endoscope channels 855or lumen test units 469, 721, 879 and residual 
ETO levels averaging 66.2 ppm even after the standard degassing time456. Failure of ETO also has been 
observed when dental handpieces were contaminated with Streptococcus mutans and exposed to 
ETO880. It is recommended that dental handpieces be steam sterilized. 
 
 Uses. ETO is used in healthcare facilities to sterilize critical items (and sometimes semicritical items) 
that are moisture or heat sensitive and cannot be sterilized by steam sterilization. 
 
Hydrogen Peroxide Gas Plasma 
 Overview. New sterilization technology based on plasma was patented in 1987 and marketed in the 
United States in 1993. Gas plasmas have been referred to as the fourth state of matter (i.e., liquids, 
solids, gases, and gas plasmas). Gas plasmas are generated in an enclosed chamber under deep 
vacuum using radio frequency or microwave energy to excite the gas molecules and produce charged 
particles, many of which are in the form of free radicals. A free radical is an atom with an unpaired 
electron and is a highly reactive species. The proposed mechanism of action of this device is the 
production of free radicals within a plasma field that are capable of interacting with essential cell 
components (e.g., enzymes, nucleic acids) and thereby disrupt the metabolism of microorganisms. The 
type of seed gas used and the depth of the vacuum are two important variables that can determine the 
effectiveness of this process. 
 
 In the late 1980s the first hydrogen peroxide gas plasma system for sterilization of medical and 
surgical devices was field-tested. According to the manufacturer, the sterilization chamber is evacuated 
and hydrogen peroxide solution is injected from a cassette and is vaporized in the sterilization chamber to 
a concentration of 6 mg/l. The hydrogen peroxide vapor diffuses through the chamber (50 minutes), 
exposes all surfaces of the load to the sterilant, and initiates the inactivation of microorganisms. An 
electrical field created by a radio frequency is applied to the chamber to create a gas plasma. Microbicidal 
free radicals (e.g., hydroxyl and hydroperoxyl) are generated in the plasma. The excess gas is removed 
and in the final stage (i.e., vent) of the process the sterilization chamber is returned to atmospheric 
pressure by introduction of high-efficiency filtered air. The by-products of the cycle (e.g., water vapor, 
oxygen) are nontoxic and eliminate the need for aeration. Thus, the sterilized materials can be handled 
safely, either for immediate use or storage. The process operates in the range of 37-44°C and has a cycle 
time of 75 minutes. If any moisture is present on the objects the vacuum will not be achieved and the 
cycle aborts856, 881-883. 
 
 A newer version of the unit improves sterilizer efficacy by using two cycles with a hydrogen peroxide 
Guideline for Disinfection and Sterilization in Healthcare Facilities (2008) 
 
Last update: Feburary 15, 2017 64 of 161 
  
diffusion stage and a plasma stage per sterilization cycle. This revision, which is achieved by a software 
modification, reduces total processing time from 73 to 52 minutes. The manufacturer believes that the 
enhanced activity obtained with this system is due in part to the pressure changes that occur during the 
injection and diffusion phases of the process and to the fact that the process consists of two equal and 
consecutive half cycles, each with a separate injection of hydrogen peroxide. 856, 884, 885 This system and a 
smaller version 400, 882 have received FDA 510[k] clearance with limited application for sterilization of 
medical devices (Table 6). The biological indicator used with this system is Bacillus atrophaeus spores851. 
The newest version of the unit, which employs a new vaporization system that removes most of the water 
from the hydrogen peroxide, has a cycle time from 28-38 minutes (see manufacturer’s literature for device 
dimension restrictions). 
 
 Penetration of hydrogen peroxide vapor into long or narrow lumens has been addressed outside the 
United States by the use of a diffusion enhancer. This is a small, breakable glass ampoule of 
concentrated hydrogen peroxide (50%) with an elastic connector that is inserted into the device lumen 
and crushed immediately before sterilization470, 885. The diffusion enhancer has been shown to sterilize 
bronchoscopes contaminated with Mycobacteria tuberculosis886. At the present time, the diffusion 
enhancer is not FDA cleared. 
 
 Another gas plasma system, which differs from the above in several important ways, including the 
use of peracetic acid-acetic acid-hydrogen peroxide vapor, was removed from the marketplace because 
of reports of corneal destruction to patients when ophthalmic surgery instruments had been processed in 
the sterilizer887, 888. In this investigation, exposure of potentially wet ophthalmologic surgical instruments 
with small bores and brass components to the plasma gas led to degradation of the brass to copper and 
zinc888, 889. The experimenters showed that when rabbit eyes were exposed to the rinsates of the gas 
plasma-sterilized instruments, corneal decompensation was documented. This toxicity is highly unlikely 
with the hydrogen peroxide gas plasma process since a toxic, soluble form of copper would not form (LA 
Feldman, written communication, April 1998). 
 
 Mode of Action. This process inactivates microorganisms primarily by the combined use of hydrogen 
peroxide gas and the generation of free radicals (hydroxyl and hydroproxyl free radicals) during the 
plasma phase of the cycle.  
 
 Microbicidal Activity. This process has the ability to inactivate a broad range of microorganisms, 
including resistant bacterial spores. Studies have been conducted against vegetative bacteria (including 
mycobacteria), yeasts, fungi, viruses, and bacterial spores469, 721, 856, 881-883, 890-893. Like all sterilization 
processes, the effectiveness can be altered by lumen length, lumen diameter, inorganic salts, and organic 
materials469, 721, 855, 856, 890, 891, 893. 
 
 Uses. Materials and devices that cannot tolerate high temperatures and humidity, such as some 
plastics, electrical devices, and corrosion-susceptible metal alloys, can be sterilized by hydrogen peroxide 
gas plasma. This method has been compatible with most (>95%) medical devices and materials tested884, 
894, 895. 
 
Peracetic Acid Sterilization 
 Overview. Peracetic acid is a highly biocidal oxidizer that maintains its efficacy in the presence of 
organic soil. Peracetic acid removes surface contaminants (primarily protein) on endoscopic tubing711, 717. 
An automated machine using peracetic acid to sterilize medical, surgical, and dental instruments 
chemically (e.g., endoscopes, arthroscopes) was introduced in 1988. This microprocessor-controlled, low-
temperature sterilization method is commonly used in the United States107. The sterilant, 35% peracetic 
acid, and an anticorrosive agent are supplied in a single-dose container. The container is punctured at the 
time of use, immediately prior to closing the lid and initiating the cycle. The concentrated peracetic acid is 
diluted to 0.2% with filtered water (0.2 µm) at a temperature of approximately 50°C. The diluted peracetic 
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acid is circulated within the chamber of the machine and pumped through the channels of the endoscope 
for 12 minutes, decontaminating exterior surfaces, lumens, and accessories. Interchangeable trays are 
available to permit the processing of up to three rigid endoscopes or one flexible endoscope. Connectors 
are available for most types of flexible endoscopes for the irrigation of all channels by directed flow. Rigid 
endoscopes are placed within a lidded container, and the sterilant fills the lumens either by immersion in 
the circulating sterilant or by use of channel connectors to direct flow into the lumen(s) (see below for the 
importance of channel connectors). The peracetic acid is discarded via the sewer and the instrument 
rinsed four times with filtered water. Concern has been raised that filtered water may be inadequate to 
maintain sterility896. Limited data have shown that low-level bacterial contamination may follow the use of 
filtered water in an AER but no data has been published on AERs using the peracetic acid system161. 
Clean filtered air is passed through the chamber of the machine and endoscope channels to remove 
excess water719. As with any sterilization process, the system can only sterilize surfaces that can be 
contacted by the sterilant. For example, bronchoscopy-related infections occurred when bronchoscopes 
were processed using the wrong connector155, 725. Investigation of these incidents revealed that 
bronchoscopes were inadequately reprocessed when inappropriate channel connectors were used and 
when there were inconsistencies between the reprocessing instructions provided by the manufacturer of 
the bronchoscope and the manufacturer of the automatic endoscope reprocessor155. The importance of 
channel connectors to achieve sterilization was also shown for rigid lumen devices137, 856.   
 
 The manufacturers suggest the use of biological monitors (G. stearothermophilus spore strips) both at 
the time of installation and routinely to ensure effectiveness of the process. The manufacturer’s clip must 
be used to hold the strip in the designated spot in the machine as a broader clamp will not allow the 
sterilant to reach the spores trapped under it897. One investigator reported a 3% failure rate when the 
appropriate clips were used to hold the spore strip within the machine718. The use of biological monitors 
designed to monitor either steam sterilization or ETO for a liquid chemical sterilizer has been questioned 
for several reasons including spore wash-off from the filter paper strips which may cause less valid 
monitoring898-901. The processor is equipped with a conductivity probe that will automatically abort the 
cycle if the buffer system is not detected in a fresh container of the peracetic acid solution. A chemical 
monitoring strip that detects that the active ingredient is >1500 ppm is available for routine use as an 
additional process control.  
 
 Mode of Action. Only limited information is available regarding the mechanism of action of peracetic 
acid, but it is thought to function as other oxidizing agents, i.e., it denatures proteins, disrupts cell wall 
permeability, and oxidizes sulfhydral and sulfur bonds in proteins, enzymes, and other metabolites654, 726. 
 
 Microbicidal Activity. Peracetic acid will inactivate gram-positive and gram-negative bacteria, fungi, 
and yeasts in <5 minutes at <100 ppm. In the presence of organic matter, 200-500 ppm is required. For 
viruses, the dosage range is wide (12-2250 ppm), with poliovirus inactivated in yeast extract in 15 
minutes with 1500 to 2250 ppm. Bacterial spores in suspension are inactivated in 15 seconds to 30 
minutes with 500 to 10,000 ppm (0.05 to 1%)654. 
 
 Simulated-use trials have demonstrated microbicidal activity 111, 718-722 and three clinical trials have 
demonstrated both microbial killing and no clinical failures leading to infection90, 723, 724. Alfa and co-
workers, who compared the peracetic acid system with ETO, demonstrated the high efficacy of the 
system. Only the peracetic acid system was able to completely kill 6-log10 of Mycobacterium chelonae, 
Enterococcus faecalis, and B. atrophaeus spores with both an organic and inorganic challenge722. Like 
other sterilization processes, the efficacy of the process can be diminished by soil challenges 902 and test 
conditions856. 
 
 Uses. This automated machine is used to chemically sterilize medical (e.g., GI endoscopes) and 
surgical (e.g., flexible endoscopes) instruments in the United States. Lumened endoscopes must be 
connected to an appropriate channel connector to ensure that the sterilant has direct contact with the 
contaminated lumen. 137, 856, 903 Olympus America has not listed this system as a compatible product for 
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use in reprocessing Olympus bronchoscopes and gastrointestinal endoscopes (Olympus America, 
January 30, 2002, written communication). 
 
Microbicidal Activity of Low-Temperature Sterilization Technologies 
 Sterilization processes used in the United States must be cleared by FDA, and they require that 
sterilizer microbicidal performance be tested under simulated-use conditions904. FDA requires that the test 
article be inoculated with 106 colony-forming units of the most resistant test organism and prepared with 
organic and inorganic test loads as would occur after actual use. FDA requires manufacturers to use 
organic soil (e.g., 5% fetal calf serum), dried onto the device with the inoculum, to represent soil 
remaining on the device following marginal cleaning. However, 5% fetal calf serum as a measure of 
marginal cleaning has not been validated by measurements of protein load on devices following use and 
the level of protein removal by various cleaning methods. The inocula must be placed in various locations 
of the test articles, including those least favorable to penetration and contact with the sterilant (e.g., 
lumens). Cleaning before sterilization is not allowed in the demonstration of sterilization efficacy904. 
Several studies have evaluated the relative microbicidal efficacy of these low-temperature sterilization 
technologies (Table 11). These studies have either tested the activity of a sterilization process against 
specific microorganisms892, 905, 906, evaluated the microbicidal activity of a singular technology 711, 719, 724, 
855, 879, 882-884, 890, 891, 907 or evaluated the comparative effectiveness of several sterilization technologies271, 
426, 469, 721, 722, 856, 908, 909. Several test methodologies use stainless steel or porcelain carriers that are 
inoculated with a test organism. Commonly used test organisms include vegetative bacteria, 
mycobacteria, and spores of Bacillus species. The available data demonstrate that low-temperature 
sterilization technologies are able to provide a 6-log10 reduction of microbes when inoculated onto carriers 
in the absence of salt and serum. However, tests can be constructed such that all of the available 
sterilization technologies are unable to reliably achieve complete inactivation of a microbial load. 425, 426, 
469, 721, 856, 909 For example, almost all of the sterilization processes will fail to reliably inactivate the 
microbial load in the presence of salt and serum469, 721, 909.  
 
 The effect of salts and serums on the sterilization process were studied initially in the 1950s and 
1960s424, 910. These studies showed that a high concentration of crystalline-type materials and a low 
protein content provided greater protection to spores than did serum with a high protein content426. A 
study by Doyle and Ernst demonstrated resistance of spores by crystalline material applied not only to 
low-temperature sterilization technology but also to steam and dry heat425. These studies showed that 
occlusion of Bacillus atrophaeus spores in calcium carbonate crystals dramatically increased the time 
required for inactivation as follows: 10 seconds to 150 minutes for steam (121°C), 3.5 hours to 50 hours 
for dry heat (121°C), 30 seconds to >2 weeks for ETO (54°C). Investigators have corroborated and 
extended these findings469, 470, 721, 855, 908, 909. While soils containing both organic and inorganic materials 
impair microbial killing, soils that contain a high inorganic salt-to-protein ratio favor crystal formation and 
impair sterilization by occlusion of organisms425, 426, 881. 
 
 Alfa and colleagues demonstrated a 6-log10 reduction of the microbial inoculum of porcelain 
penicylinders using a variety of vegetative and spore-forming organisms (Table 11)469. However, if the 
bacterial inoculum was in tissue-culture medium supplemented with 10% serum, only the ETO 12/88 and 
ETO-HCFC sterilization mixtures could sterilize 95% to 97% of the penicylinder carriers. The plasma and 
100% ETO sterilizer demonstrated significantly reduced activity (Table 11). For all sterilizers evaluated 
using penicylinder carriers (i.e., ETO 12/88, 100% ETO, hydrogen peroxide gas plasma), there was a 3- 
to 6-log10 reduction of inoculated bacteria even in the presence of serum and salt. For each sterilizer 
evaluated, the ability to inactivate microorganisms in the presence of salt and serum was reduced even 
further when the inoculum was placed in a narrow-lumen test object (3 mm diameter by 125 cm long). 
Although there was a 2- to 4-log10 reduction in microbial kill, less than 50% of the lumen test objects were 
sterile when processed using any of the sterilization methods evaluated except the peracetic acid 
immersion system (Table 11)721. Complete killing (or removal) of 6-log10 of Enterococcus faecalis, 
Mycobacterium chelonei, and Bacillus atrophaeus spores in the presence of salt and serum and lumen 
test objects was observed only for the peracetic acid immersion system.  
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 With respect to the results by Alfa and coworkers469, Jacobs showed that the use of the tissue culture 
media created a technique-induced sterilization failure426. Jacobs et al. showed that microorganisms 
mixed with tissue culture media, used as a surrogate body fluid, formed physical crystals that protected 
the microorganisms used as a challenge. If the carriers were exposed for 60 sec to nonflowing water, the 
salts dissolved and the protective effect disappeared. Since any device would be exposed to water for a 
short period of time during the washing procedure, these protective effects would have little clinical 
relevance426.  
 
 Narrow lumens provide a challenge to some low-temperature sterilization processes. For example, 
Rutala and colleagues showed that, as lumen size decreased, increased failures occurred with some low-
temperature sterilization technologies. However, some low-temperature processes such as ETO-HCFC 
and the hydrogen peroxide gas plasma process remained effective even when challenged by a lumen as 
small as 1 mm in the absence of salt and serum856. 
 
 The importance of allowing the sterilant to come into contact with the inoculated carrier is 
demonstrated by comparing the results of two investigators who studied the peracetic acid immersion 
system. Alfa and coworkers demonstrated excellent activity of the peracetic acid immersion system 
against three test organisms using a narrow-lumen device. In these experiments, the lumen test object 
was connected to channel irrigators, which ensured that the sterilant had direct contact with the 
contaminated carriers722. This effectiveness was achieved through a combination of organism wash-off 
and peracetic acid sterilant killing the test organisms722. The data reported by Rutala et al. demonstrated 
failure of the peracetic acid immersion system to eliminate Geobacillus stearothermophilus spores from a 
carrier placed in a lumen test object. In these experiments, the lumen test unit was not connected to 
channel irrigators. The authors attributed the failure of the peracetic acid immersion system to eliminate 
the high levels of spores from the center of the test unit to the inability of the peracetic acid to diffuse into 
the center of 40-cm long, 3-mm diameter tubes. This may be caused by an air lock or air bubbles formed 
in the lumen, impeding the flow of the sterilant through the long and narrow lumen and limiting complete 
access to the Bacillus spores137, 856. Experiments using a channel connector specifically designed for 1-, 
2-, and 3-mm lumen test units with the peracetic acid immersion system were completely effective in 
eliminating an inoculum of 106 Geobacillus stearothermophilus spores7. The restricted diffusion 
environment that exists in the test conditions would not exist with flexible scopes processed in the 
peracetic acid immersion system, because the scopes are connected to channel irrigators to ensure that 
the sterilant has direct contact with contaminated surfaces. Alfa and associates attributed the efficacy of 
the peracetic acid immersion system to the ability of the liquid chemical process to dissolve salts and 
remove protein and bacteria due to the flushing action of the fluid722. 
 
Bioburden of Surgical Devices 
 In general, used medical devices are contaminated with a relatively low bioburden of organisms179, 911, 
912. Nystrom evaluated medical instruments used in general surgical, gynecological, orthopedic, and ear-
nose-throat operations and found that 62% of the instruments were contaminated with <101 organisms 
after use, 82% with <102, and 91% with <103. After being washed in an instrument washer, more than 
98% of the instruments had <101 organisms, and none >102 organisms911. Other investigators have 
published similar findings179, 912. For example, after a standard cleaning procedure, 72% of 50 surgical 
instruments contained <101 organisms, 86% <102, and only 6% had >3 X 102912. In another study of rigid-
lumen medical devices, the bioburden on both the inner and outer surface of the lumen ranged from 101 
to 104 organisms per device. After cleaning, 83% of the devices had a bioburden ≤102 organisms179. In all 
of these studies, the contaminating microflora consisted mainly of vegetative bacteria, usually of low 
pathogenicity (e.g., coagulase-negative Staphylococcus)179, 911, 912.  
 
 An evaluation of the microbial load on used critical medical devices such as spinal anesthesia 
needles and angiographic catheters and sheaths demonstrated that mesophilic microorganisms were 
detected at levels of 101 to 102 in only two of five needles. The bioburden on used angiographic catheters 
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and sheath introducers exceeded 103 CFUs on 14% (3 of 21) and 21% (6 of 28), respectively907.   
 
Effect of Cleaning on Sterilization Efficacy 
 The effect of salt and serum on the efficacy of low-temperature sterilization technologies has raised 
concern regarding the margin of safety of these technologies. Experiments have shown that salts have 
the greatest impact on protecting microorganisms from killing426, 469. However, other studies have 
suggested that these concerns may not be clinically relevant. One study evaluated the relative rate of 
removal of inorganic salts, organic soil, and microorganisms from medical devices to better understand 
the dynamics of the cleaning process426. These tests were conducted by inoculating Alfa soil (tissue-
culture media and 10% fetal bovine serum) 469 containing 106 G. stearothermophilus spores onto the 
surface of a stainless-steel scalpel blade. After drying for 30 minutes at 35°C followed by 30 minutes at 
room temperature, the samples were placed in water at room temperature. The blades were removed at 
specified times, and the concentration of total protein and chloride ion was measured. The results showed 
that soaking in deionized water for 60 seconds resulted in a >95% release rate of chloride ion from NaCl 
solution in 20 seconds, Alfa soil in 30 seconds, and fetal bovine serum in 120 seconds. Thus, contact with 
water for short periods, even in the presence of protein, rapidly leads to dissolution of salt crystals and 
complete inactivation of spores by a low-temperature sterilization process (Table 10). Based on these 
experimental data, cleaning procedures would eliminate the detrimental effect of high salt content on a 
low-temperature sterilization process. 
 
 These articles 426, 469, 721 assessing low-temperature sterilization technology reinforce the importance 
of meticulous cleaning before sterilization. These data support the critical need for healthcare facilities to 
develop rigid protocols for cleaning contaminated objects before sterilization472. Sterilization of 
instruments and medical devices is compromised if the process is not preceded by meticulous cleaning. 
 
 The cleaning of any narrow-lumen medical device used in patient care presents a major challenge to 
reprocessing areas. While attention has been focused on flexible endoscopes, cleaning issues related to 
other narrow-lumen medical devices such as sphinctertomes have been investigated913. This study 
compared manual cleaning with that of automated cleaning with a narrow-lumen cleaner and found that 
only retro-flushing with the narrow lumen cleaner provided adequate cleaning of the three channels. If 
reprocessing was delayed for more than 24 hours, retro-flush cleaning was no longer effective and ETO 
sterilization failure was detected when devices were held for 7 days 913. In another study involving 
simulated-use cleaning of laparoscopic devices, Alfa found that minimally the use of retro-flushing should 
be used during cleaning of non-ported laparoscopic devices914. 
 
Other Sterilization Methods 
 Ionizing Radiation. Sterilization by ionizing radiation, primarily by cobalt 60 gamma rays or electron 
accelerators, is a low-temperature sterilization method that has been used for a number of medical 
products (e.g., tissue for transplantation, pharmaceuticals, medical devices). There are no FDA-cleared 
ionizing radiation sterilization processes for use in healthcare facilities. Because of high sterilization costs, 
this method is an unfavorable alternative to ETO and plasma sterilization in healthcare facilities but is 
suitable for large-scale sterilization. Some deleterious effects on patient-care equipment associated with 
gamma radiation include induced oxidation in polyethylene 915 and delamination and cracking in 
polyethylene knee bearings916. Several reviews 917, 918 dealing with the sources, effects, and application of 
ionizing radiation may be referred to for more detail. 
 
 Dry-Heat Sterilizers. This method should be used only for materials that might be damaged by moist 
heat or that are impenetrable to moist heat (e.g., powders, petroleum products, sharp instruments). The 
advantages for dry heat include the following: it is nontoxic and does not harm the environment; a dry 
heat cabinet is easy to install and has relatively low operating costs; it penetrates materials; and it is 
noncorrosive for metal and sharp instruments. The disadvantages for dry heat are the slow rate of heat 
penetration and microbial killing makes this a time-consuming method. In addition, the high temperatures 
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are not suitable for most materials919. The most common time-temperature relationships for sterilization 
with hot air sterilizers are 170°C (340°F) for 60 minutes, 160°C (320°F) for 120 minutes, and 150°C 
(300°F) for 150 minutes. B. atrophaeus spores should be used to monitor the sterilization process for dry 
heat because they are more resistant to dry heat than are G. stearothermophilus spores. The primary 
lethal process is considered to be oxidation of cell constituents. 
 
 There are two types of dry-heat sterilizers: the static-air type and the forced-air type. The static-air 
type is referred to as the oven-type sterilizer as heating coils in the bottom of the unit cause the hot air to 
rise inside the chamber via gravity convection. This type of dry-heat sterilizer is much slower in heating, 
requires longer time to reach sterilizing temperature, and is less uniform in temperature control 
throughout the chamber than is the forced-air type. The forced-air or mechanical convection sterilizer is 
equipped with a motor-driven blower that circulates heated air throughout the chamber at a high velocity, 
permitting a more rapid transfer of energy from the air to the instruments920.  
 
 Liquid Chemicals. Several FDA-cleared liquid chemical sterilants include indications for sterilization 
of medical devices (Tables 4 and 5)69. The indicated contact times range from 3 hours to 12 hours. 
However, except for a few of the products, the contact time is based only on the conditions to pass the 
AOAC Sporicidal Test as a sterilant and not on simulated use testing with devices. These solutions are 
commonly used as high-level disinfectants when a shorter processing time is required. Generally, 
chemical liquid sterilants cannot be monitored using a biological indicator to verify sterility899, 900.  
 
 The survival kinetics for thermal sterilization methods, such as steam and dry heat, have been 
studied and characterized extensively, whereas the kinetics for sterilization with liquid sterilants are less 
well understood921. The information that is available in the literature suggests that sterilization processes 
based on liquid chemical sterilants, in general, may not convey the same sterility assurance level as 
sterilization achieved using thermal or physical methods823. The data indicate that the survival curves for 
liquid chemical sterilants may not exhibit log-linear kinetics and the shape of the survivor curve may vary 
depending of the formulation, chemical nature and stability of the liquid chemical sterilant. In addition, the 
design of the AOAC Sporicidal Test does not provide quantification of the microbial challenge. Therefore, 
sterilization with a liquid chemical sterilant may not convey the same sterility assurance as other 
sterilization methods. 
 
 One of the differences between thermal and liquid chemical processes for sterilization of devices is 
the accessibility of microorganisms to the sterilant. Heat can penetrate barriers, such as biofilm, tissue, 
and blood, to attain organism kill, whereas liquids cannot adequately penetrate these barriers. In addition, 
the viscosity of some liquid chemical sterilants impedes their access to organisms in the narrow lumens 
and mated surfaces of devices922. Another limitation to sterilization of devices with liquid chemical 
germicides is the post-processing environment of the device. Devices cannot be wrapped or adequately 
contained during processing in a liquid chemical sterilant to maintain sterility following processing and 
during storage. Furthermore, devices may require rinsing following exposure to the liquid chemical 
sterilant with water that typically is not sterile. Therefore, due to the inherent limitations of using liquid 
chemical sterilants, their use should be restricted to reprocessing critical devices that are heat-sensitive 
and incompatible with other sterilization methods. 
 
 Several published studies compare the sporicidal effect of liquid chemical germicides against spores 
of Bacillus and Clostridium78, 659, 660, 715.  
 
 Performic Acid. Performic acid is a fast-acting sporicide that was incorporated into an automated 
endoscope reprocessing system400. Systems using performic acid are not currently FDA cleared.  
 
 Filtration. Although filtration is not a lethality-based process and is not an FDA-cleared sterilization 
method, this technology is used to remove bacteria from thermolabile pharmaceutical fluids that cannot 
be purified by any other means. In order to remove bacteria, the membrane pore size (e.g., 0.22 µm) 
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must be smaller than the bacteria and uniform throughout923. Some investigators have appropriately 
questioned whether the removal of microorganisms by filtration really is a sterilization method because of 
slight bacterial passage through filters, viral passage through filters, and transference of the sterile filtrate 
into the final container under aseptic conditions entail a risk of contamination924. 
 
 Microwave. Microwaves are used in medicine for disinfection of soft contact lenses, dental 
instruments, dentures, milk, and urinary catheters for intermittent self-catheterization925-931. However, 
microwaves must only be used with products that are compatible (e.g., do not melt) 931. Microwaves are 
radio-frequency waves, which are usually used at a frequency of 2450 MHz. The microwaves produce 
friction of water molecules in an alternating electrical field. The intermolecular friction derived from the 
vibrations generates heat and some authors believe that the effect of microwaves depends on the heat 
produced while others postulate a nonthermal lethal effect932-934. The initial reports showed microwaves to 
be an effective microbicide. The microwaves produced by a "home-type" microwave oven (2.45 GHz) 
completely inactivate bacterial cultures, mycobacteria, viruses, and G. stearothermophilus spores within 
60 seconds to 5 minutes depending on the challenge organism933, 935-937. Another study confirmed these 
resuIts but also found that higher power microwaves in the presence of water may be needed for 
sterilization932. Complete destruction of Mycobacterium bovis was obtained with 4 minutes of microwave 
exposure (600W, 2450 MHz)937. The effectiveness of microwave ovens for different sterilization and 
disinfection purposes should be tested and demonstrated as test conditions affect the results (e.g., 
presence of water, microwave power). Sterilization of metal instruments can be accomplished but 
requires certain precautions.926. Of concern is that home-type microwave ovens may not have even 
distribution of microwave energy over the entire dry device (there may be hot and cold spots on solid 
medical devices); hence there may be areas that are not sterilized or disinfected. The use of microwave 
ovens to disinfect intermittent-use catheters also has been suggested. Researchers found that test 
bacteria (e.g., E. coli, Klebsiella pneumoniae, Candida albicans) were eliminated from red rubber 
catheters within 5 minutes 931. Microwaves used for sterilization of medical devices have not been FDA 
cleared. 
 
 Glass Bead “Sterilizer”. Glass bead “sterilization” uses small glass beads (1.2-1.5 mm diameter) 
and high temperature (217 °C -232°C) for brief exposure times (e.g., 45 seconds) to inactivate 
microorganisms. These devices have been used for several years in the dental profession938-940. FDA 
believes there is a risk of infection with this device because of potential failure to sterilize dental 
instruments and their use should be discontinued until the device has received FDA clearance. 
 
 Vaporized Hydrogen Peroxide (VHP). Hydrogen peroxide solutions have been used as chemical 
sterilants for many years. However, the VHP was not developed for the sterilization of medical 
equipment until the mid-1980s. One method for delivering VHP to the reaction site uses a deep vacuum 
to pull liquid hydrogen peroxide (30-35% concentration) from a disposable cartridge through a heated 
vaporizer and then, following vaporization, into the sterilization chamber. A second approach to VHP 
delivery is the flow-through approach in which the VHP is carried into the sterilization chamber by a 
carrier gas such as air using either a slight negative pressure (vacuum) or slight positive pressure. 
Applications of this technology include vacuum systems for industrial sterilization of medical devices and 
atmospheric systems for decontaminating for large and small areas853. VHP offers several appealing 
features that include rapid cycle time (e.g., 30-45 minutes); low temperature; environmentally safe by-
products (H2O, oxygen [O2]); good material compatibility; and ease of operation, installation and 
monitoring. VHP has limitations including that cellulose cannot be processed; nylon becomes brittle; and 
VHP penetration capabilities are less than those of ETO. VHP has not been cleared by FDA for 
sterilization of medical devices in healthcare facilities. 
 
 The feasibility of utilizing vapor-phase hydrogen peroxide as a surface decontaminant and sterilizer 
was evaluated in a centrifuge decontamination application. In this study, vapor-phase hydrogen peroxide 
was shown to possess significant sporicidal activity 941. In preliminary studies, hydrogen peroxide vapor 
decontamination has been found to be a highly effective method of eradicating MRSA, Serratia 
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marcescens, Clostridium botulinum spores and Clostridium difficile from rooms, furniture, surfaces and/or 
equipment; however, further investigation of this method to demonstrate both safety and effectiveness in 
reducing infection rates are required942-945.  
 
 Ozone. Ozone has been used for years as a drinking water disinfectant. Ozone is produced when O2 
is energized and split into two monatomic (O1) molecules. The monatomic oxygen molecules then collide 
with O2 molecules to form ozone, which is O3. Thus, ozone consists of O2 with a loosely bonded third 
oxygen atom that is readily available to attach to, and oxidize, other molecules. This additional oxygen 
atom makes ozone a powerful oxidant that destroys microorganisms but is highly unstable (i.e., half-life of 
22 minutes at room temperature). 
 
 A new sterilization process, which uses ozone as the sterilant, was cleared by FDA in August 2003 
for processing reusable medical devices. The sterilizer creates its own sterilant internally from USP grade 
oxygen, steam-quality water and electricity; the sterilant is converted back to oxygen and water vapor at 
the end of the cycle by a passing through a catalyst before being exhausted into the room. The duration 
of the sterilization cycle is about 4 h and 15 m, and it occurs at 30-35°C. Microbial efficacy has been 
demonstrated by achieving a SAL of 10-6 with a variety of microorganisms to include the most resistant 
microorganism, Geobacillus stearothermophilus.  
 
 The ozone process is compatible with a wide range of commonly used materials including stainless 
steel, titanium, anodized aluminum, ceramic, glass, silica, PVC, Teflon, silicone, polypropylene, 
polyethylene and acrylic. In addition, rigid lumen devices of the following diameter and length can be 
processed: internal diameter (ID): > 2 mm, length ≤ 25 cm; ID > 3 mm, length ≤ 47 cm; and ID > 4 mm, 
length ≤ 60 cm. 
 
 The process should be safe for use by the operator because there is no handling of the sterilant, no 
toxic emissions, no residue to aerate, and low operating temperature means there is no danger of an 
accidental burn. The cycle is monitored using a self-contained biological indicator and a chemical 
indicator. The sterilization chamber is small, about 4 ft3 (Written communication, S Dufresne, July 2004).  
 
 A gaseous ozone generator was investigated for decontamination of rooms used to house patients 
colonized with MRSA. The results demonstrated that the device tested would be inadequate for the 
decontamination of a hospital room946. 
 
 Formaldehyde Steam. Low-temperature steam with formaldehyde is used as a low-temperature 
sterilization method in many countries, particularly in Scandinavia, Germany, and the United Kingdom. 
The process involves the use of formalin, which is vaporized into a formaldehyde gas that is admitted into 
the sterilization chamber. A formaldehyde concentration of 8-16 mg/l is generated at an operating 
temperature of 70-75°C. The sterilization cycle consists of a series of stages that include an initial 
vacuum to remove air from the chamber and load, followed by steam admission to the chamber with the 
vacuum pump running to purge the chamber of air and to heat the load, followed by a series of pulses of 
formaldehyde gas, followed by steam. Formaldehyde is removed from the sterilizer and load by repeated 
alternate evacuations and flushing with steam and air. This system has some advantages, e.g., the cycle 
time for formaldehyde gas is faster than that for ETO and the cost per cycle is relatively low. However, 
ETO is more penetrating and operates at lower temperatures than do steam/formaldehyde sterilizers. 
Low-temperature steam formaldehyde sterilization has been found effective against vegetative bacteria, 
mycobacteria, B. atrophaeus and G. stearothermophilus spores and Candida albicans947-949. 
 
 Formaldehyde vapor cabinets also may be used in healthcare facilities to sterilize heat-sensitive 
medical equipment950. Commonly, there is no circulation of formaldehyde and no temperature and 
humidity controls. The release of gas from paraformaldehyde tablets (placed on the lower tray) is slow 
and produces a low partial pressure of gas. The microbicidal quality of this procedure is unknown951. 
 
 Reliable sterilization using formaldehyde is achieved when performed with a high concentration of 
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gas, at a temperature between 60° and 80°C and with a relative humidity of 75 to 100%. 
 
 Studies indicate that formaldehyde is a mutagen and a potential human carcinogen, and OSHA 
regulates formaldehyde. The permissible exposure limit for formaldehyde in work areas is 0.75 ppm 
measured as a 8-hour TWA. The OSHA standard includes a 2 ppm STEL (i.e., maximum exposure 
allowed during a 15-minute period). As with the ETO standard, the formaldehyde standard requires that 
the employer conduct initial monitoring to identify employees who are exposed to formaldehyde at or 
above the action level or STEL. If this exposure level is maintained, employers may discontinue exposure 
monitoring until there is a change that could affect exposure levels or an employee reports formaldehyde-
related signs and symptoms269, 578. The formaldehyde steam sterilization system has not been FDA 
cleared for use in healthcare facilities.  
 
 Gaseous chlorine dioxide. A gaseous chlorine dioxide system for sterilization of healthcare products 
was developed in the late 1980s853, 952, 953. Chlorine dioxide is not mutagenic or carcinogenic in humans. As 
the chlorine dioxide concentration increases, the time required to achieve sterilization becomes 
progressively shorter. For example, only 30 minutes were required at 40 mg/l to sterilize the 106 B. 
atrophaeus spores at 30° to 32°C954. Currently, no gaseous chlorine dioxide system is FDA cleared. 
 
 Vaporized Peracetic Acid. The sporicidal activity of peracetic acid vapor at 20, 40, 60, and 80% 
relative humidity and 25°C was determined on Bacillus atrophaeus spores on paper and glass surfaces. 
Appreciable activity occurred within 10 minutes of exposure to 1 mg of peracetic acid per liter at 40% or 
higher relative humidity955. No vaporized peracetic acid system is FDA cleared. 
 
 Infrared radiation. An infrared radiation prototype sterilizer was investigated and found to destroy B. 
atrophaeus spores. Some of the possible advantages of infrared technology include short cycle time, low 
energy consumption, no cycle residuals, and no toxicologic or environmental effects. This may provide an 
alternative technology for sterilization of selected heat-resistant instruments but there are no FDA-cleared 
systems for use in healthcare facilities 956. 
 
 The other sterilization technologies mentioned above may be used for sterilization of critical medical 
items if cleared by the FDA and ideally, the microbicidal effectiveness of the technology has been 
published in the scientific literature. The selection and use of disinfectants, chemical sterilants and 
sterilization processes in the healthcare field is dynamic, and products may become available that are not 
in existence when this guideline was written. As newer disinfectants and sterilization processes become 
available, persons or committees responsible for selecting disinfectants and sterilization processes 




 Overview. The delivery of sterile products for use in patient care depends not only on the 
effectiveness of the sterilization process but also on the unit design, decontamination, disassembling and 
packaging of the device, loading the sterilizer, monitoring, sterilant quality and quantity, and the 
appropriateness of the cycle for the load contents, and other aspects of device reprocessing. Healthcare 
personnel should perform most cleaning, disinfecting, and sterilizing of patient-care supplies in a central 
processing department in order to more easily control quality. The aim of central processing is the orderly 
processing of medical and surgical instruments to protect patients from infections while minimizing risks to 
staff and preserving the value of the items being reprocessed957. Healthcare facilities should promote the 
same level of efficiency and safety in the preparation of supplies in other areas (e.g., operating room, 
respiratory therapy) as is practiced in central processing. 
 
 Ensuring consistency of sterilization practices requires a comprehensive program that ensures 
operator competence and proper methods of cleaning and wrapping instruments, loading the sterilizer, 
operating the sterilizer, and monitoring of the entire process. Furthermore, care must be consistent from 
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an infection prevention standpoint in all patient-care settings, such as hospital and outpatient facilities.  
 
 Sterilization Cycle Verification. A sterilization process should be verified before it is put into use in 
healthcare settings. All steam, ETO, and other low-temperature sterilizers are tested with biological and 
chemical indicators upon installation, when the sterilizer is relocated, redesigned, after major repair and 
after a sterilization failure has occurred to ensure they are functioning prior to placing them into routine 
use. Three consecutive empty steam cycles are run with a biological and chemical indicator in an 
appropriate test package or tray. Each type of steam cycle used for sterilization (e.g., vacuum-assisted, 
gravity) is tested separately. In a prevacuum steam sterilizer three consecutive empty cycles are also run 
with a Bowie-Dick test. The sterilizer is not put back into use until all biological indicators are negative and 
chemical indicators show a correct end-point response811-814, 819, 958. 
 
 Biological and chemical indicator testing is also done for ongoing quality assurance testing of 
representative samples of actual products being sterilized and product testing when major changes are 
made in packaging, wraps, or load configuration. Biological and chemical indicators are placed in 
products, which are processed in a full load. When three consecutive cycles show negative biological 
indicators and chemical indicators with a correct end point response, you can put the change made into 
routine use811-814, 958. Items processed during the three evaluation cycles should be quarantined until the 
test results are negative.  
 
 Physical Facilities. The central processing area(s) ideally should be divided into at least three areas: 
decontamination, packaging, and sterilization and storage. Physical barriers should separate the 
decontamination area from the other sections to contain contamination on used items. In the 
decontamination area reusable contaminated supplies (and possibly disposable items that are reused) 
are received, sorted, and decontaminated. The recommended airflow pattern should contain 
contaminates within the decontamination area and minimize the flow of contaminates to the clean areas. 
The American Institute of Architects 959 recommends negative pressure and no fewer than six air 
exchanges per hour in the decontamination area (AAMI recommends 10 air changes per hour) and 10 air 
changes per hour with positive pressure in the sterilizer equipment room. The packaging area is for 
inspecting, assembling, and packaging clean, but not sterile, material. The sterile storage area should be 
a limited access area with a controlled temperature (may be as high as 75°F) and relative humidity (30-
60% in all works areas except sterile storage, where the relative humidity should not exceed 70%)819. The 
floors and walls should be constructed of materials capable of withstanding chemical agents used for 
cleaning or disinfecting. Ceilings and wall surfaces should be constructed of non-shedding materials. 
Physical arrangements of processing areas are presented schematically in four references811, 819, 920, 957. 
 
 Cleaning. As repeatedly mentioned, items must be cleaned using water with detergents or enzymatic 
cleaners 465, 466, 468 before processing. Cleaning reduces the bioburden and removes foreign material (i.e., 
organic residue and inorganic salts) that interferes with the sterilization process by acting as a barrier to 
the sterilization agent179, 426, 457, 911, 912. Surgical instruments are generally presoaked or prerinsed to 
prevent drying of blood and tissue. Precleaning in patient-care areas may be needed on items that are 
heavily soiled with feces, sputum, blood, or other material. Items sent to central processing without 
removing gross soil may be difficult to clean because of dried secretions and excretions. Cleaning and 
decontamination should be done as soon as possible after items have been used. 
 
 Several types of mechanical cleaning machines (e.g., utensil washer-sanitizer, ultrasonic cleaner, 
washer-sterilizer, dishwasher, washer-disinfector) may facilitate cleaning and decontamination of most 
items. This equipment often is automated and may increase productivity, improve cleaning effectiveness, 
and decrease worker exposure to blood and body fluids. Delicate and intricate objects and heat- or 
moisture-sensitive articles may require careful cleaning by hand. All used items sent to the central 
processing area should be considered contaminated (unless decontaminated in the area of origin), 
handled with gloves (forceps or tongs are sometimes needed to avoid exposure to sharps), and 
decontaminated by one of the aforementioned methods to render them safer to handle. Items composed 
of more than one removable part should be disassembled. Care should be taken to ensure that all parts 
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are kept together, so that reassembly can be accomplished efficiently811. 
 
 Investigators have described the degree of cleanliness by visual and microscopic examination. One 
study found 91% of the instruments to be clean visually but, when examined microscopically, 84% of the 
instruments had residual debris. Sites that contained residual debris included junctions between 
insulating sheaths and activating mechanisms of laparoscopic instruments and articulations and grooves 
of forceps. More research is needed to understand the clinical significance of these findings 960 and how 
to ensure proper cleaning. 
 
 Personnel working in the decontamination area should wear household-cleaning-type rubber or 
plastic gloves when handling or cleaning contaminated instruments and devices. Face masks, eye 
protection such as goggles or full-length faceshields, and appropriate gowns should be worn when 
exposure to blood and contaminated fluids may occur (e.g., when manually cleaning contaminated 
devices)961. Contaminated instruments are a source of microorganisms that could inoculate personnel 
through nonintact skin on the hands or through contact with the mucous membranes of eyes, nose, or 
mouth214, 811, 813. Reusable sharps that have been in contact with blood present a special hazard. 
Employees must not reach with their gloved hands into trays or containers that hold these sharps to 




 Packaging. Once items are cleaned, dried, and inspected, those requiring sterilization must be 
wrapped or placed in rigid containers and should be arranged in instrument trays/baskets according to the 
guidelines provided by the AAMI and other professional organizations454, 811-814, 819, 836, 962. These 
guidelines state that hinged instruments should be opened; items with removable parts should be 
disassembled unless the device manufacturer or researchers provide specific instructions or test data to 
the contrary181; complex instruments should be prepared and sterilized according to device 
manufacturer’s instructions and test data; devices with concave surfaces should be positioned to facilitate 
drainage of water; heavy items should be positioned not to damage delicate items; and the weight of the 
instrument set should be based on the design and density of the instruments and the distribution of metal 
mass811, 962. While there is no longer a specified sterilization weight limit for surgical sets, heavy metal 
mass is a cause of wet packs (i.e., moisture inside the case and tray after completion of the sterilization 
cycle)963. Other parameters that may influence drying are the density of the wraps and the design of the 
set964. 
 
 There are several choices in methods to maintain sterility of surgical instruments, including rigid 
containers, peel-open pouches (e.g., self-sealed or heat-sealed plastic and paper pouches), roll stock or 
reels (i.e., paper-plastic combinations of tubing designed to allow the user to cut and seal the ends to 
form a pouch) 454 and sterilization wraps (woven and nonwoven). Healthcare facilities may use all of these 
packaging options. The packaging material must allow penetration of the sterilant, provide protection 
against contact contamination during handling, provide an effective barrier to microbial penetration, and 
maintain the sterility of the processed item after sterilization 965. An ideal sterilization wrap would 
successfully address barrier effectiveness, penetrability (i.e., allows sterilant to penetrate), aeration (e.g., 
allows ETO to dissipate), ease of use, drapeability, flexibility, puncture resistance, tear strength, toxicity, 
odor, waste disposal, linting, cost, and transparency966. Unacceptable packaging for use with ETO (e.g., 
foil, polyvinylchloride, and polyvinylidene chlorine [kitchen-type transparent wrap]) 814 or hydrogen 
peroxide gas plasma (e.g., linens and paper) should not be used to wrap medical items. 
 
 In central processing, double wrapping can be done sequentially or nonsequentially (i.e., 
simultaneous wrapping). Wrapping should be done in such a manner to avoid tenting and gapping. The 
sequential wrap uses two sheets of the standard sterilization wrap, one wrapped after the other. This 
procedure creates a package within a package. The nonsequential process uses two sheets wrapped at 
the same time so that the wrapping needs to be performed only once. This latter method provides 
multiple layers of protection of surgical instruments from contamination and saves time since wrapping is 
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done only once. Multiple layers are still common practice due to the rigors of handling within the facility 
even though the barrier efficacy of a single sheet of wrap has improved over the years966. Written and 
illustrated procedures for preparation of items to be packaged should be readily available and used by 
personnel when packaging procedures are performed454. 
 
 Loading. All items to be sterilized should be arranged so all surfaces will be directly exposed to the 
sterilizing agent. Thus, loading procedures must allow for free circulation of steam (or another sterilant) 
around each item. Historically, it was recommended that muslin fabric packs should not exceed the 
maximal dimensions, weight, and density of 12 inches wide × 12 inches high × 20 inches long, 12 lbs, 
and 7.2 lbs per cubic foot, respectively. Due to the variety of textiles and metal/plastic containers on the 
market, the textile and metal/plastic container manufacturer and the sterilizer manufacturers should be 
consulted for instructions on pack preparation and density parameters819. 
 
 There are several important basic principles for loading a sterilizer: allow for proper sterilant 
circulation; perforated trays should be placed so the tray is parallel to the shelf; nonperforated containers 
should be placed on their edge (e.g., basins); small items should be loosely placed in wire baskets; and 
peel packs should be placed on edge in perforated or mesh bottom racks or baskets454, 811, 836. 
 
 Storage. Studies in the early 1970s suggested that wrapped surgical trays remained sterile for 
varying periods depending on the type of material used to wrap the trays. Safe storage times for sterile 
packs vary with the porosity of the wrapper and storage conditions (e.g., open versus closed cabinets). 
Heat-sealed, plastic peel-down pouches and wrapped packs sealed in 3-mil (3/1000 inch) polyethylene 
overwrap have been reported to be sterile for as long as 9 months after sterilization. The 3-mil 
polyethylene is applied after sterilization to extend the shelf life for infrequently used items967. Supplies 
wrapped in double-thickness muslin comprising four layers, or equivalent, remain sterile for at least 30 
days. Any item that has been sterilized should not be used after the expiration date has been exceeded 
or if the sterilized package is wet, torn, or punctured. 
 
 Although some hospitals continue to date every sterilized product and use the time-related shelf-life 
practice, many hospitals have switched to an event-related shelf-life practice. This latter practice 
recognizes that the product should remain sterile until some event causes the item to become 
contaminated (e.g., tear in packaging, packaging becomes wet, seal is broken)968. Event-related factors 
that contribute to the contamination of a product include bioburden (i.e., the amount of contamination in 
the environment), air movement, traffic, location, humidity, insects, vermin, flooding, storage area space, 
open/closed shelving, temperature, and the properties of the wrap material966, 969. There are data that 
support the event-related shelf-life practice970-972. One study examined the effect of time on the sterile 
integrity of paper envelopes, peel pouches, and nylon sleeves. The most important finding was the 
absence of a trend toward an increased rate of contamination over time for any pack when placed in 
covered storage971. Another evaluated the effectiveness of event-related outdating by microbiologically 
testing sterilized items. During the 2-year study period, all of the items tested were sterile972. Thus, 
contamination of a sterile item is event-related and the probability of contamination increases with 
increased handling973. 
 
 Following the sterilization process, medical and surgical devices must be handled using aseptic 
technique in order to prevent contamination. Sterile supplies should be stored far enough from the floor (8 
to 10 inches), the ceiling (5 inches unless near a sprinkler head [18 inches from sprinkler head]), and the 
outside walls (2 inches) to allow for adequate air circulation, ease of cleaning, and compliance with local 
fire codes (e.g., supplies must be at least 18 inches from sprinkler heads). Medical and surgical supplies 
should not be stored under sinks or in other locations where they can become wet. Sterile items that 
become wet are considered contaminated because moisture brings with it microorganisms from the air 
and surfaces. Closed or covered cabinets are ideal but open shelving may be used for storage. Any 
package that has fallen or been dropped on the floor must be inspected for damage to the packaging and 
contents (if the items are breakable). If the package is heat-sealed in impervious plastic and the seal is 
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still intact, the package should be considered not contaminated. If undamaged, items packaged in plastic 
need not be reprocessed. 
 
 Monitoring. The sterilization procedure should be monitored routinely by using a combination of 
mechanical, chemical, and biological indicators to evaluate the sterilizing conditions and indirectly the 
microbiologic status of the processed items. The mechanical monitors for steam sterilization include the 
daily assessment of cycle time and temperature by examining the temperature record chart (or computer 
printout) and an assessment of pressure via the pressure gauge. The mechanical monitors for ETO 
include time, temperature, and pressure recorders that provide data via computer printouts, gauges, 
and/or displays814. Generally, two essential elements for ETO sterilization (i.e., the gas concentration and 
humidity) cannot be monitored in healthcare ETO sterilizers. 
 
 Chemical indicators are convenient, are inexpensive, and indicate that the item has been exposed to 
the sterilization process. In one study, chemical indicators were more likely than biological indicators to 
inaccurately indicate sterilization at marginal sterilization times (e.g., 2 minutes)847. Chemical indicators 
should be used in conjunction with biological indicators, but based on current studies should not replace 
them because they indicate sterilization at marginal sterilization time and because only a biological 
indicator consisting of resistant spores can measure the microbial killing power of the sterilization 
process.847, 974. Chemical indicators are affixed on the outside of each pack to show that the package has 
been processed through a sterilization cycle, but these indicators do not prove sterilization has been 
achieved. Preferably, a chemical indicator also should be placed on the inside of each pack to verify 
sterilant penetration. Chemical indicators usually are either heat-or chemical-sensitive inks that change 
color when one or more sterilization parameters (e.g., steam-time, temperature, and/or saturated steam; 
ETO-time, temperature, relative humidity and/or ETO concentration) are present. Chemical indicators 
have been grouped into five classes based on their ability to monitor one or multiple sterilization 
parameters813, 819. If the internal and/or external indicator suggests inadequate processing, the item 
should not be used815. An air-removal test (Bowie-Dick Test) must be performed daily in an empty 
dynamic-air-removal sterilizer (e.g., prevacuum steam sterilizer) to ensure air removal. 
 
 Biological indicators are recognized by most authorities as being closest to the ideal monitors of the 
sterilization process 974, 975 because they measure the sterilization process directly by using the most 
resistant microorganisms (i.e., Bacillus spores), and not by merely testing the physical and chemical 
conditions necessary for sterilization. Since the Bacillus spores used in biological indicators are more 
resistant and present in greater numbers than are the common microbial contaminants found on patient-
care equipment, the demonstration that the biological indicator has been inactivated strongly implies that 
other potential pathogens in the load have been killed844.  
 
 An ideal biological monitor of the sterilization process should be easy to use, be inexpensive, not be 
subject to exogenous contamination, provide positive results as soon as possible after the cycle so that 
corrective action may be accomplished, and provide positive results only when the sterilization 
parameters (e.g., steam-time, temperature, and/or saturated steam; ETO-time, temperature, relative 
humidity and/or ETO concentration) are inadequate to kill microbial contaminates847.  
 
 Biological indicators are the only process indicators that directly monitor the lethality of a given 
sterilization process. Spores used to monitor a sterilization process have demonstrated resistance to the 
sterilizing agent and are more resistant than the bioburden found on medical devices179, 911, 912. B. 
atrophaeus spores (106) are used to monitor ETO and dry heat, and G. stearothermophilus spores (105) 
are used to monitor steam sterilization, hydrogen peroxide gas plasma, and liquid peracetic acid 
sterilizers. G. stearothermophilus is incubated at 55-60°C, and B. atrophaeus is incubated at 35-37°C. 
Steam and low temperature sterilizers (e.g., hydrogen peroxide gas plasma, peracetic acid) should be 
monitored at least weekly with the appropriate commercial preparation of spores. If a sterilizer is used 
frequently (e.g., several loads per day), daily use of biological indicators allows earlier discovery of 
equipment malfunctions or procedural errors and thus minimizes the extent of patient surveillance and 
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product recall needed in the event of a positive biological indicator811. Each load should be monitored if it 
contains implantable objects. If feasible, implantable items should not be used until the results of spore 
tests are known to be negative.  
 
 Originally, spore-strip biological indicators required up to 7 days of incubation to detect viable spores 
from marginal cycles (i.e., when few spores remained viable). The next generation of biological indicator 
was self-contained in plastic vials containing a spore-coated paper strip and a growth media in a 
crushable glass ampoule. This indicator had a maximum incubation of 48 hours but significant failures 
could be detected in ≤24 hours. A rapid-readout biological indicator that detects the presence of enzymes 
of G. stearothermophilus by reading a fluorescent product produced by the enzymatic breakdown of a 
nonfluorescent substrate has been marketed for the more than 10 years. Studies demonstrate that the 
sensitivity of rapid-readout tests for steam sterilization (1 hour for 132°C gravity sterilizers, 3 hrs for 121°C 
gravity and 132°C vacuum sterilizers) parallels that of the conventional sterilization-specific biological 
indicators 846, 847, 976, 977 and the fluorescent rapid readout results reliably predict 24- and 48-hour and 7-
day growth978. The rapid-readout biological indicator is a dual indicator system as it also detects acid 
metabolites produced during growth of the G. stearothermophilus spores. This system is different from the 
indicator system consisting of an enzyme system of bacterial origin without spores. Independent 
comparative data using suboptimal sterilization cycles (e.g., reduced time or temperature) with the 
enzyme-based indicator system have not been published979.  
 
 A new rapid-readout ETO biological indicator has been designed for rapid and reliable monitoring of 
ETO sterilization processes. The indicator has been cleared by the FDA for use in the United States400. 
The rapid-readout ETO biological indicator detects the presence of B. atrophaeus by detecting a 
fluorescent signal indicating the activity of an enzyme present within the B. atrophaeus organism, beta-
glucosidase. The fluorescence indicates the presence of an active spore-associated enzyme and a 
sterilization process failure. This indicator also detects acid metabolites produced during growth of the B. 
atrophaeus spore. Per manufacturer’s data, the enzyme always was detected whenever viable spores 
were present. This was expected because the enzyme is relatively ETO resistant and is inactivated at a 
slightly longer exposure time than the spore. The rapid-readout ETO biological indicator can be used to 
monitor 100% ETO, and ETO-HCFC mixture sterilization cycles. It has not been tested in ETO-CO2 
mixture sterilization cycles. 
 
 The standard biological indicator used for monitoring full-cycle steam sterilizers does not provide 
reliable monitoring flash sterilizers980. Biological indicators specifically designed for monitoring flash 
sterilization are now available, and studies comparing them have been published846, 847, 981.  
 
 Since sterilization failure can occur (about 1% for steam)982, a procedure to follow in the event of 
positive spore tests with steam sterilization has been provided by CDC and the Association of 
periOperative Registered Nurses (AORN). The 1981 CDC recommendation is that "objects, other than 
implantable objects, do not need to be recalled because of a single positive spore test unless the steam 
sterilizer or the sterilization procedure is defective." The rationale for this recommendation is that single 
positive spore tests in sterilizers occur sporadically. They may occur for reasons such as slight variation in 
the resistance of the spores983, improper use of the sterilizer, and laboratory contamination during culture 
(uncommon with self-contained spore tests). If the mechanical (e.g., time, temperature, pressure in the 
steam sterilizer) and chemical (internal and/or external) indicators suggest that the sterilizer was 
functioning properly, a single positive spore test probably does not indicate sterilizer malfunction but the 
spore test should be repeated immediately 983. If the spore tests remain positive, use of the sterilizer 
should be discontinued until it is serviced1. Similarly, AORN states that a single positive spore test does 
not necessarily indicate a sterilizer failure. If the test is positive, the sterilizer should immediately be 
rechallenged for proper use and function. Items, other than implantable ones, do not necessarily need to 
be recalled unless a sterilizer malfunction is found. If a sterilizer malfunction is discovered, the items must 
be considered nonsterile, and the items from the suspect load(s) should be recalled, insofar as possible, 
and reprocessed 984. A suggested protocol for management of positive biological indicators is shown in 
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Table 12839. A more conservative approach also has been recommended 813 in which any positive spore 
test is assumed to represent sterilizer malfunction and requires that all materials processed in that 
sterilizer, dating from the sterilization cycle having the last negative biologic indicator to the next cycle 
showing satisfactory biologic indicator challenge results, must be considered nonsterile and retrieved, if 
possible, and reprocessed. This more conservative approach should be used for sterilization methods 
other than steam (e.g., ETO, hydrogen peroxide gas plasma). However, no action is necessary if there is 
strong evidence for the biological indicator being defective 983 or the growth medium contained a Bacillus 
contaminant985. 
 
 If patient-care items were used before retrieval, the infection control professional should assess the 
risk of infection in collaboration with central processing, surgical services, and risk management staff. The 
factors that should be considered include the chemical indicator result (e.g., nonreactive chemical 
indicator may indicate temperature not achieved); the results of other biological indicators that followed 
the positive biological indicator (e.g., positive on Tuesday, negative on Wednesday); the parameters of 
the sterilizer associated with the positive biological indicator (e.g., reduced time at correct temperature); 
the time-temperature chart (or printout); and the microbial load associated with decontaminated surgical 
instruments (e.g., 85% of decontaminated surgical instruments have less than 100 CFU). The margin of 
safety in steam sterilization is sufficiently large that there is minimal infection risk associated with items in 
a load that show spore growth, especially if the item was properly cleaned and the temperature was 
achieved (e.g., as shown by acceptable chemical indicator or temperature chart). There are no published 
studies that document disease transmission via a nonretrieved surgical instrument following a sterilization 
cycle with a positive biological indicator. 
 
 False-positive biological indicators may occur from improper testing or faulty indicators. The latter 
may occur from improper storage, processing, product contamination, material failure, or variation in 
resistance of spores. Gram stain and subculture of a positive biological indicator may determine if a 
contaminant has created a false-positive result839, 986. However, in one incident, the broth used as growth 
medium contained a contaminant, B. coagulans, which resulted in broth turbidity at 55°C985. Testing of 
paired biological indicators from different manufacturers can assist in assessing a product defect839. 
False-positive biological indicators due to extrinsic contamination when using self-contained biological 
indicators should be uncommon. A biological indicator should not be considered a false-positive indicator 
until a thorough analysis of the entire sterilization process shows this to be likely. 
 
 The size and composition of the biological indicator test pack should be standardized to create a 
significant challenge to air removal and sterilant penetration and to obtain interpretable results. There is a 
standard 16-towel pack recommended by AAMI for steam sterilization 813, 819, 987 consisting of 16 clean, 
preconditioned, reusable huck or absorbent surgical towels each of which is approximately 16 inches by 
26 inches. Each towel is folded lengthwise into thirds and then folded widthwise in the middle. One or 
more biological indicators are placed between the eight and ninth towels in the approximate geometric 
center of the pack. When the towels are folded and placed one on top of another, to form a stack 
(approximately 6 inch height) it should weigh approximately 3 pounds and should have a density of 
approximately 11.3 pounds per cubic foot813. This test pack has not gained universal use as a standard 
pack that simulates the actual in-use conditions of steam sterilizers. Commercially available disposable 
test packs that have been shown to be equivalent to the AAMI 16 towel test pack also may be used. The 
test pack should be placed flat in an otherwise fully loaded sterilizer chamber, in the area least favorable 
to sterilization (i.e., the area representing the greatest challenge to the biological indicator). This area is 
normally in the front, bottom section of the sterilizer, near the drain811, 813. A control biological indicator 
from the lot used for testing should be left unexposed to the sterilant, and then incubated to verify the 
presterilization viability of the test spores and proper incubation. The most conservative approach would 
be to use a control for each run; however, less frequent use may be adequate (e.g., weekly). There also 
is a routine test pack for ETO where a biological indicator is placed in a plastic syringe with plunger, then 
placed in the folds of a clean surgical towel, and wrapped. Alternatively, commercially available disposal 
test packs that have been shown to be equivalent to the AAMI test pack may be used. The test pack is 
placed in the center of the sterilizer load814. Sterilization records (mechanical, chemical, and biological) 
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should be retained for a time period in compliance with standards (e.g., Joint Commission for the 
Accreditation of Healthcare Facilities requests 3 years) and state and federal regulations. 
 
 In Europe, biological monitors are not used routinely to monitor the sterilization process. Instead, 
release of sterilizer items is based on monitoring the physical conditions of the sterilization process that is 
termed “parametric release.” Parametric release requires that there is a defined quality system in place at 
the facility performing the sterilization and that the sterilization process be validated for the items being 
sterilized. At present in Europe, parametric release is accepted for steam, dry heat, and ionizing radiation 
processes, as the physical conditions are understood and can be monitored directly988. For example, with 
steam sterilizers the load could be monitored with probes that would yield data on temperature, time, and 
humidity at representative locations in the chamber and compared to the specifications developed during 
the validation process. 
 
 Periodic infection control rounds to areas using sterilizers to standardize the sterilizer’s use may 
identify correctable variances in operator competence; documentation of sterilization records, including 
chemical and biological indicator test results; sterilizer maintenance and wrapping; and load numbering of 
packs. These rounds also may identify improvement activities to ensure that operators are adhering to 
established standards989.  
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Reuse of Single-Use Medical Devices 
 
 The reuse of single-use medical devices began in the late 1970s. Before this time most devices were 
considered reusable. Reuse of single-use devices increased as a cost-saving measure. Approximately 20 
to 30% of U.S. hospitals reported that they reuse at least one type of single-use device. Reuse of single-
use devices involves regulatory, ethical, medical, legal and economic issues and has been extremely 
controversial for more than two decades990. The U.S. public has expressed increasing concern regarding 
the risk of infection and injury when reusing medical devices intended and labeled for single use. 
Although some investigators have demonstrated it is safe to reuse disposable medical devices such as 
cardiac electrode catheters, 991-993 additional studies are needed to define the risks 994 and document the 
benefits. In August 2000, FDA released a guidance document on single-use devices reprocessed by third 
parties or hospitals995. In this guidance document, FDA states that hospitals or third-party reprocessors 
will be considered “manufacturers” and regulated in the same manner. A reused single-use device will 
have to comply with the same regulatory requirements of the device when it was originally manufactured. 
This document presents FDA’s intent to enforce premarket submission requirements within 6 months 
(February 2001) for class III devices (e.g., cardiovascular intra-aortic balloon pump, transluminal coronary 
angioplasty catheter); 12 months (August 2001) for class II devices (e.g., blood pressure cuff, 
bronchoscope biopsy forceps); and 18 months (February 2002) for class I devices (e.g., disposable 
medical scissors, ophthalmic knife). FDA uses two types of premarket requirements for nonexempt class I 
and II devices, a 510(k) submission that may have to show that the device is as safe and effective as the 
same device when new, and a premarket approval application. The 510(k) submission must provide 
scientific evidence that the device is safe and effective for its intended use. FDA allowed hospitals a year 
to comply with the nonpremarket requirements (registration and listing, reporting adverse events 
associated with medical devices, quality system regulations, and proper labeling). The options for 
hospitals are to stop reprocessing single-use devices, comply with the rule, or outsource to a third-party 
reprocessor. FDA guidance document does not apply to permanently implantable pacemakers, 
hemodialyzers, opened but unused single-use devices, or healthcare settings other than acute-care 
hospitals. The reuse of single use medical devices continues to be an evolving area of regulations. For 
this reason, healthcare workers should refer to FDA (http://www.fda.gov/) for the latest guidance 996. 
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 When properly used, disinfection and sterilization can ensure the safe use of invasive and non-
invasive medical devices. However, current disinfection and sterilization guidelines must be strictly 
followed. 
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Web-Based Disinfection and Sterilization Resources 
 
 Additional information about disinfection and sterilization is available at the following dedicated 
websites: 
 
Food and Drug Administration, Rockville, Maryland  
[This link is no longer active: http://www.fda.gov/dcrh/ode/germlab.html.] 
 
Environmental Protection Agency, Washington, D.C  
Selected EPA-registered Disinfectants (https://www.epa.gov/pesticide-registration/selected-epa-
registered-disinfectants) 
 
Centers for Disease Control and Prevention, Atlanta, Georgia  
Healthcare-associated Infections (HAI) (https://www.cdc.gov/HAI/index.html)  
 
University of North Carolina, Chapel Hill, North Carolina  
Disinfection and Sterilization (http://www.disinfectionandsterilization.org)  
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 The ultimate goal of the Recommendations for Disinfection and Sterilization in Health-Care Facilities, 
2008, is to reduce rates of health-care associated infections through appropriate use of both disinfection 
and sterilization. Each recommendation is categorized according to scientific evidence, theoretical 
rationale, applicability, and federal regulations. Examples are included in some recommendations to aid 
the reader; however, these examples are not intended to define the only method of implementing the 




Category IA. Strongly recommended for implementation and strongly supported by well-designed 
experimental, clinical, or epidemiologic studies. 
Category IB. Strongly recommended for implementation and supported by some experimental, clinical, 
or epidemiologic studies, and by a strong theoretical rationale. 
Category IC. Required by state or federal regulations. Because of state differences, readers should not 
assume that the absence of an IC recommendation implies the absence of state regulations. 
Category II. Suggested for implementation and supported by suggestive clinical or epidemiologic 
studies or by a theoretical rationale. 
No recommendation. Unresolved issue. These include practices for which insufficient evidence or no 
consensus exists regarding efficacy. 
 
C. Recommendations 
1.  Occupational Health and Exposure 
a. Inform each worker of the possible health effects of his or her exposure to infectious agents 
(e.g., hepatitis B virus [HBV], hepatitis C virus, human immunodeficiency virus [HIV]), and/or 
chemicals (e.g., EtO, formaldehyde). The information should be consistent with Occupational 
Safety and Health Administration (OSHA) requirements and identify the areas and tasks in which 
potential exists for exposure. Category II, IC214, 320, 959, 997, 998 
b. Educate health-care workers in the selection and proper use of personal protective equipment 
(PPE). Category II, IC 
c. Ensure that workers wear appropriate PPE to preclude exposure to infectious agents or chemicals 
through the respiratory system, skin, or mucous membranes of the eyes, nose, or mouth. PPE can 
include gloves, gowns, masks, and eye protection. The exact type of PPE depends on the 
infectious or chemical agent and the anticipated duration of exposure. The employer is responsible 
for making such equipment and training available. Category II, IC. 214, 997-999 
d. Establish a program for monitoring occupational exposure to regulated chemicals (e.g., 
formaldehyde, EtO) that adheres to state and federal regulations. Category II, IC. 997, 1000, 1001 
e. Exclude healthcare workers with weeping dermatitis of hands from direct contact with patient-
care equipment. Category IB. 1002, 1003 
2. Cleaning of Patient-Care Devices 
a. In hospitals, perform most cleaning, disinfection, and sterilization of patient-care devices in a 
central processing department in order to more easily control quality. Category II. 454, 836, 959 
b. Meticulously clean patient-care items with water and detergent, or with water and enzymatic 
cleaners before high-level disinfection or sterilization procedures. Category IB. 6, 83, 101, 104-106, 124, 
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179, 424-426, 436, 465, 471, 911-913, 1004 
i. Remove visible organic residue (e.g., residue of blood and tissue) and inorganic salts 
with cleaning. Use cleaning agents that are capable of removing visible organic and 
inorganic residues. Category IB. 424-426, 466, 468, 469, 471, 908, 910 
ii. Clean medical devices as soon as practical after use (e.g., at the point of use) because 
soiled materials become dried onto the instruments. Dried or baked materials on the 
instrument make the removal process more difficult and the disinfection or sterilization 
process less effective or ineffective. Category IB. 55, 56, 59, 291, 465, 1005, 1006 
c. Perform either manual cleaning (i.e., using friction) or mechanical cleaning (e.g., with ultrasonic 
cleaners, washer-disinfector, washer-sterilizers). Category IB. 426, 456, 471, 999 
d. If using an automatic washer/disinfector, ensure that the unit is used in accordance with the 
manufacturer’s recommendations. Category IB. 7, 133, 155, 725 
e. Ensure that the detergents or enzymatic cleaners selected are compatible with the metals and 
other materials used in medical instruments. Ensure that the rinse step is adequate for removing 
cleaning residues to levels that will not interfere with subsequent disinfection/sterilization 
processes. Category II. 836, 1004 
f. Inspect equipment surfaces for breaks in integrity that would impair either cleaning or 
disinfection/sterilization. Discard or repair equipment that no longer functions as intended or 
cannot be properly cleaned, and disinfected or sterilized. Category II. 888 
3. Indications for Sterilization, High-Level Disinfection, and Low-Level 
Disinfection 
a. Before use on each patient, sterilize critical medical and surgical devices and instruments that 
enter normally sterile tissue or the vascular system or through which a sterile body fluid flows 
(e.g., blood). See recommendation 7g for exceptions. Category IA. 179, 497, 821, 822, 907, 911, 912 
b. Provide, at a minimum, high-level disinfection for semicritical patient-care equipment (e.g., 
gastrointestinal endoscopes, endotracheal tubes, anesthesia breathing circuits, and respiratory 
therapy equipment) that touches either mucous membranes or nonintact skin. Category IA. 6-8, 17, 
20, 99, 101, 108, 113-115, 129, 138, 139, 147, 152-154, 471, 1007 
c. Perform low-level disinfection for noncritical patient-care surfaces (e.g., bedrails, over-the-bed 
table) and equipment (e.g., blood pressure cuff) that touch intact skin (see Recommendation 
5g). Category II. 17, 46-48, 50-52, 67, 68, 372, 373, 378, 382, 401 
4.  Selection and Use of Low-Level Disinfectants for Noncritical Patient-Care 
Devices 
a. Process noncritical patient-care devices using a disinfectant and the concentration of germicide 
listed in Table 1. Category IB. 17, 46-48, 50-52, 67, 68, 378, 382, 401 
b. Disinfect noncritical medical devices (e.g., blood pressure cuff) with an EPA-registered hospital 
disinfectant using the label’s safety precautions and use directions. Most EPA-registered 
hospital disinfectants have a label contact time of 10 minutes. However, multiple scientific 
studies have demonstrated the efficacy of hospital disinfectants against pathogens with a 
contact time of at least 1 minute. By law, all applicable label instructions on EPA-registered 
products must be followed. If the user selects exposure conditions that differ from those on the 
EPA-registered product label, the user assumes liability from any injuries resulting from off-label 
use and is potentially subject to enforcement action under FIFRA. Category IB. 17, 47, 48, 50, 51, 53-57, 
59, 60, 62-64, 355, 378, 382  
c. Ensure that, at a minimum, noncritical patient-care devices are disinfected when visibly soiled 
and on a regular basis (such as after use on each patient or once daily or once weekly). 
Category II. 378, 380, 1008 
d. If dedicated, disposable devices are not available, disinfect noncritical patient-care equipment 
after using it on a patient who is on contact precautions before using this equipment on another 
patient. Category IB. 47, 67, 391, 1009 
Guideline for Disinfection and Sterilization in Healthcare Facilities (2008) 
 
Last update: Feburary 15, 2017 85 of 161 
  
5.  Cleaning and Disinfecting Environmental Surfaces in Healthcare Facilities 
a. Clean housekeeping surfaces (e.g., floors, tabletops) on a regular basis, when spills occur, and 
when these surfaces are visibly soiled. Category II. 23, 378, 380, 382, 1008, 1010 
b. Disinfect (or clean) environmental surfaces on a regular basis (e.g., daily, three times per week) 
and when surfaces are visibly soiled. Category II. 378, 380, 402, 1008 
c. Follow manufacturers’ instructions for proper use of disinfecting (or detergent) products --- such 
as recommended use-dilution, material compatibility, storage, shelf-life, and safe use and 
disposal. Category II. 327, 365, 404 
d. Clean walls, blinds, and window curtains in patient-care areas when these surfaces are visibly 
contaminated or soiled. Category II. 1011 
e. Prepare disinfecting (or detergent) solutions as needed and replace these with fresh solution 
frequently (e.g., replace floor mopping solution every three patient rooms, change no less often 
than at 60-minute intervals), according to the facility’s policy. Category IB. 68, 379 
f. Decontaminate mop heads and cleaning cloths regularly to prevent contamination (e.g., launder 
and dry at least daily). Category II. 68, 402, 403 
g. Use a one-step process and an EPA-registered hospital disinfectant designed for housekeeping 
purposes in patient care areas where  
1. uncertainty exists about the nature of the soil on the surfaces (e.g., blood or body fluid 
contamination versus routine dust or dirt); or  
2. uncertainty exists about the presence of multidrug resistant organisms on such surfaces. 
See 5n for recommendations requiring cleaning and disinfecting blood-contaminated 
surfaces.  
Category II. 23, 47, 48, 51, 214, 378, 379, 382, 416, 1012 
h. Detergent and water are adequate for cleaning surfaces in nonpatient-care areas (e.g., 
administrative offices). Category II. 23 
i. Do not use high-level disinfectants/liquid chemical sterilants for disinfection of non-critical 
surfaces. Category IB. 23, 69, 318 
j. Wet-dust horizontal surfaces regularly (e.g., daily, three times per week) using clean cloths 
moistened with an EPA-registered hospital disinfectant (or detergent). Prepare the disinfectant 
(or detergent) as recommended by the manufacturer. Category II. 68, 378, 380, 402, 403, 1008 
k. Disinfect noncritical surfaces with an EPA-registered hospital disinfectant according to the label’s 
safety precautions and use directions. Most EPA-registered hospital disinfectants have a label 
contact time of 10 minutes. However, many scientific studies have demonstrated the efficacy of 
hospital disinfectants against pathogens with a contact time of at least 1 minute. By law, the user 
must follow all applicable label instructions on EPA-registered products. If the user selects 
exposure conditions that differ from those on the EPA-registered product label, the user 
assumes liability for any injuries resulting from off-label use and is potentially subject to 
enforcement action under FIFRA. Category II, IC. 17, 47, 48, 50, 51, 53-57, 59, 60, 62-64, 355, 378, 382  
l. Do not use disinfectants to clean infant bassinets and incubators while these items are occupied. 
If disinfectants (e.g., phenolics) are used for the terminal cleaning of infant bassinets and 
incubators, thoroughly rinse the surfaces of these items with water and dry them before these 
items are reused. Category IB. 17, 739, 740 
m. Promptly clean and decontaminate spills of blood and other potentially infectious materials. 
Discard blood-contaminated items in compliance with federal regulations. Category IB, IC. 214 
n. For site decontamination of spills of blood or other potentially infectious materials (OPIM), 
implement the following procedures. Use protective gloves and other PPE (e.g., when sharps 
are involved use forceps to pick up sharps, and discard these items in a puncture-resistant 
container) appropriate for this task. Disinfect areas contaminated with blood spills using an EPA-
registered tuberculocidal agent, a registered germicide on the EPA Lists D and E (i.e., products 
with specific label claims for HIV or HBV or freshly diluted hypochlorite solution. Category II, IC. 
214, 215, 557, 1013  
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1. * If sodium hypochlorite solutions are selected use a 1:100 dilution (e.g., 1:100 dilution of a 
5.25-6.15% sodium hypochlorite provides 525-615 ppm available chlorine) to decontaminate 
nonporous surfaces after a small spill (e.g., <10 mL) of either blood or OPIM. If a spill 
involves large amounts (e.g., >10 mL) of blood or OPIM, or involves a culture spill in the 
laboratory, use a 1:10 dilution for the first application of hypochlorite solution before cleaning 
in order to reduce the risk of infection during the cleaning process in the event of a sharp 
injury. Follow this decontamination process with a terminal disinfection, using a 1:100 
dilution of sodium hypochlorite. Category IB, IC. 63, 215, 557 
o. If the spill contains large amounts of blood or body fluids, clean the visible matter with 
disposable absorbent material, and discard the contaminated materials in appropriate, labeled 
containment. Category II, IC. 44, 214 
p. Use protective gloves and other PPE appropriate for this task. Category II, IC. 44, 214 
q. In units with high rates of endemic Clostridium difficile infection or in an outbreak setting, use 
dilute solutions of 5.25%–6.15% sodium hypochlorite (e.g., 1:10 dilution of household bleach) for 
routine environmental disinfection. Currently, no products are EPA-registered specifically for 
inactivating C. difficile spores. Category II. 257-259 
r. If chlorine solution is not prepared fresh daily, it can be stored at room temperature for up to 30 
days in a capped, opaque plastic bottle with a 50% reduction in chlorine concentration after 30 
days of storage (e.g., 1000 ppm chlorine [approximately a 1:50 dilution] at day 0 decreases to 
500 ppm chlorine by day 30). Category IB. 327, 1014 
s. An EPA-registered sodium hypochlorite product is preferred, but if such products are not 
available, generic versions of sodium hypochlorite solutions (e.g., household chlorine bleach) 
can be used. Category II. 44 
6.  Disinfectant Fogging 
a. Do not perform disinfectant fogging for routine purposes in patient-care areas. Category II. 23, 228 
 Environmental Fogging Clarification Statement [December 2009]: CDC and HICPAC have 
recommendations in the 2008 Guideline for Disinfection and Sterilization in Healthcare Facilities that 
state that the CDC does not support disinfectant fogging.  
These recommendations refer to the spraying or fogging of chemicals (e.g., formaldehyde, phenol-
based agents, or quaternary ammonium compounds) as a way to decontaminate environmental 
surfaces or disinfect the air in patient rooms. The recommendation against fogging was based on 
studies in the 1970’s that reported a lack of microbicidal efficacy (e.g., use of quaternary ammonium 
compounds in mist applications) but also adverse effects on healthcare workers and others in facilities 
where these methods were utilized. Furthermore, some of these chemicals are not EPA-registered for 
use in fogging-type applications. 
These recommendations do not apply to newer technologies involving fogging for room 
decontamination (e.g., ozone mists, vaporized hydrogen peroxide) that have become available since 
the 2008 recommendations were made. These newer technologies were assessed by CDC and 
HICPAC in the 2011 Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks 
in Healthcare Settings, which makes the recommendation:  
“More research is required to clarify the effectiveness and reliability of fogging, UV irradiation, 
and ozone mists to reduce norovirus environmental contamination. (No recommendation/ 
unresolved issue)”  
The 2008 recommendations still apply; however, CDC does not yet make a recommendation regarding 
these newer technologies. This issue will be revisited as additional evidence becomes available.  
7. High-Level Disinfection of Endoscopes  
a. To detect damaged endoscopes, test each flexible endoscope for leaks as part of each 
reprocessing cycle. Remove from clinical use any instrument that fails the leak test, and repair this 
instrument. Category II. 113, 115, 116 
b. Immediately after use, meticulously clean the endoscope with an enzymatic cleaner that is 
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compatible with the endoscope. Cleaning is necessary before both automated and manual 
disinfection. Category IA. 83, 101, 104-106, 113, 115, 116, 124, 126, 456, 465, 466, 471, 1015 
c. Disconnect and disassemble endoscopic components (e.g., suction valves) as completely as 
possible and completely immerse all components in the enzymatic cleaner. Steam sterilize these 
components if they are heat stable. Category IB. 115, 116, 139, 465, 466 
d. Flush and brush all accessible channels to remove all organic (e.g., blood, tissue) and other 
residue. Clean the external surfaces and accessories of the devices by using a soft cloth or 
sponge or brushes. Continue brushing until no debris appears on the brush. Category IA 6, 17, 108, 
113, 115, 116, 137, 145, 147, 725, 856, 903. 
e. Use cleaning brushes appropriate for the size of the endoscope channel or port (e.g., bristles 
should contact surfaces). Cleaning items (e.g., brushes, cloth) should be disposable or, if they are 
not disposable, they should be thoroughly cleaned and either high-level disinfected or sterilized 
after each use. Category II. 113, 115, 116, 1016 
f. Discard enzymatic cleaners (or detergents) after each use because they are not microbicidal and, 
therefore, will not retard microbial growth. Category IB. 38, 113, 115, 116, 466 
g. Process endoscopes (e.g., arthroscopes, cystoscope, laparoscopes) that pass through normally 
sterile tissues using a sterilization procedure before each use; if this is not feasible, provide at 
least high-level disinfection. High-level disinfection of arthroscopes, laparoscopes, and 
cystoscopes should be followed by a sterile water rinse. Category IB. 1, 17, 31, 32, 35, 89, 90, 113, 554  
h. Phase out endoscopes that are critical items (e.g., arthroscopes, laparoscopes) but cannot be 
steam sterilized. Replace these endoscopes with steam sterilizable instruments when feasible. 
Category II. 
i. Mechanically clean reusable accessories inserted into endoscopes (e.g., biopsy forceps or other 
cutting instruments) that break the mucosal barrier (e.g., ultrasonically clean biopsy forceps) and 
then sterilize these items between each patient. Category IA. 1, 6, 8, 17, 108, 113, 115, 116, 138, 145, 147, 153, 278 
j. Use ultrasonic cleaning of reusable endoscopic accessories to remove soil and organic material 
from hard-to-clean areas. Category II. 116, 145, 148 
k. Process endoscopes and accessories that contact mucous membranes as semicritical items, and 
use at least high-level disinfection after use on each patient. Category IA. 1, 6, 8, 17, 108, 113, 115, 116, 129, 
138, 145-148, 152-154, 278 
l. Use an FDA-cleared sterilant or high-level disinfectant for sterilization or high-level disinfection 
(Table 1). Category IA. 1, 6-8, 17, 85, 108, 113, 115, 116, 147 
m. After cleaning, use formulations containing glutaraldehyde, glutaraldehyde with phenol/phenate, 
ortho-phthalaldehyde, hydrogen peroxide, and both hydrogen peroxide and peracetic acid to 
achieve high-level disinfection followed by rinsing and drying (see Table 1 for recommended 
concentrations). Category IB. 1, 6-8, 17, 38, 85, 108, 113, 145-148  
n. Extend exposure times beyond the minimum effective time for disinfecting semicritical patient-care 
equipment cautiously and conservatively because extended exposure to a high-level disinfectant is 
more likely to damage delicate and intricate instruments such as flexible endoscopes. The 
exposure times vary among the Food and Drug Administration (FDA)-cleared high-level 
disinfectants (Table 2). Category IB. 17, 69, 73, 76, 78, 83 
o. Federal regulations are to follow the FDA-cleared label claim for high-level disinfectants. The FDA-
cleared labels for high-level disinfection with >2% glutaraldehyde at 25°C range from 20-90 
minutes, depending upon the product based on three tier testing which includes AOAC sporicidal 
tests, simulated use testing with mycobacterial and in-use testing. Category IC.  
p. Several scientific studies and professional organizations support the efficacy of >2% 
glutaraldehyde for 20 minutes at 20ºC; that efficacy assumes adequate cleaning prior to 
disinfection, whereas the FDA-cleared label claim incorporates an added margin of safety to 
accommodate possible lapses in cleaning practices. Facilities that have chosen to apply the 20 
minute duration at 20ºC have done so based on the IA recommendation in the July 2003 SHEA 
position paper, “Multi-society Guideline for Reprocessing Flexible Gastrointestinal Endoscopes.” 12, 
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17, 19, 26, 27, 49, 55, 57, 58, 60, 73, 76, 79-81, 83-85, 93, 94, 104-106, 110, 111, 115-121, 124, 125, 233, 235, 236, 243, 265, 266, 609 




q. When using FDA-cleared high-level disinfectants, use manufacturers’ recommended exposure 
conditions. Certain products may require a shorter exposure time (e.g., 0.55% ortho-phthalaldehyde 
for 12 minutes at 20°C, 7.35% hydrogen peroxide plus 0.23% peracetic acid for 15 minutes at 20°C) 
than glutaraldehyde at room temperature because of their rapid inactivation of mycobacteria or 
reduced exposure time because of increased mycobactericidal activity at elevated temperature (e.g., 
2.5% glutaraldehyde at 5 minutes at 35°C). Category IB. 83, 100, 689, 693, 694, 700  
r. Select a disinfectant or chemical sterilant that is compatible with the device that is being 
reprocessed. Avoid using reprocessing chemicals on an endoscope if the endoscope 
manufacturer warns against using these chemicals because of functional damage (with or without 
cosmetic damage). Category IB. 69, 113, 116  
s. Completely immerse the endoscope in the high-level disinfectant, and ensure all channels are 
perfused. As soon as is feasible, phase out nonimmersible endoscopes. Category IB. 108, 113-116, 137, 
725, 856, 882 
t. After high-level disinfection, rinse endoscopes and flush channels with sterile water, filtered water, 
or tapwater to prevent adverse effects on patients associated with disinfectant retained in the 
endoscope (e.g., disinfectant induced colitis). Follow this water rinse with a rinse with 70% - 90% 
ethyl or isopropyl alcohol. Category IB. 17, 31-35, 38, 39, 108, 113, 115, 116, 134, 145-148, 620-622, 624-630, 1017 
u. After flushing all channels with alcohol, purge the channels using forced air to reduce the likelihood 
of contamination of the endoscope by waterborne pathogens and to facilitate drying. Category IB. 
39, 113, 115, 116, 145, 147 
v. Hang endoscopes in a vertical position to facilitate drying. Category II. 17, 108, 113, 115, 116, 145, 815 
w. Store endoscopes in a manner that will protect them from damage or contamination. Category II. 
17, 108, 113, 115, 116, 145 
x. Sterilize or high-level disinfect both the water bottle used to provide intraprocedural flush solution 
and its connecting tube at least once daily. After sterilizing or high-level disinfecting the water 
bottle, fill it with sterile water. Category IB. 10, 31-35, 113, 116, 1017 
y. Maintain a log for each procedure and record the following: patient’s name and medical record 
number (if available), procedure, date, endoscopist, system used to reprocess the endoscope (if 
more than one system could be used in the reprocessing area), and serial number or other 
identifier of the endoscope used. Category II. 108, 113, 115, 116 
z. Design facilities where endoscopes are used and disinfected to provide a safe environment for 
healthcare workers and patients. Use air-exchange equipment (e.g., the ventilation system, out-
exhaust ducts) to minimize exposure of all persons to potentially toxic vapors (e.g., glutaraldehyde 
vapor). Do not exceed the allowable limits of the vapor concentration of the chemical sterilant or 
high-level disinfectant (e.g., those of ACGIH and OSHA). Category IB, IC. 116, 145, 318, 322, 577, 652 
aa. Routinely test the liquid sterilant/high-level disinfectant to ensure minimal effective concentration of 
the active ingredient. Check the solution each day of use (or more frequently) using the 
appropriate chemical indicator (e.g., glutaraldehyde chemical indicator to test minimal effective 
concentration of glutaraldehyde) and document the results of this testing. Discard the solution if 
the chemical indicator shows the concentration is less than the minimum effective concentration. 
Do not use the liquid sterilant/high-level disinfectant beyond the reuse-life recommended by the 
manufacturer (e.g., 14 days for ortho-phthalaldehyde). Category IA. 76, 108, 113, 115, 116, 608, 609 
ab. * Provide personnel assigned to reprocess endoscopes with device-specific reprocessing 
instructions to ensure proper cleaning and high-level disinfection or sterilization. Require 
competency testing on a regular basis (e.g., beginning of employment, annually) of all personnel 
who reprocess endoscopes. Category IA. 6-8, 108, 113, 115, 116, 145, 148, 155 
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ac. * Educate all personnel who use chemicals about the possible biologic, chemical, and 
environmental hazards of performing procedures that require disinfectants. Category IB, IC. 116, 997, 
998, 1018, 1019 
ad. * Make PPE (e.g., gloves, gowns, eyewear, face mask or shields, respiratory protection devices) 
available and use these items appropriately to protect workers from exposure to both chemicals 
and microorganisms (e.g., HBV). Category IB, IC. 115, 116, 214, 961, 997, 998, 1020, 1021 
ae. * If using an automated endoscope reprocessor (AER), place the endoscope in the reprocessor 
and attach all channel connectors according to the AER manufacturer’s instructions to ensure 
exposure of all internal surfaces to the high-level disinfectant/chemical sterilant. Category IB. 7, 8, 
115, 116, 155, 725, 903 
af. * If using an AER, ensure the endoscope can be effectively reprocessed in the AER. Also, ensure 
any required manual cleaning/disinfecting steps are performed (e.g., elevator wire channel of 
duodenoscopes might not be effectively disinfected by most AERs). Category IB. 7, 8, 115, 116, 155, 725  
ag. * Review the FDA advisories and the scientific literature for reports of deficiencies that can lead to 
infection because design flaws and improper operation and practices have compromised the 
effectiveness of AERs. Category II. 7, 98, 133, 134, 155, 725  
ah. * Develop protocols to ensure that users can readily identify an endoscope that has been properly 
processed and is ready for patient use. Category II. 
ai. * Do not use the carrying case designed to transport clean and reprocessed endoscopes outside 
of the healthcare environment to store an endoscope or to transport the instrument within the 
healthcare environment. Category II. 
aj. * No recommendation is made about routinely performing microbiologic testing of either 
endoscopes or rinse water for quality assurance purposes. Unresolved Issue. 116, 164 
ak. * If environmental microbiologic testing is conducted, use standard microbiologic techniques. 
Category II. 23, 116, 157, 161, 167 
al. * If a cluster of endoscopy-related infections occurs, investigate potential routes of transmission 
(e.g., person-to-person, common source) and reservoirs. Category IA. 8, 1022  
am. * Report outbreaks of endoscope-related infections to persons responsible for institutional infection 
control and risk management and to FDA. Category IB. 6, 7, 113, 116, 1023  
1. * Notify the local and the state health departments, CDC, and the manufacturer(s). Category II. 
an. * No recommendation is made regarding the reprocessing of an endoscope again immediately 
before use if that endoscope has been processed after use according to the recommendations in 
this guideline. Unresolved issue. 157 
ao. * Compare the reprocessing instructions provided by both the endoscope’s and the AER’s 
manufacturer’s instructions and resolve any conflicting recommendations. Category IB. 116, 155 
8. Management of Equipment and Surfaces in Dentistry 
a. Dental instruments that penetrate soft tissue or bone (e.g., extraction forceps, scalpel blades, 
bone chisels, periodontal scalers, and surgical burs) are classified as critical and should be 
sterilized after each use or discarded. In addition, after each use, sterilize dental instruments that 
are not intended to penetrate oral soft tissue or bone (e.g., amalgam condensers, air-water 
syringes) but that might contact oral tissues and are heat-tolerant, although classified as 
semicritical. Clean and, at a minimum, high-level disinfect heat-sensitive semicritical items. 
Category IA. 43, 209-211 
b. Noncritical clinical contact surfaces, such as uncovered operatory surfaces (e.g., countertops, 
switches, light handles), should be barrier-protected or disinfected between patients with an 
intermediate-disinfectant (i.e., EPA-registered hospital disinfectant with a tuberculocidal claim) or 
low-level disinfectant (i.e., EPA-registered hospital disinfectant with HIV and HBV claim). 
Category IB. 43, 209-211 
c. Barrier protective coverings can be used for noncritical clinical contact surfaces that are touched 
frequently with gloved hands during the delivery of patient care, that are likely to become 
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contaminated with blood or body substances, or that are difficult to clean. Change these 
coverings when they are visibly soiled, when they become damaged, and on a routine basis 
(e.g., between patients). Disinfect protected surfaces at the end of the day or if visibly soiled. 
Category II. 43, 210 
9.  Processing Patient-Care Equipment Contaminated with Bloodborne Pathogens 
(HBV, Hepatitis C Virus, HIV), Antibiotic-Resistant Bacteria (e.g., Vancomycin-
Resistant Enterococci, Methicillin-Resistant Staphylococcus aureus, Multidrug 
Resistant Tuberculosis), or Emerging Pathogens (e.g., Cryptosporidium, 
Helicobacter pylori, Escherichia coli O157:H7, Clostridium difficile, 
Mycobacterium tuberculosis, Severe Acute Respiratory Syndrome 
Coronavirus), or Bioterrorist Agents  
a. Use standard sterilization and disinfection procedures for patient-care equipment (as 
recommended in this guideline), because these procedures are adequate to sterilize or disinfect 
instruments or devices contaminated with blood or other body fluids from persons infected with 
bloodborne pathogens or emerging pathogens, with the exception of prions. No changes in 
these procedures for cleaning, disinfecting, or sterilizing are necessary for removing bloodborne 
and emerging pathogens other than prions. Category IA. 22, 53, 60-62, 73, 79-81, 105, 118-121, 125, 126, 221, 224-
234, 236, 244, 265, 266, 271-273, 279, 282, 283, 354-357, 666 
10. Disinfection Strategies for Other Semicritical Devices 
a. Even if probe covers have been used, clean and high-level disinfect other semicritical devices 
such as rectal probes, vaginal probes, and cryosurgical probes with a product that is not toxic to 
staff, patients, probes, and retrieved germ cells (if applicable). Use a high-level disinfectant at 
the FDA-cleared exposure time. (See Recommendation 7p for exceptions.) Category IB. 6-8, 17, 69 
b. When probe covers are available, use a probe cover or condom to reduce the level of microbial 
contamination. Category II. 197-201  
Do not use a lower category of disinfection or cease to follow the appropriate disinfectant 
recommendations when using probe covers because these sheaths and condoms can fail. 
Category IB 197-201 
c. After high-level disinfection, rinse all items. Use sterile water, filtered water or tapwater followed 
by an alcohol rinse for semicritical equipment that will have contact with mucous membranes of 
the upper respiratory tract (e.g., nose, pharynx, esophagus). Category II. 10, 31-35, 1017 
d. There is no recommendation to use sterile or filtered water rather than tapwater for rinsing 
semicritical equipment that contact the mucous membranes of the rectum (e.g., rectal probes, 
anoscope) or vagina (e.g., vaginal probes). Unresolved issue. 11 
e. Wipe clean tonometer tips and then disinfect them by immersing for 5-10 minutes in either 5000 
ppm chlorine or 70% ethyl alcohol. None of these listed disinfectant products are FDA-cleared 
high-level disinfectants. Category II. 49, 95, 185, 188, 293 
11. Disinfection by Healthcare Personnel in Ambulatory Care and Home Care 
a. Follow the same classification scheme described above (i.e., that critical devices require 
sterilization, semicritical devices require high-level disinfection, and noncritical equipment 
requires low-level disinfection) in the ambulatory-care (outpatient medical/surgical facilities) 
setting because risk for infection in this setting is similar to that in the hospital setting (see Table 
1). Category IB. 6-8, 17, 330 
b. When performing care in the home, clean and disinfect reusable objects that touch mucous 
membranes (e.g., tracheostomy tubes) by immersing these objects in a 1:50 dilution of 5.25%-
6.15% sodium hypochlorite (household bleach) (3 minutes), 70% isopropyl alcohol (5 minutes), 
or 3% hydrogen peroxide (30 minutes) because the home environment is, in most instances, 
safer than either hospital or ambulatory care settings because person-to-person transmission is 
less likely. Category II. 327, 328, 330, 331 
c. Clean noncritical items that would not be shared between patients (e.g., crutches, blood 
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pressure cuffs) in the home setting with a detergent or commercial household disinfectant. 
Category II. 53, 330 
12. Microbial Contamination of Disinfectants 
a. Institute the following control measures to reduce the occurrence of contaminated disinfectants:  
1. prepare the disinfectant correctly to achieve the manufacturer’s recommended use-dilution; and  
2. prevent common sources of extrinsic contamination of germicides (e.g., container contamination 
or surface contamination of the healthcare environment where the germicide are prepared 
and/or used).  
Category IB. 404, 406, 1024 
13. Flash Sterilization  
a. Do not flash sterilize implanted surgical devices unless doing so is unavoidable. Category IB. 849, 
850 
b. Do not use flash sterilization for convenience, as an alternative to purchasing additional 
instrument sets, or to save time. Category II. 817, 962  
c. When using flash sterilization, make sure the following parameters are met:  
1. clean the item before placing it in the sterilizing container (that are FDA cleared for use with 
flash sterilization) or tray;  
2. prevent exogenous contamination of the item during transport from the sterilizer to the 
patient; and 3) monitor sterilizer function with mechanical, chemical, and biologic monitors. 
Category IB. 812, 819, 846, 847, 962 
d. Do not use packaging materials and containers in flash sterilization cycles unless the sterilizer 
and the packaging material/container are designed for this use. Category IB. 812, 819, 1025 
e. When necessary, use flash sterilization for patient-care items that will be used immediately (e.g., 
to reprocess an inadvertently dropped instrument). Category IB. 812, 817, 819, 845 
f. When necessary, use flash sterilization for processing patient-care items that cannot be 
packaged, sterilized, and stored before use. Category IB. 812, 819 
14. Methods of Sterilization 
a. Steam is the preferred method for sterilizing critical medical and surgical instruments that are not 
damaged by heat, steam, pressure, or moisture. Category IA. 181, 271, 425, 426, 827, 841, 1026, 1027 
b. Cool steam- or heat-sterilized items before they are handled or used in the operative setting. 
Category IB. 850 
c. Follow the sterilization times, temperatures, and other operating parameters (e.g., gas 
concentration, humidity) recommended by the manufacturers of the instruments, the sterilizer, 
and the container or wrap used, and that are consistent with guidelines published by government 
agencies and professional organizations. Category IB. 811-814, 819, 825, 827, 841, 1026-1028  
d. Use low-temperature sterilization technologies (e.g., EtO, hydrogen peroxide gas plasma) for 
reprocessing critical patient-care equipment that is heat or moisture sensitive. Category IA 469, 
721, 825, 856, 858, 878, 879, 881, 882, 890, 891, 1027. 
e. Completely aerate surgical and medical items that have been sterilized in the EtO sterilizer (e.g., 
polyvinylchloride tubing requires 12 hours at 50°C, 8 hours at 60°C) before using these items in 
patient care. Category IB. 814 
f. Sterilization using the peracetic acid immersion system can be used to sterilize heat-sensitive 
immersible medical and surgical items. Category IB. 90, 717-719, 721-724 
g. Critical items that have been sterilized by the peracetic acid immersion process must be used 
immediately (i.e., items are not completely protected from contamination, making long-term 
storage unacceptable). Category II. 817, 825  
h. Dry-heat sterilization (e.g., 340°F for 60 minutes) can be used to sterilize items (e.g., powders, 
oils) that can sustain high temperatures. Category IB. 815, 827 
i. Comply with the sterilizer manufacturer’s instructions regarding the sterilizer cycle parameters 
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(e.g., time, temperature, concentration). Category IB. 155, 725, 811-814, 819 
j. Because narrow-lumen devices provide a challenge to all low-temperature sterilization 
technologies and direct contact is necessary for the sterilant to be effective, ensure that the 
sterilant has direct contact with contaminated surfaces (e.g., scopes processed in peracetic acid 
must be connected to channel irrigators). Category IB. 137, 725, 825, 856, 890, 891, 1029 
15.  Packaging 
a. Ensure that packaging materials are compatible with the sterilization process and have received 
FDA 510[k] clearance. Category IB. 811-814, 819, 966 
b. Ensure that packaging is sufficiently strong to resist punctures and tears to provide a barrier to 
microorganisms and moisture. Category IB. 454, 811-814, 819, 966 
16.  Monitoring of Sterilizers 
a. Use mechanical, chemical, and biologic monitors to ensure the effectiveness of the sterilization 
process. Category IB. 811-815, 819, 846, 847, 975-977 
b. Monitor each load with mechanical (e.g., time, temperature, pressure) and chemical (internal 
and external) indicators. If the internal chemical indicator is visible, an external indicator is not 
needed. Category II. 811-815, 819, 846, 847, 975-977, 980 
c. Do not use processed items if the mechanical (e.g., time, temperature, pressure) or chemical 
(internal and/or external) indicators suggest inadequate processing. Category IB 811-814, 819.  
d. Use biologic indicators to monitor the effectiveness of sterilizers at least weekly with an FDA-
cleared commercial preparation of spores (e.g., Geobacillus stearothermophilus for steam) 
intended specifically for the type and cycle parameters of the sterilizer. Category IB. 1, 811, 813-815, 
819, 846, 847, 976, 977 
e. After a single positive biologic indicator used with a method other than steam sterilization, treat 
as nonsterile all items that have been processed in that sterilizer, dating from the sterilization 
cycle having the last negative biologic indicator to the next cycle showing satisfactory biologic 
indicator results. These nonsterile items should be retrieved if possible and reprocessed. 
Category II. 1 
f. After a positive biologic indicator with steam sterilization, objects other than implantable objects 
do not need to be recalled because of a single positive spore test unless the sterilizer or the 
sterilization procedure is defective as determined by maintenance personnel or inappropriate 
cycle settings. If additional spore tests remain positive, consider the items nonsterile and recall 
and reprocess the items from the implicated load(s). Category II. 1 
g. Use biologic indicators for every load containing implantable items and quarantine items, 
whenever possible, until the biologic indicator is negative. Category IB. 811-814, 819  
17. Load Configuration. 
a. Place items correctly and loosely into the basket, shelf, or cart of the sterilizer so as not to 
impede the penetration of the sterilant. Category IB. 445, 454, 811, 813, 819, 836 
18. Storage of Sterile Items 
a. Ensure the sterile storage area is a well-ventilated area that provides protection against dust, 
moisture, insects, and temperature and humidity extremes. Category II. 454, 819, 836, 969 
b. Store sterile items so the packaging is not compromised (e.g., punctured, bent). Category II. 454, 
816, 819, 968, 969, 1030  
c. Label sterilized items with a load number that indicates the sterilizer used, the cycle or load 
number, the date of sterilization, and, if applicable, the expiration date. Category IB. 811, 812, 814, 
816, 819 
d. The shelf life of a packaged sterile item depends on the quality of the wrapper, the storage 
conditions, the conditions during transport, the amount of handling, and other events (moisture) 
that compromise the integrity of the package. If event-related storage of sterile items is used, 
then packaged sterile items can be used indefinitely unless the packaging is compromised (see f 
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and g below). Category IB. 816, 819, 836, 968, 973, 1030, 1031  
e. Evaluate packages before use for loss of integrity (e.g., torn, wet, punctured). The pack can be 
used unless the integrity of the packaging is compromised. Category II. 819, 968  
f. If the integrity of the packaging is compromised (e.g., torn, wet, or punctured), repack and 
reprocess the pack before use. Category II. 819, 1032 
g. If time-related storage of sterile items is used, label the pack at the time of sterilization with an 
expiration date. Once this date expires, reprocess the pack. Category II. 819, 968 
19. Quality Control 
a. Provide comprehensive and intensive training for all staff assigned to reprocess semicritical and 
critical medical/surgical instruments to ensure they understand the importance of reprocessing 
these instruments. To achieve and maintain competency, train each member of the staff that 
reprocesses semicritical and/or critical instruments as follows:  
1. provide hands-on training according to the institutional policy for reprocessing critical and 
semicritical devices;  
2. supervise all work until competency is documented for each reprocessing task;  
3. conduct competency testing at beginning of employment and regularly thereafter (e.g., 
annually); and  
4. review the written reprocessing instructions regularly to ensure they comply with the 
scientific literature and the manufacturers’ instructions.  
Category IB. 6-8, 108, 114, 129, 155, 725, 813, 819  
b. Compare the reprocessing instructions (e.g., for the appropriate use of endoscope connectors, 
the capping/noncapping of specific lumens) provided by the instrument manufacturer and the 
sterilizer manufacturer and resolve any conflicting recommendations by communicating with 
both manufacturers. Category IB. 155, 725 
c. Conduct infection control rounds periodically (e.g., annually) in high-risk reprocessing areas 
(e.g., the Gastroenterology Clinic, Central Processing); ensure reprocessing instructions are 
current and accurate and are correctly implemented. Document all deviations from policy. All 
stakeholders should identify what corrective actions will be implemented. Category IB. 6-8, 129  
d. Include the following in a quality control program for sterilized items: a sterilizer maintenance 
contract with records of service; a system of process monitoring; air-removal testing for 
prevacuum steam sterilizers; visual inspection of packaging materials; and traceability of load 
contents. Category II 811-814, 819. 
e. For each sterilization cycle, record the type of sterilizer and cycle used; the load identification 
number; the load contents; the exposure parameters (e.g., time and temperature); the operator’s 
name or initials; and the results of mechanical, chemical, and biological monitoring. Category II 
811-814, 819. 
f. Retain sterilization records (mechanical, chemical, and biological) for a time period that complies 
with standards (e.g., 3 years), statutes of limitations, and state and federal regulations. Category 
II, IC. 1033 
g. Prepare and package items to be sterilized so that sterility can be achieved and maintained to 
the point of use. Consult the Association for the Advancement of Medical Instrumentation or the 
manufacturers of surgical instruments, sterilizers, and container systems for guidelines for the 
density of wrapped packages. Category II. 811-814, 819 
h. Periodically review policies and procedures for sterilization. Category II. 1033 
i. Perform preventive maintenance on sterilizers by qualified personnel who are guided by the 
manufacturer’s instruction. Category II. 811-814, 819 
20. Reuse of Single-Use Medical Devices 
a. Adhere to the FDA enforcement document for single-use devices reprocessed by hospitals. FDA 
considers the hospital that reprocesses a single-use device as the manufacturer of the device 
and regulates the hospital using the same standards by which it regulates the original equipment 
manufacturer. Category II, IC. 995  
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1. Monitor adherence to high-level disinfection and/or sterilization guidelines for endoscopes on a 
regular basis. This monitoring should include ensuring the proper training of persons performing 
reprocessing and their adherence to all endoscope reprocessing steps, as demonstrated by 
competency testing at commencement of employment and annually. 
2. Develop a mechanism for the occupational health service to report all adverse health events 
potentially resulting from exposure to disinfectants and sterilants; review such exposures; and 
implement engineering, work practice, and PPE to prevent future exposures. 
3. Monitor possible sterilization failures that resulted in instrument recall. Assess whether additional 
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Action level: concentration of a regulated substance (e.g., ethylene oxide, formaldehyde) within the 
employee breathing zone, above which OSHA requirements apply. 
Activation of a sterilant: process of mixing the contents of a chemical sterilant that come in two 
containers (small vial with the activator solution; container of the chemical). Keeping the two chemicals 
separate until use extends the shelf life of the chemicals. 
Aeration: method by which ethylene oxide (EtO) is removed from EtO-sterilized items by warm air 
circulation in an enclosed cabinet specifically designed for this purpose. 
Antimicrobial agent: any agent that kills or suppresses the growth of microorganisms. 
Antiseptic: substance that prevents or arrests the growth or action of microorganisms by inhibiting their 
activity or by destroying them. The term is used especially for preparations applied topically to living tissue. 
Asepsis: prevention of contact with microorganisms. 
Autoclave: device that sterilizes instruments or other objects using steam under pressure. The length of 
time required for sterilization depends on temperature, vacuum, and pressure. 
Bacterial count: method of estimating the number of bacteria per unit sample. The term also refers to the 
estimated number of bacteria per unit sample, usually expressed as number of colony-forming units. 
Bactericide: agent that kills bacteria. 
Bioburden: number and types of viable microorganisms with which an item is contaminated; also called 
bioload or microbial load. 
Biofilm: accumulated mass of bacteria and extracellular material that is tightly adhered to a surface and 
cannot be easily removed. 
Biologic indicator: device for monitoring the sterilization process. The device consists of a standardized, 
viable population of microorganisms (usually bacterial spores) known to be resistant to the sterilization 
process being monitored. Biologic indicators are intended to demonstrate whether conditions were 
adequate to achieve sterilization. A negative biologic indicator does not prove that all items in the load are 
sterile or that they were all exposed to adequate sterilization conditions. 
Bleach: Household bleach (that includes 5.25% or 6.00%–6.15% sodium hypochlorite depending on 
manufacturer) is usually diluted in water at 1:10 or 1:100. Approximate dilutions are 1.5 cups of bleach in 
a gallon of water for a 1:10 dilution (~6,000 ppm) and 0.25 cup of bleach in a gallon of water for a 1:100 
dilution (~600 ppm). Sodium hypochlorite products that make pesticidal claims, such as sanitization or 
disinfection, must be registered by EPA and be labeled with an EPA Registration Number. 
 
Expected Chlorine Concentrations by Various 
Dulitions of Househod Bleach (5.25-6.15% sodium 
hypochlorite)   
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Bowie-Dick test: diagnostic test of a sterilizer’s ability to remove air from the chamber of a prevacuum 
steam sterilizer. The air-removal or Bowie-Dick test is not a test for sterilization. 
 
Ceiling limit: concentration of an airborne chemical contaminant that should not be exceeded during any 
part of the workday. If instantaneous monitoring is not feasible, the ceiling must be assessed as a 15-
minute time-weighted average exposure. 
 
Centigrade or Celsius: a temperature scale (0°C = freezing point of water; 100°C = boiling point of water 
at sea level). Equivalents mentioned in the guideline are as follows: 20°C = 68°F; 25°C = 77°F; 121°C = 
250°F; 132°C = 270°F; 134°C = 273°F. For other temperatures the formula is: F° = (C° × 9 ∕ 5) + 32 or C° 
= (F° – 32) × 5 ∕ 9.  
 
Central processing or Central service department: the department within a health-care facility that 
processes, issues, and controls professional supplies and equipment, both sterile and nonsterile, for 
some or all patient-care areas of the facility. 
 
Challenge test pack: pack used in installation, qualification, and ongoing quality assurance testing of 
health-care facility sterilizers. 
 
Chemical indicator: device for monitoring a sterilization process. The device is designed to respond with 
a characteristic chemical or physical change to one or more of the physical conditions within the sterilizing 
chamber. Chemical indicators are intended to detect potential sterilization failures that could result from 
incorrect packaging, incorrect loading of the sterilizer, or malfunctions of the sterilizer. The “pass” 
response of a chemical indicator does not prove the item accompanied by the indicator is necessarily 
sterile. The Association for the Advancement of Medical Instrumentation has defined five classes of 
chemical indicators: Class 1 (process indicator); Class 2 (Bowie-Dick test indicator); Class 3 (single-
parameter indicator); Class 4 (multi-parameter indicator); and Class 5 (integrating indicator). 
 
Contact time: time a disinfectant is in direct contact with the surface or item to be disinfected. For surface 
disinfection, this period is framed by the application to the surface until complete drying has occurred. 
 
Container system, rigid container: sterilization containment device designed to hold medical devices for 
sterilization, storage, transportation, and aseptic presentation of contents. 
 
Contaminated: state of having actual or potential contact with microorganisms. As used in health care, 
the term generally refers to the presence of microorganisms that could produce disease or infection. 
 
Control, positive: biologic indicator, from the same lot as a test biologic indicator, that is left unexposed 
to the sterilization cycle and then incubated to verify the viability of the test biologic indicator. 
 
Cleaning: removal, usually with detergent and water or enzyme cleaner and water, of adherent visible 
soil, blood, protein substances, microorganisms and other debris from the surfaces, crevices, serrations, 
joints, and lumens of instruments, devices, and equipment by a manual or mechanical process that 
prepares the items for safe handling and/or further decontamination. 
 
Culture: growth of microorganisms in or on a nutrient medium; to grow microorganisms in or on such a 
medium. 
 
Culture medium: substance or preparation used to grow and cultivate microorganisms. 
 
Cup: 8 fluid ounces. 
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Decontamination: according to OSHA, “the use of physical or chemical means to remove, inactivate, or 
destroy bloodborne pathogens on a surface or item to the point where they are no longer capable of 
transmitting infectious particles and the surface or item is rendered safe for handling, use, or disposal” [29 
CFR 1910.1030]. In health-care facilities, the term generally refers to all pathogenic organisms. 
 
Decontamination area: area of a health-care facility designated for collection, retention, and cleaning of 
soiled and/or contaminated items. 
 
Detergent: cleaning agent that makes no antimicrobial claims on the label. They comprise a hydrophilic 
component and a lipohilic component and can be divided into four types: anionic, cationic, amphoteric, 
and non-ionic detergents. 
 
Disinfectant: usually a chemical agent (but sometimes a physical agent) that destroys disease-causing 
pathogens or other harmful microorganisms but might not kill bacterial spores. It refers to substances 
applied to inanimate objects. EPA groups disinfectants by product label claims of “limited,” “general,” or 
“hospital” disinfection. 
 
Disinfection: thermal or chemical destruction of pathogenic and other types of microorganisms. 
Disinfection is less lethal than sterilization because it destroys most recognized pathogenic 
microorganisms but not necessarily all microbial forms (e.g., bacterial spores). 
 
D value: time or radiation dose required to inactivate 90% of a population of the test microorganism under 
stated exposure conditions. 
 
Endoscope: an instrument that allows examination and treatment of the interior of the body canals and 
hollow organs. 
 
Enzyme cleaner: a solution used before disinfecting instruments to improve removal of organic material 
(e.g., proteases to assist in removing protein). 
 
EPA Registration Number or EPA Reg. No.: a hyphenated, two- or three-part number assigned by EPA 
to identify each germicidal product registered within the United States. The first number is the company 
identification number, the second is the specific product number, and the third (when present) is the 
company identification number for a supplemental registrant. 
 
Exposure time: period in a sterilization process during which items are exposed to the sterilant at the 
specified sterilization parameters. For example, in a steam sterilization process, exposure time is the 
period during which items are exposed to saturated steam at the specified temperature. 
 
Flash sterilization: process designed for the steam sterilization of unwrapped patient-care items for 
immediate use (or placed in a specially designed, covered, rigid container to allow for rapid penetration of 
steam). 
 
Fungicide: agent that destroys fungi (including yeasts) and/or fungal spores pathogenic to humans or 
other animals in the inanimate environment. 
 
General disinfectant: EPA-registered disinfectant labeled for use against both gram-negative and gram-
positive bacteria. Efficacy is demonstrated against both Salmonella choleraesuis and Staphylococcus 
aureus. Also called broad-spectrum disinfectant. 
 
Germicide: agent that destroys microorganisms, especially pathogenic organisms. 
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Germicidal detergent: detergent that also is EPA-registered as a disinfectant. 
 
High-level disinfectant: agent capable of killing bacterial spores when used in sufficient concentration 
under suitable conditions. It therefore is expected to kill all other microorganisms. 
 
Hospital disinfectant: disinfectant registered for use in hospitals, clinics, dental offices, and any other 
medical-related facility. Efficacy is demonstrated against Salmonella choleraesuis, Staphylococcus 
aureus, and Pseudomonas aeruginosa. EPA has registered approximately 1,200 hospital disinfectants. 
 
Huck towel: all-cotton surgical towel with a honey-comb weave; both warp and fill yarns are tightly 
twisted. Huck towels can be used to prepare biologic indicator challenge test packs. 
 
Implantable device: according to FDA, “device that is placed into a surgically or naturally formed cavity 
of the human body if it is intended to remain there for a period of 30 days or more” [21 CFR 812.3(d)]. 
 
Inanimate surface: nonliving surface (e.g., floors, walls, furniture). 
 
Incubator: apparatus for maintaining a constant and suitable temperature for the growth and cultivation 
of microorganisms. 
 
Infectious microorganisms: microorganisms capable of producing disease in appropriate hosts. 
 
Inorganic and organic load: naturally occurring or artificially placed inorganic (e.g., metal salts) or 
organic (e.g., proteins) contaminants on a medical device before exposure to a microbicidal process. 
 
Intermediate-level disinfectant: agent that destroys all vegetative bacteria, including tubercle bacilli, 
lipid and some nonlipid viruses, and fungi, but not bacterial spores. 
 
Limited disinfectant: disinfectant registered for use against a specific major group of organisms (gram-
negative or gram-positive bacteria). Efficacy has been demonstrated in laboratory tests against either 
Salmonella choleraesuis or Staphylococcus aureus bacteria. 
 
Lipid virus: virus surrounded by an envelope of lipoprotein in addition to the usual core of nucleic acid 
surrounded by a coat of protein. This type of virus (e.g., HIV) is generally easily inactivated by many types 
of disinfectants. Also called enveloped or lipophilic virus. 
 
Low-level disinfectant: agent that destroys all vegetative bacteria (except tubercle bacilli), lipid viruses, 
some nonlipid viruses, and some fungi, but not bacterial spores. 
 
Mechanical indicator: devices that monitor the sterilization process (e.g., graphs, gauges, printouts). 
 
Medical device: instrument, apparatus, material, or other article, whether used alone or in combination, 
including software necessary for its application, intended by the manufacturer to be used for human 
beings for 
• diagnosis, prevention, monitoring treatment, or alleviation of disease; 
• diagnosis, monitoring, treatment, or alleviation of or compensation for an injury or handicap; 
• investigation, replacement, or modification of the anatomy or of a physiologic process; or 
• control of conception 
and that does not achieve its primary intended action in or on the human body by pharmacologic, 
immunologic, or metabolic means but might be assisted in its function by such means. 
 
Microbicide: any substance or mixture of substances that effectively kills microorganisms. 
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Microorganisms: animals or plants of microscopic size. As used in health care, generally refers to 
bacteria, fungi, viruses, and bacterial spores. 
 
Minimum effective concentration (MEC): the minimum concentration of a liquid chemical germicide 
needed to achieve the claimed microbicidal activity as determined by dose-response testing. Sometimes 
used interchangeably with minimum recommended concentration. 
 
Muslin: loosely woven (by convention, 140 threads per square inch), 100% cotton cloth. Formerly used 
as a wrap for sterile packs or a surgical drape. Fabric wraps used currently consist of a cotton-polyester 
blend. 
 
Mycobacteria: bacteria with a thick, waxy coat that makes them more resistant to chemical germicides 
than other types of vegetative bacteria. 
 
Nonlipid viruses: generally considered more resistant to inactivation than lipid viruses. Also called 
nonenveloped or hydrophilic viruses. 
 
One-step disinfection process: simultaneous cleaning and disinfection of a noncritical surface or item. 
 
Pasteurization: process developed by Louis Pasteur of heating milk, wine, or other liquids to 65–77°C (or 
the equivalent) for approximately 30 minutes to kill or markedly reduce the number of pathogenic and 
spoilage organisms other than bacterial spores. 
 
Parametric release: declaration that a product is sterile on the basis of physical and/or chemical process 
data rather than on sample testing or biologic indicator results. 
 
Penicylinder: carriers inoculated with the test bacteria for in vitro tests of germicides. Can be constructed 
of stainless steel, porcelain, glass, or other materials and are approximately 8 x 10 mm in diameter. 
 
Permissible exposure limit (PEL): time-weighted average maximum concentration of an air contaminant 
to which a worker can be exposed, according to OSHA standards. Usually calculated over 8 hours, with 
exposure considered over a 40-hour work week. 
 
Personal protective equipment (PPE): specialized clothing or equipment worn by an employee for 
protection against a hazard. General work clothes (e.g., uniforms, pants, shirts) not intended to function 
as protection against a hazard are not considered to be PPE. 
 
Parts per million (ppm): common measurement for concentrations by volume of trace contaminant 
gases in the air (or chemicals in a liquid); 1 volume of contaminated gas per 1 million volumes of 
contaminated air or 1¢ in $10,000 both equal 1 ppm. Parts per million = µg ∕ mL or mg ∕ L. 
 
Prions: transmissible pathogenic agents that cause a variety of neurodegenerative diseases of humans 
and animals, including sheep and goats, bovine spongiform encephalopathy in cattle, and Creutzfeldt-
Jakob disease in humans. They are unlike any other infectious pathogens because they are composed of 
an abnormal conformational isoform of a normal cellular protein, the prion protein (PrP). Prions are 
extremely resistant to inactivation by sterilization processes and disinfecting agents. 
 
Process challenge device (PCD): item designed to simulate product to be sterilized and to constitute a 
defined challenge to the sterilization process and used to assess the effective performance of the 
process. A PCD is a challenge test pack or test tray that contains a biologic indicator, a Class 5 
integrating indicator, or an enzyme-only indicator. 
 
QUAT: abbreviation for quaternary ammonium compound, a surface-active, water-soluble disinfecting 
substance that has four carbon atoms linked to a nitrogen atom through covalent bonds. 
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Recommended exposure limit (REL): occupational exposure limit recommended by NIOSH as being 
protective of worker health and safety over a working lifetime. Frequently expressed as a 40-hour time-
weighted-average exposure for up to 10 hours per day during a 40-work week. 
 
Reprocess: method to ensure proper disinfection or sterilization; can include: cleaning, inspection, 
wrapping, sterilizing, and storing. 
 
Sanitizer: agent that reduces the number of bacterial contaminants to safe levels as judged by public 
health requirements. Commonly used with substances applied to inanimate objects. According to the 
protocol for the official sanitizer test, a sanitizer is a chemical that kills 99.999% of the specific test 
bacteria in 30 seconds under the conditions of the test. 
 
Shelf life: length of time an undiluted or use dilution of a product can remain active and effective. Also 
refers to the length of time a sterilized product (e.g., sterile instrument set) is expected to remain sterile. 
 
Spaulding classification: strategy for reprocessing contaminated medical devices. The system classifies 
a medical device as critical, semicritical, or noncritical on the basis of risk to patient safety from 
contamination on a device. The system also established three levels of germicidal activity (sterilization, 
high-level disinfection, and low-level disinfection) for strategies with the three classes of medical devices 
(critical, semicritical, and noncritical). 
 
Spore: relatively water-poor round or elliptical resting cell consisting of condensed cytoplasm and 
nucleus surrounded by an impervious cell wall or coat. Spores are relatively resistant to disinfectant and 
sterilant activity and drying conditions (specifically in the genera Bacillus and Clostridium). 
 
Spore strip: paper strip impregnated with a known population of spores that meets the definition of 
biological indicators. 
 
Steam quality: steam characteristic reflecting the dryness fraction (weight of dry steam in a mixture of dry 
saturated steam and entrained water) and the level of noncondensable gas (air or other gas that will not 
condense under the conditions of temperature and pressure used during the sterilization process). The 
dryness fraction (i.e., the proportion of completely dry steam in the steam being considered) should not 
fall below 97%. 
 
Steam sterilization: sterilization process that uses saturated steam under pressure for a specified 
exposure time and at a specified temperature, as the sterilizing agent. 
 
Steam sterilization, dynamic air removal type: one of two types of sterilization cycles in which air is 
removed from the chamber and the load by a series of pressure and vacuum excursions (prevacuum 
cycle) or by a series of steam flushes and pressure pulses above atmospheric pressure (steam-flush-
pressure-pulse cycle). 
 
Sterile or Sterility: state of being free from all living microorganisms. In practice, usually described as a 
probability function, e.g., as the probability of a microorganism surviving sterilization being one in one 
million. 
 
Sterility assurance level (SAL): probability of a viable microorganism being present on a product unit 
after sterilization. Usually expressed as 10–6; a SAL of 10-6 means ≤1/1 million chance that a single viable 
microorganism is present on a sterilized item. A SAL of 10-6 generally is accepted as appropriate for items 
intended to contact compromised tissue (i.e., tissue that has lost the integrity of the natural body barriers). 
The sterilizer manufacturer is responsible for ensuring the sterilizer can achieve the desired SAL. The 
user is responsible for monitoring the performance of the sterilizer to ensure it is operating in 
conformance to the manufacturer’s recommendations. 
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Sterilization: validated process used to render a product free of all forms of viable microorganisms. In a 
sterilization process, the presence of microorganisms on any individual item can be expressed in terms of 
probability. Although this probability can be reduced to a very low number, it can never be reduced to 
zero. 
 
Sterilization area: area of a health-care facility designed to house sterilization equipment, such as steam 
ethylene oxide, hydrogen peroxide gas plasma, or ozone sterilizers. 
 
Sterilizer: apparatus used to sterilize medical devices, equipment, or supplies by direct exposure to the 
sterilizing agent. 
 
Sterilizer, gravity-displacement type: type of steam sterilizer in which incoming steam displaces 
residual air through a port or drain in or near the bottom (usually) of the sterilizer chamber. Typical 
operating temperatures are 121–123°C (250–254°F) and 132–135°C (270–275°F). 
 
Sterilizer, prevacuum type: type of steam sterilizer that depends on one or more pressure and vacuum 
excursions at the beginning of the cycle to remove air. This method of operation results in shorter cycle 
times for wrapped items because of the rapid removal of air from the chamber and the load by the 
vacuum system and because of the usually higher operating temperature (132–135°C [270–275°F]; 141–
144°C [285–291°F]). This type of sterilizer generally provides for shorter exposure time and accelerated 
drying of fabric loads by pulling a further vacuum at the end of the sterilizing cycle. 
 
Sterilizer, steam-flush pressure-pulse type: type of sterilizer in which a repeated sequence consisting 
of a steam flush and a pressure pulse removes air from the sterilizing chamber and processed materials 
using steam at above atmospheric pressure (no vacuum is required). Like a prevacuum sterilizer, a 
steam-flush pressure-pulse sterilizer rapidly removes air from the sterilizing chamber and wrapped items; 
however, the system is not susceptible to air leaks because air is removed with the sterilizing chamber 
pressure at above atmospheric pressure. Typical operating temperatures are 121–123°C (250–254°F), 
132–135°C (270–275°F), and 141–144°C (285–291°F). 
 
Surfactant: agent that reduces the surface tension of water or the tension at the interface between water 
and another liquid; a wetting agent found in many sterilants and disinfectants. 
 
Tabletop steam sterilizer: a compact gravity-displacement steam sterilizer that has a chamber volume of 
not more than 2 cubic feet and that generates its own steam when distilled or deionized water is added. 
 
Time-weighted average (TWA): an average of all the concentrations of a chemical to which a worker has 
been exposed during a specific sampling time, reported as an average over the sampling time. For 
example, the permissible exposure limit for ethylene oxide is 1 ppm as an 8-hour TWA. Exposures above 
the ppm limit are permitted if they are compensated for by equal or longer exposures below the limit 
during the 8-hour workday as long as they do not exceed the ceiling limit; short-term exposure limit; or, in 
the case of ethylene oxide, excursion limit of 5 ppm averaged over a 15-minute sampling period. 
 
Tuberculocide: an EPA-classified hospital disinfectant that also kills Mycobacterium tuberculosis 
(tubercle bacilli). EPA has registered approximately 200 tuberculocides. Such agents also are called 
mycobactericides. 
 
Use-life: the length of time a diluted product can remain active and effective. The stability of the chemical 
and the storage conditions (e.g., temperature and presence of air, light, organic matter, or metals) 
determine the use-life of antimicrobial products. 
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Vegetative bacteria: bacteria that are devoid of spores and usually can be readily inactivated by many 
types of germicides. 
 
Virucide: an agent that kills viruses to make them noninfective. 
 
Adapted from Association for the Advancement of Medical Instrumentation; 811-814, 819 Association of 
periOperating Registered Nurses (AORN), 815 American Hospital Association, 319 and Block. 16, 1034 
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Tables and Figure 
Table 1. Methods of sterilization and disinfection 
Sterilization 
• Critical items (will enter tissue or vascular system or blood will flow through them)  
 
Disinfection  
• High-level (semicritical items; [except dental] will come in contact with mucous membrane or nonintact skin) 
• Intermediate-level (some semicritical items1 and noncritical items) 
• Low-level (noncritical items; will come in contact with intact skin) 
 
 Format Change [February 2017]: The format of this section was changed to improve readability and accessibility. 
The content is unchanged. 
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disinfection claim of 5 
minutes at 35°C. 
10 h at 20–
25°C 
Hydrogen peroxide (7.35%) and 
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corrode metal instruments) 
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0.23% peracetic acid; hydrogen 
peroxide 1% and peracetic acid 
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high-level disinfection claim of 5 
minutes at 35°C. 
n/a n/a 
Ethylene oxide gas (see 
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recommendations, generally 
1–6 hours processing time plus 





Ortho-phthalaldehyde (OPA) 0.55% n/a n/a 
Hydrogen peroxide gas plasma 
(see manufacturer’s 
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 ≥1 m) 9 
Heat sterilization, including 
steam or hot air (see 
manufacturer’s 
recommendations, steam 
sterilization processing time 





(>2% glutaraldehyde, caution should 
be exercised with all glutaraldehyde 
formulations when further in-use 
dilution is anticipated); 
glutaraldehyde (1.12%) and 1.93% 
phenol/phenate. One 
glutaraldehyde-based product has a 
high-level disinfection claim of 5 
minutes at 35°C. 
n/a n/a 
Ethylene oxide gas (see 
manufacturer’s 
recommendations, generally 
1–6 hours processing time plus 





Ortho-phthalaldehyde (OPA) 0.55% n/a n/a 
Hydrogen peroxide gas plasma 
(see manufacturer’s 
recommendations for internal 
diameter and length 
restrictions, processing time 




Hydrogen peroxide 7.5% (will 




glutaraldehyde, caution should 
be exercised with all 
glutaraldehyde formulations 
when further in-use dilution is 
anticipated); glutaraldehyde 
(1.12%) and 1.93% 
phenol/phenate. One 
glutaraldehyde-based product 
has a high-level disinfection 
claim of 5 minutes at 35°C. 
10 h at 20–
25°C 
Hydrogen peroxide (7.35%) and 
0.23% peracetic acid; hydrogen 
peroxide 1% and peracetic acid 
0.08% (will corrode metal 
instruments) 
n/a n/a 
Hydrogen peroxide 7.5% (will 
corrode copper, zinc, and 
brass) 
6 h Wet pasteurization at 70°C for 30 
minutes with detergent cleaning 6 
n/a n/a 
Peracetic acid, concentration 
variable but 0.2% or greater is 
sporicidal. Peracetic acid 
immersion system operates at 
50–56°C 
12 m at 50-
56°C 
Hypochlorite, single use chlorine 
generated on-site by electrolyzing 
saline containing >650–675 active 
free chlorine; (will corrode metal 
instruments) 
n/a n/a 
Hydrogen peroxide (7.35%) 
and 0.23% peracetic acid; 
hydrogen peroxide 1% and 
peracetic acid 0.08% (will 
corrode metal instruments) 
3-8 h n/a n/a n/a 
 
Modified from Rutala and Simmons. 15, 17, 18, 421 The selection and use of disinfectants in the healthcare field is dynamic, 
and products may become available that are not in existence when this guideline was written. As newer disinfectants 
become available, persons or committees responsible for selecting disinfectants and sterilization processes should be 
guided by products cleared by the FDA and the EPA as well as information in the scientific literature.  
 
1 See text for discussion of hydrotherapy. 
2 The longer the exposure to a disinfectant, the more likely it is that all microorganisms will be eliminated. Follow the 
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FDA-cleared high-level disinfection claim. Ten-minute exposure is not adequate to disinfect many objects, especially 
those that are difficult to clean because they have narrow channels or other areas that can harbor organic material and 
bacteria. Twenty-minute exposure at 20°C is the minimum time needed to reliably kill M. tuberculosis and 
nontuberculous mycobacteria with a 2% glutaraldehyde. Some high-level disinfectants have a reduced exposure time 
(e.g., ortho-phthalaldehyde at 12 minutes at 20°C) because of their rapid activity against mycobacteria or reduced 
exposure time due to increased mycobactericidal activity at elevated temperature (e.g., 2.5% glutaraldehyde at 5 
minutes at 35°C, 0.55% OPA at 5 min at 25°C in automated endoscope reprocessor).  
3 Tubing must be completely filled for high-level disinfection and liquid chemical sterilization; care must be taken to avoid 
entrapment of air bubbles during immersion. 
4 Material compatibility should be investigated when appropriate. 
5 A concentration of 1000 ppm available chlorine should be considered where cultures or concentrated preparations of 
microorganisms have spilled (5.25% to 6.15% household bleach diluted 1:50 provides > 1000 ppm available chlorine). 
This solution may corrode some surfaces. 
6 Pasteurization (washer-disinfector) of respiratory therapy or anesthesia equipment is a recognized alternative to high-
level disinfection. Some data challenge the efficacy of some pasteurization units. 
7 Thermostability should be investigated when appropriate. 
8 Do not mix rectal and oral thermometers at any stage of handling or processing. 
9 By law, all applicable label instructions on EPA-registered products must be followed. If the user selects exposure 
conditions that differ from those on the EPA-registered products label, the user assumes liability from any injuries 
resulting from off-label use and is potentially subject to enforcement action under FIFRA. 
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Table 2. Properties of an ideal disinfectant 
• Broad spectrum: should have a wide antimicrobial spectrum 
• Fast acting: should produce a rapid kill 
• Not affected by environmental factors: should be active in the presence of organic 
matter (e.g., blood, sputum, feces) and compatible with soaps, detergents, and other 
chemicals encountered in use 
• Nontoxic: should not be harmful to the user or patient 
• Surface compatibility: should not corrode instruments and metallic surfaces and 
should not cause the deterioration of cloth, rubber, plastics, and other materials 
• Residual effect on treated surfaces: should leave an antimicrobial film on the treated 
surface 
• Easy to use with clear label directions 
• Odorless: should have a pleasant odor or no odor to facilitate its routine use 
• Economical: should not be prohibitively high in cost 
• Solubility: should be soluble in water 
• Stability: should be stable in concentrate and use-dilution 
• Cleaner: should have good cleaning properties 
• Environmentally friendly: should not damage the environment on disposal 
Modified from Molinari1035. 
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Table 3. Epidemiologic evidence associated with the use of surface disinfectants 
or detergents on noncritical environmental surfaces 
Justification for Use of Disinfectants for Noncritical Environmental Surfaces 
• Surfaces may contribute to transmission of epidemiologically important microbes (e.g., vancomycin-resistant 
Enterococci, methicillin-resistant S. aureus, viruses) 
• Disinfectants are needed for surfaces contaminated by blood and other potentially infective material 
• Disinfectants are more effective than detergents in reducing microbial load on floors 
• Detergents become contaminated and result in seeding the patient’s environment with bacteria 
• Disinfection of noncritical equipment and surfaces is recommended for patients on isolation precautions by the 
Centers for Disease Control and Prevention. 
• Advantage of using a single product for decontamination of noncritical surfaces, both floors and equipment 
• Some newer disinfectants have persistent antimicrobial activity 
 
Justification for Using a Detergent on Noncritical Environmental Surfaces 
• Noncritical surfaces contribute minimally to endemic healthcare-associated infections 
• No difference in healthcare-associated infection rates when floors are cleaned with detergent versus disinfectant 
• No environmental impact (aquatic or terrestrial) issues with disposal 
• No occupational health exposure issues 
• Lower costs 
• Use of antiseptics/disinfectants selects for antibiotic-resistant bacteria (?) 
• More aesthetically pleasing floor 
Modified from Rutala378. 
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Figure 1. Decreasing order of resistance of microorganisms to disinfection and 
sterilization (with the disinfection levels indicated) 
 
 
 Format Change [February 2017]: The format of this section was changed to improve readability and accessibility. 




Modified from Russell and Favero 13, 344. 
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Table 4. Comparison of the characteristics of selected chemicals used as high-
level disinfectants or chemical Sterilants 
 
 Format Change [February 2017]: The format of this section was changed to improve readability and accessibility. 














30 minutes @ 
20°C 
Not Applicable 20-90 minutes @  
20o-25°C 
12 minutes @ 20°C,  
5 minutes @ 25°C in 
AER 
15 minutes @ 
20°C 
Sterilization Claim 6 hours @ 20°C 12 minutes @  
50-56°C 
10 hours @ 20o-25°C None 3 h @ 20°C 
Activation No No Yes (alkaline glutaraldehyde) No No 
Reuse life (number of 
days a product can be 
reused as determined 
by re-use protocol) 
21 days Single use 14-30 days 14 days 14 days 
Shelf life stability (time 
a product can remain 
in storage (unused)) 
2 years 6 months 2 years 2 years 2 years 
Disposal Restrictions None None Local (no U.S. EPA 
regulations exist but some 
states and local authorities 
have disposal restrictions) 
Local (no U.S. EPA 
regulations exist but 




Materials Compatibility Good Good Excellent Excellent No data 
Monitor MEC of 
solution 
Yes (6%) No Yes (1.5% or higher) Yes (0.3% OPA) No 
Safety Serious eye 
irritant (safety 
glasses) 




Respiratory irritant Eye irritant, stains skin Eye irritant 
Processing Manual or 
automated 
Automated Manual or automated Manual or automated Manual 
Organic material 
resistance 
Yes Yes Yes Yes Yes 
OSHA exposure limit 1 ppm TWA None None (The ceiling limit 
recommended by the 
American Conference of 
Governmental Industrial 
Hygienists is 0.05 ppm.) 
None Hydrogen 
Peroxide - 1 
ppm (time-
weighted 
average for a 
conventional 8-
hour workday.) 
Cost profile (per 
cycle)1 




+ (manual)  
++ (automated) 
++ (manual) ++ (manual) 
Modified from Rutala 69. 
 
Abbreviations and Footnotes:  
OPA  ortho-phthalaldehyde (FDA cleared as a high-level disinfectant, included for comparison to other chemical agents 
used for high-level disinfection) 
AER Automated Endoscope Reprocessor 
MEC  minimum effective concentration is the lowest concentration of active ingredients at which the product is still effective 
1 per cycle cost profile considers cost of the processing solution (suggested list price to healthcare facilities in August 
2001) and assumes maximum use life (e.g., 21 days for hydrogen peroxide, 14 days for glutaraldehyde), 5 
reprocessing cycles per day, 1-gallon basin for manual processing, and 4-gallon tank for automated processing. 
+  least expensive;  
+++++ most expensive 
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Table 5. Summary of advantages and disadvantages of chemical agents used as 
chemical sterilants1 or as high-level disinfectants 




• No activation required  
• Odor or irritation not significant  
• Materials compatibility concerns (lead, 
brass, copper, zinc) both cosmetic 
and functional 
• Limited clinical experience 
• Potential for eye and skin damage 
Glutaraldehyde • Numerous use studies published 
• Relatively inexpensive 
• Excellent materials compatibility 
• Respiratory irritation from 
glutaraldehyde vapor 
• Pungent and irritating odor 
• Relatively slow mycobactericidal 
activity 
• Coagulates blood and fixes tissue to 
surfaces 
• Allergic contact dermatitis 
• Glutaraldehyde vapor monitoring 
recommended 
Hydrogen Peroxide • No activation required 
• May enhance removal of organic matter and organisms 
• No disposal issues 
• No odor or irritation issues 
• Does not coagulate blood or fix tissues to surfaces 
• Inactivates Cryptosporidium 
• Use studies published 
• Material compatibility concerns (brass, 
zinc, copper, and nickel/silver plating) 
both cosmetic and functional  
• Serious eye damage with contact 
Ortho-
phthalaldehyde 
• Fast acting high-level disinfectant 
• No activation required 
• Odor not significant 
• Excellent materials compatibility claimed 
• Does not coagulate blood or fix tissues to surfaces 
claimed 
• Stains skin, mucous membranes, 
clothing, and environmental surfaces 
• Repeated exposure may result in 
hypersensitivity in some patients with 
bladder cancer  
• More expensive than glutaraldehyde 
• Eye irritation with contact 
• Slow sporicidal activity 
Peracetic Acid • Rapid sterilization cycle time (30-45 minutes) 
• Low temperature (50-55°C) liquid immersion sterilization 
• Environmental friendly by-products (acetic acid, O2, H20) 
• Fully automated  
• Single-use system eliminates need for concentration 
testing 
• Standardized cycle 
• May enhance removal of organic material and endotoxin 
• No adverse health effects to operators under normal 
operating conditions 
• Compatible with many materials and instruments 
• Does not coagulate blood or fix tissues to surfaces 
• Sterilant flows through scope facilitating salt, protein, 
and microbe removal 
• Rapidly sporicidal 
• Provides procedure standardization (constant dilution, 
perfusion of channel, temperatures, exposure) 
• Potential material incompatibility (e.g., 
aluminum anodized coating becomes 
dull) 
• Used for immersible instruments only 
• Biological indicator may not be 
suitable for routine monitoring 
• One scope or a small number of 
instruments can be processed in a 
cycle 
• More expensive (endoscope repairs, 
operating costs, purchase costs) than 
high-level disinfection 
• Serious eye and skin damage 
(concentrated solution) with contact 
• Point-of-use system, no sterile 
storage 
Modified from Rutala69. 
 
1All products effective in presence of organic soil, relatively easy to use, and have a broad spectrum of antimicrobial 
activity (bacteria, fungi, viruses, bacterial spores, and mycobacteria). The above characteristics are documented in the 
literature; contact the manufacturer of the instrument and sterilant for additional information. All products listed above are 
FDA-cleared as chemical sterilants except OPA, which is an FDA-cleared high-level disinfectant.
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Table 6. Summary of advantages and disadvantages of commonly used 
sterilization technologies 
Sterilization Method Advantages Disadvantages 
Steam • Nontoxic to patient, staff, environment 
• Cycle easy to control and monitor 
• Rapidly microbicidal 
• Least affected by organic/inorganic 
soils among sterilization processes 
listed 
• Rapid cycle time 
• Penetrates medical packing, device 
lumens 
• Deleterious for heat-sensitive instruments 
• Microsurgical instruments damaged by repeated 
exposure 
• May leave instruments wet, causing them to rust 
• Caution: Potential for burns 
Hydrogen Peroxide Gas 
Plasma 
• Safe for the environment  
• Leaves no toxic residuals  
• Cycle time is 28-75 minutes (varies 
with model type) and no aeration 
necessary 
• Used for heat- and moisture-sensitive 
items since process temperature 
<50°C  
• Simple to operate, install (208 V 
outlet), and monitor 
• Compatible with most medical 
devices 
• Only requires electrical outlet 
• Cellulose (paper), linens and liquids cannot be processed 
• Sterilization chamber size from 1.8-9.4 ft3 total volume 
(varies with model type) 
• Some endoscopes or medical devices with long or 
narrow lumens cannot be processed at this time in the 
United States (see manufacturer’s recommendations for 
internal diameter and length restrictions)  
• Requires synthetic packaging (polypropylene wraps, 
polyolefin pouches) and special container tray 
• Caution: Hydrogen peroxide may be toxic at levels 
greater than 1 ppmTWA 
100% Ethylene Oxide 
(ETO) 
• Penetrates packaging materials, 
device lumens 
• Single-dose cartridge and negative- 
pressure chamber minimizes the 
potential for gas leak and ETO 
exposure 
• Simple to operate and monitor 
• Compatible with most medical 
materials 
• Requires aeration time to remove ETO residue 
• Sterilization chamber size from 4.0-7.9 ft3 total volume 
(varies with model type) 
• ETO emission regulated by states but catalytic cell 
removes 99.9% of ETO and converts it to CO2 and H2O 
• ETO cartridges should be stored in flammable liquid 
storage cabinet 
• Lengthy cycle/aeration time 





10% ETO/90% HCFC 
8.5% ETO/91.5% CO2 
• Penetrates medical packaging and 
many plastics 
• Compatible with most medical 
materials 
• Cycle easy to control and monitor 
• Some states (e.g., CA, NY, MI) require ETO emission 
reduction of 90-99.9% 
• Chlorofluorocarbon (CFC) (inert gas that eliminates 
explosion hazard) banned in 1995 
• Potential hazards to staff and patients 
• Lengthy cycle/aeration time 
• Caution: ETO is toxic, a carcinogen, and flammable 
Peracetic Acid • Rapid cycle time (30-45 minutes) 
• Low temperature (50-55°C) liquid 
immersion sterilization 
• Environmental friendly by-products 
• Sterilant flows through endoscope 
which facilitates salt, protein and 
microbe removal 
• Point-of-use system, no sterile storage 
• Biological indicator may not be suitable for routine 
monitoring 
• Used for immersible instruments only 
• Some material incompatibility (e.g., aluminum anodized 
coating becomes dull) 
• One scope or a small number of instruments processed 
in a cycle 
• Caution: Potential for serious eye and skin damage 
(concentrated solution) with contact 
Modified from Rutala. 825 
Abbreviations:  
HCFC=hydrochlorofluorocarbon.
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Table 7. Minimum cycle times for steam sterilization cycles 
Type of Sterilizer Item 
Exposure time at 
250°F (121°C) 
Exposure time at 
270°F (132°C) Drying time 
Gravity displacement Wrapped instruments 30 min 15 min 15-30 min 
Gravity displacement Textile packs 30 min 25 min 15 min 
Gravity displacement Wrapped utensils 30 min 15 min 15-30 min 
Dynamic-air-removal 
(e.g., prevacuum) 
Wrapped instruments Not Applicable 4 min 20-30 min 
Dynamic-air-removal 
(e.g., prevacuum) 
Textile packs Not Applicable 4 min 5-20 min 
Dynamic-air-removal 
(e.g., prevacuum) 
Wrapped utensils Not Applicable  4 min 20 min 
Modified from Association for the Advancement of Medical Instrumentation. 813, 819  
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Table 8. Examples of flash steam sterilization parameters 
Type of Sterilizer Load configuration Temperature Time 
Gravity displacement Nonporous items only (i.e., routine metal 
instruments, no lumens) 
132°C (270°F) 3 minutes 
Gravity displacement Nonporous and porous items (e.g., rubber 
or plastic items, items with lumens) 
sterilized together 
132°C (270°F) 10 minutes 
Dynamic-air-removal (e.g., 
prevacuum) 
Nonporous items only (i.e., routine metal 
instruments, no lumens) 
132°C (270°F) 3 minutes 
Dynamic-air-removal (e.g., 
prevacuum) 
Nonporous and porous items (e.g., rubber 
or plastic items, items with lumens) 
sterilized together 
132°C (270°F) 4 minutes 






Modified from Association for the Advancement of Medical Instrumentation. 812, 819 
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Table 9. Characteristics of an ideal low-temperature sterilization process 
• High efficacy: the agent should be virucidal, bactericidal, tuberculocidal, fungicidal and sporicidal 
• Rapid activity: ability to quickly achieve sterilization 
• Strong penetrability: ability to penetrate common medical-device packaging materials and penetrate into the interior 
of device lumens 
• Material compatibility: produces only negligible changes in the appearance or the function of processed items and 
packaging materials even after repeated cycling 
• Nontoxic: presents no toxic health risk to the operator or the patient and poses no hazard to the environment 
• Organic material resistance: withstands reasonable organic material challenge without loss of efficacy 
• Adaptability: suitable for large or small (point of use) installations 
• Monitoring capability: monitored easily and accurately with physical, chemical, and biological process monitors 
• Cost effectiveness: reasonable cost for installation and for routine operation  
Modified from Schneider. 851 
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Table 10. Factors affecting the efficacy of sterilization 
Factors Effect 
Cleaning1 Failure to adequately clean instrument results in higher bioburden, protein load, and salt 
concentration. These will decrease sterilization efficacy. 
Bioburden1 The natural bioburden of used surgical devices is 100 to 103 organisms (primarily vegetative 
bacteria), which is substantially below the 105-106 spores used with biological indicators.  
Pathogen type Spore-forming organisms are most resistant to sterilization and are the test organisms 
required for FDA clearance. However, the contaminating microflora on used surgical 
instruments consists mainly of vegetative bacteria. 
Protein1 Residual protein decreases efficacy of sterilization. However, cleaning appears to rapidly 
remove protein load.  
Salt1 Residual salt decreases efficacy of sterilization more than does protein load. However, 
cleaning appears to rapidly remove salt load.  
Biofilm accumulation1 Biofilm accumulation reduces efficacy of sterilization by impairing exposure of the sterilant 
to the microbial cell.  
Lumen length Increasing lumen length impairs sterilant penetration. May require forced flow through 
lumen to achieve sterilization. 
Lumen diameter Decreasing lumen diameter impairs sterilant penetration. May require forced flow through 
lumen to achieve sterilization. 
Restricted flow Sterilant must come into contact with microorganisms. Device designs that prevent or 
inhibit this contact (e.g., sharp bends, blind lumens) will decrease sterilization efficacy. 
Device design and 
construction 
Materials used in construction may affect compatibility with different sterilization processes 
and affect sterilization efficacy. Design issues (e.g., screws, hinges) will also affect 
sterilization efficacy. 
 Modified from Alfa and Rutala. 470, 825   
1 Factor only relevant for reused surgical/medical devices 
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Table 11. Comparative evaluation of the microbicidal activity of low-temperature 



















No salt or serum1 100% 100% 96% 100% No Data No Data Alfa 721 
10% serum and 0.65% 
salt2 
97% 60% 95% 37% No Data No Data Alfa 721 
Lumen (125 cm long × 3 
mm wide) without serum 
or salt1 
No Data 96% 96% No Data No Data No Data Alfa 721 
Lumen (125 cm long × 3 
mm wide) with 10% 
serum and 0.65% salt2 
44% 40% 49% 35% No Data 100%1 Alfa 721 
Lumen (40 cm long × 3 
mm wide)3 
No Data No Data 100% 95% 100% 8% Rutala 856 
Lumen (40 cm long × 2 
mm wide)3 
No Data No Data 100% 93% 100% No Data Rutala 856 
Lumen (40 cm long × 1 
mm wide)3 
No Data No Data 100% 26% 100% No Data Rutala 856 
Lumen (40 cm long × 3 
mm wide)4 
No Data No Data 100% 100% 100% No Data Rutala 856 
Modified from Rutala. 825 
 
HCFC=hydrochlorofluorocarbon 
1 Test organisms included Enterococcus faecalis, Mycobacterium chelonae, and Bacillus atrophaeus spores. 
2 Test organisms included E. faecalis, P. aeruginosa, E. coli, M. chelonae, B. atrophaeus spores, G. stearothermophilus 
spores, and B. circulans spores. 
3 Test organism was G. stearothermophilus spores . The lumen test units had a removable 5 cm center piece (1.2 cm 
diameter) of stainless steel sealed to the narrower steel tubing by hard rubber septums. 
4 Test organism was G. stearothermophilus spores. The lumen test unit was a straight stainless steel tube. 
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Table 12. Suggested protocol for management of positive biological indicator in 
a steam sterilizer 
 
 Format Change [February 2017]: The format of this section was changed to improve readability and accessibility. 
The content is unchanged. 
 
1. Take the sterilizer out of service. Notify area supervisor and infection control department. 
2. Objects, other than implantable objects, do not need to be recalled because of a single positive spore test unless the 
sterilizer or the sterilization procedure is defective. As soon as possible, repeat biological indicator test in three 
consecutive sterilizer cycles. If additional spore tests remain positive, the items should be considered nonsterile, and 
supplies processed since the last acceptable (negative) biological indicator should be recalled. The items from the 
suspect load(s) should be recalled and reprocessed.  
3. Check to ensure the sterilizer was used correctly (e.g., verify correct time and temperature setting). If not, repeat 
using appropriate settings and recall and reprocess all inadequately processed items. 
4. Check with hospital maintenance for irregularities (e.g., electrical) or changes in the hospital steam supply (i.e., from 
standard ≥97% steam, <3% moisture). Any abnormalities should be reported to the person who performs sterilizer 
maintenance (e.g., medical engineering, sterilizer manufacturer).  
5. Check to ensure the correct biological indicator was used and appropriately interpreted. If not, repeat using 
appropriate settings. 
6. If steps 1 through 5 resolve the problem 
If all three repeat biological indicators from three consecutive sterilizer cycles (step 2 above) are negative, put the 
sterilizer back in service. 
7. If one or both biological indicators are positive, do one or more of the following until problem is resolved. 
A. Request an inspection of the equipment by sterilizer maintenance personnel. 
B. Have hospital maintenance inspect the steam supply lines. 
C. Discuss the abnormalities with the sterilizer manufacturer. 
D. Repeat the biological indicator using a different manufacturer’s indicator. 
 
If step 7 does not resolve the problem 
Close sterilizer down until the manufacturer can assure that it is operating properly. Retest at that time with biological 
indicators in three consecutive sterilizer cycles. 
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